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Lymphedema 
Lymphedema is a multi-causal chronic condition that can lead to symptoms and 
complaints that can be described in terms of impairments of functions and 
structures, limitations in activities, and participation restrictions and that often 
result in distress and loss of quality of life (1). Lymphedema presents clinically as 
swelling that is due to an imbalance between interstitial filtration, fluid and 
protein discharge caused by compromised lymphatic system transport capacity 
(2). This impairment can be relative or absolute. In the former, hyper filtration 
causes fluid overflow in the tissue despite maximal or normal lymphatic function 
(high output lymphedema) (2). With regard to absolute impairment, which is 
more common, lymphatic vessel transport capacity is decreased due to 
insufficient physical activity, a genetic predisposition, or lymphatic vessel 
obstruction or absence (low output lymphedema) (2). Lymphedema can also be 
subdivided into primary and secondary lymphedema (figure 1).  
- 11 -
  Figure 1. Subdivision of lymphedema.  * primary lymphedema can vary among praecox and  
 tarda forms. 
 
Primary lymphedema 
Primary lymphedema, a congenital and sometimes hereditary disease, may be 
present at birth; however, most cases of primary lymphedema manifest 
themselves during puberty and even later (lymphedema tarda). Different types of 
gene mutations lead to lymph vessels and/or nodes with an abnormal structure 
and/or function. The final result of an abnormal or even absent system is a serious 
disturbance in the clearance of interstitial fluid. This condition is most commonly 
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observed in the legs but can occur throughout the entire body. Genital region 
involvement needs special attention when intestinal lymphatic impairment is 
present. Connell et al. (3) proposed a flowchart presenting a subdivision of 
primary lymphedema based on the clinical diagnosis (phenotype). This subdivision 
results from the following decision points (yes or no) (3):  
1.  syndromic 
2.  systematic/visceral involvement pre- or postnatal onset 
3.  disturbed growth / cutaneous manifestations / vascular anomalies with 
lymphedema 
4.  distichiasis present (a genetic multisystem disorder characterized by the 
development of extra eyelashes and swelling of the legs because of fluid 
accumulation) 
5.  congenital (onset less than a year after birth) . 
In the last decade, genetic mapping has changed the primary diagnostic tool from 
a phenotypic diagnosis into a diagnosis that is based on the underlying genetic 
disturbance (genotype). All genetic diseases are classified according the OMIM 
(Online Mendelian Inheritance in Man) database (3). This database counts 79 
different genotypes of lymphedema. For some examples, see table 1. 
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Table 1. Well-known examples of genetic classification of primary lymphedema (from: OMIM 
database www.OMIM.org (3)). 
 
 
Name Gene OMIM code 
Lymphedema-
distichiasis syndrome 
FOXC2 602402 
Milroy disease FLT4 136352 
MLCRD syndrome KIF11 148760 
Lymphedema late-onset FLT4 136352 
Hennekam 
lymphangiectasia 
syndrome 
CCBE1 612753 
Hereditary primary 
lymphedema 
GJC2 608803 
Emberger syndrome GATA2 137295 
Vascular endothelial 
growth factor-related 
protein lymphedema 
VEGFC 615907 
 
Secondary lymphedema 
Secondary lymphedema is much more common and is the result of an overload of 
interstitial fluid due to an increase of capillary filtration (as in chronic venous 
insufficiency) or a blockage/interruption of one or more major lymph vessels (e.g., 
after trauma, surgery, infection or radiotherapy). In the case of overload, dermal 
backflow (re-entry of more proximal lymph fluid into the skin) leads to 
lymphedema. In the case of a lymph blockage, stasis due to diminished or blocked 
lymph transport is the result. In cases of overload, secondary lymphedema is 
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classified as high output lymphedema (4). Infections can be present due to a 
completely different etiology, which can be bacterial, viral, fungal, or parasitic. 
Erysipelas, an obligate streptococcal skin infection, is often thought to be an end 
result of lymphedema. However, this appears to be incorrect: subclinical 
(congenital) lymphedema is more prone to streptococcal infections than normal 
skin. For this reason, erysipelas is usually the first clinical sign of lymphedema (5). 
In the tropical, underdeveloped world, lymphedema mainly occurs as the result of 
an infection. As for parasitic infections, according to a WHO report, approximately 
120 million people in 72 countries were infected with a parasite (lymphatic 
filariasis) in 2010 (6). Of these infected individuals, 15 million people suffered 
from consequent manifestations of lymphedema (filarial elephantiasis), which 
were a serious burden (6). Podoconiosis is an endemic non-parasitic and non-
infectious form of elephantiasis due to long-term barefoot exposure to irritant 
volcanic soils in tropical Africa, leading to serious problems in that part of the 
world (7). 
 
Localization of lymphedema 
Lymphedema may occur anywhere in the body, but it mostly occurs in the upper 
and lower limbs and the midline (head, neck, thorax and genital region). 
Abdominal lymphedema is very rare.  
Lymphedema in an upper limb occurs most often as a result of breast cancer 
treatment because of the resection of axillary lymph nodes and/or radiation 
therapy. In the lower limbs, lymphedema originates both secondary to cancer 
treatment and primarily as a genetic predisposition. 
Midline lymphedema located in the head/neck-region is also almost exclusively 
due to cancer treatment in that region, although some non-oncological types 
exist: solid facial edema, Ascher’s syndrome, M. Morbihan, and Melkersson-
Rosenthal syndrome are well-known examples (8). Lymphedema in the genital 
region often results from the oncological treatment of the internal or external 
genital organs, from lymphatic injury in the pelvic region, or as part of M. Milroy 
(Table 1).  
Genital lymph drainage is bidirectional: one route flows directly to the superficial 
regions of the groin and the other flows through the pelvic region. If one of the 
routes is spared, it can serve as an alternative pathway. Abdominal lymphedema 
occurs most frequently because of an obstruction of the lymph vessels caused by 
cancer processes. 
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Incidence and prevalence of lymphedema 
Unfortunately, the incidence and prevalence of lymphedema are not precisely 
known because it is not a well-registered disease worldwide and because 
epidemiological studies have been scarce. Its prevalence worldwide is estimated 
to be approximately 140-250 million people (4). In the Netherlands, information 
about the incidence of lymphedema is hard to find because of the great variance 
in studies, symptoms, methods of lymphedema diagnosis, and lack of sufficient 
registration of lymphedema patients because patients are predominantly 
classified in hospital registration systems according to the ‘primary’ disease, such 
as cancer. Moreover, in most patients lymphedema develops after hospital 
discharge. Sound epidemiological data are always mandatory when organizing 
health care programs. For a serious problem, such as lymphedema, a registration 
system is needed. The consensus document of the International Society for 
Lymphedema (ISL) (9) and the best practice document of the International 
Lymphedema Framework (ILF) (10) give guidelines to solve this problem. 
However, in many countries there have been no governmental programs or 
supportive actions by health insurance companies to develop a registration 
system according to these guidelines.  
 
Symptoms of lymphedema 
Lymphedema is a slowly progressive disease, often suddenly inflicted by a (minor) 
trauma. Early in the disease process, the lymphedema is pitting, although it is a 
protein rich edema, and the affected skin feels soft (see figure 2). 
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 Figure 2. Example of pitting lymphedema in the foot. 
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 Figure 4. Example of lymphedema in the upper extremity. (all photos published with permission of
 the patients).
 
In later stages, the skin may feel hard and thickened as a result of chronic 
inflammation, leading to fibrosis of the dermis and subcutis as well as of the 
adipose tissue in the swollen area (see figures 2 and 3). In this stage the edema is 
non-pitting and irreversible. In severe long-lasting lymphedema, secondary skin 
changes are visible, such as papillomatosis and verrucosis (see figure 4). If 
untreated, lymphedema leads to further deterioration, a high risk of infection 
(especially erysipelas), swelling, and feelings of heaviness and tightness. In 
addition, patients report that jewelry and clothing feel uncomfortable or tight on 
the affected body parts (11-13). Moreover, other impairments occur, such as 
decreased limb mobility, and, as a consequence, limitations in walking and 
personal care and restrictions in domestic life, occupation, and socialization (7). 
Altered body shape (an impairment in structure), often leading to stigmatization 
as well as the need to use garments or bandaging daily, makes acceptance difficult 
for the patient as well as his/her family (14). Untreated lymphedema can lead to 
significant loss of health-related quality of life and even social isolation (14). Thus, 
lymphedema is a serious disease that needs the full attention of the medical 
world. The prognosis for the patient is best when appropriate care is provided 
starting from the first signs (15). However, the author has commonly found that 
the vast majority of lymphedema patients receive the care they need too late. As 
lymphedema is not curable, lifetime treatment is mandatory. For optimal lifetime 
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care, good motivation of the patient, and the commitment of specialized health 
care professionals are the keys to success.  
 
Treatment  
The treatment of lymphedema is very challenging. Therapy is roughly divided into 
two major steps: 1. the initial phase and 2. the maintenance phase. The 
therapeutic options for lymphedema include conservative and surgical modalities 
and should be fine-tuned to the patient’s personal circumstances, including work 
and home environments as well as personal factors, such as age, co-morbidities, 
(malignant) disease prognosis, psychosocial aspects, and physical potential (10). 
The goal of conservative treatment in the initial treatment phase is to eliminate 
ĞĚĞŵĂ ďǇ ƌĞĚƵĐŝŶŐ ŝŶƚĞƌƐƚŝƚŝĂů ŇƵŝĚ ƉƌŽĚƵĐƚŝŽŶ ĂŶĚ ƐƚŝŵƵůĂƚŝŶŐ ůǇŵƉŚĂƚŝĐ
propulsion by compression therapy (16). In addition, lymph flow is stimulated by 
manual lymph drainage (MLD) (16). Exercises aimed at improving mobility and 
physical strength and reconditioning are important to stimulate natural lymph 
drainage from the tissues (16). Pursuit of a normal body mass index (BMI) and 
weight control are essential components of lymphedema treatment (17). To 
minimize the risk of infection, the maintenance of skin integrity and special skin 
care are mandatory (18). Decongestive lymphatic therapy and a combination of 
various evidence-based conservative interventions are used to reduce the edema 
as much as possible and to obtain a shape as normal as possible. In conclusion, in 
the initial phase, the treatment consists of edema reduction, prevention of 
infection and maintaining a lifestyle to cope with the results of the lymphedema. 
Once the maximal initial therapeutic result is achieved, the maintenance phase 
begins. This phase - starting when there is no more pitting edema and maximal 
edema reduction is reached - depends mainly on patient self-management, 
including strict compliance in wearing compression garments (bandages, wraps 
and/or hosiery) and an adapted lifestyle (16). These aspects are essential to 
preserve the treatment results of the initial phase and to accommodate long-term 
management. In severe lymphedema with concurrent lipedema, circumferential 
suction-assisted lipectomy can be applied to alleviate irreversible alterations, such 
as adipose tissue formation and fibrosis (19).  
In 2012, the ILF published a ‘best practice document’ for the management of 
lymphedema (10). It proposes a comprehensive lymphedema service based on the 
chronic care model and use of the International Classification of Functioning, 
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Disability and Health (ICF) as a vehicle for determining and delivering care fine-
tuned to the patient’s needs (10). 
For an in-depth understanding of optimal lymphedema management and an 
objective follow-up, the use of reliable and valid assessment instruments and 
systematic consideration of the ILF recommendations are needed. To gather data 
for monitoring individual progress, the ICF can be of great value. 
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Figure 5. Schedule of lymphedema treatment. Blue sections represent classifications; red sections 
represent treatments. 
Diagnosis of lymphedema 
Primary lymphedema Secondary lymphedema 
Non-infectious Infectious 
Treat infection 
Pitting Non-pitting 
CT/MLD 
Maximal reduction 
Maintenance phase Lymphosuction 
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International Classification of Functioning, Disability 
and Health (ICF) 
 
The ICF provides a comprehensive framework of human functioning (see figure 6) 
as well as a classification system (20). The ICF offers a universal language that is 
understood by health professionals, researchers, policy makers, patients, and 
patient organizations.  
 
 
Figure 6. ICF-scheme. 
 
The ICF consists of two separate parts. Part 1 addresses functioning and is 
composed of three components: ‘Body Functions’, ‘Body Structures’, and 
‘Activities and Participation’. Part 2 addresses contextual factors and is composed 
of two components: ‘Environmental Factors’ and ‘Personal Factors’. However, 
‘Personal Factors’ are not elaborated as a classification in the current ICF because 
of significant social and cultural variations (21).  
Each ICF category is assigned an alphanumerical code consisting of a letter and 
one or more numbers. The letter refers to the classification component (b: Body 
Functions, s: Body Structures, d: (domains of) Activities and Participation, and e: 
Environmental Factors). Each letter is followed by one or more numbers, starting 
with the first level (chapter) (one digit), followed by second-level specifications 
(three digits) and the third- and fourth-level specifications (four and five digits), 
      disease / disorder / trauma 
body functions & 
structures 
(impairments) 
activities 
(limitations) 
participation 
(restrictions) 
personal factors 
(positive & negative) 
environmental factors 
(positive & negative) 
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where applicable. In registration systems, ICF Qualifiers are to be added to 
indicate the severity of the indicated features in the individual patient. 
Although its classifications with more than 1400 categories can serve as a 
reference, the ICF is not easily applicable in daily clinical practice. For this reason, 
tools, such as ICF Core Sets (20) (ICF selections applied to a specific diagnostic 
group), have been developed to make the ICF more useful for health care 
providers (22). The selected items are investigator-independent (established for 
universal application) and generic for all patients with a certain health condition. 
The ICF Core Sets facilitate the description of the functioning of patients and the 
formulation of treatment goals. Description uniformity is needed to compare data 
for evaluations of treatment efficacy and to collect data for research. The ICF Core 
Sets may be used as a guide for clinical reasoning and to record the results of 
clinical reasoning in electronic patient files. They can help the health care provider 
in the objective follow-up of their patients if valid and reliable measurement 
instruments are being used. 
Two types of Core Sets exist, brief Core Sets and comprehensive ones. The brief 
ICF Core Set is used as a quick scan of the patient’s functioning in a clinical study 
or clinical situation (mono-disciplinary); the comprehensive ICF Core Set guides 
multidisciplinary assessments (20). Both sets include a selection of ICF categories; 
as few categories as possible are included for practical purposes, but as many 
categories as needed to describe the typical spectrum of functional problems in 
clinical studies, clinical encounters, multidisciplinary assessments, and treatment 
evaluations. Core Sets can be used by health care providers, researchers, health 
insurance companies, and policy-makers. Today, ICF Core Sets have been 
developed for various burdensome chronic conditions, such as cerebral stroke, 
multiple sclerosis and breast cancer (23-25). Core Sets have also been developed 
for acute hospital and early post-acute rehabilitation facilities (26-28). They have 
been proven to be of great value in daily practice (26-28). Because lymphedema is 
a serious, chronic and worldwide problem in health care, specific Core Sets for 
lymphedema could help to describe and record the total scope of the problems in 
functioning of these patients worldwide. To date, these Core Sets have not yet 
been developed. 
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The value of ICF Core Sets for lymphedema  
 
The value of ICF Core Sets for lymphedema expresses itself in various ways: 
1. ICF Core Sets can act as a guideline for the choice of relevant outcomes 
from different perspectives.  
The most dramatic symptom of lymphedema is swelling of the affected 
body part. In terms of the ICF, this is an impairment of the lymphatic 
function, belonging to the component Body Functions, and results in an 
anatomical change of the body part (second qualifier, code 7: ‘qualitative 
change in structure, including accumulation of fluid’), belonging to the 
component Body Structures (21). For the greater part, studies in 
lymphedema have used volume as an outcome measure. Using the ICF, 
which is a bio-psycho-social conceptual framework, it is apparent that 
there are also other components that are important, such as activities and 
participation and that functioning of the patient is influenced by 
contextual factors (environmental and personal factors). Tsauo et al. (29) 
used the ICF in a study about breast cancer-related lymphedema, and 
their findings indicate that according to the patients themselves, their 
major problems were limitations in activities and participation 
restrictions. In their studies about health related quality of life in 
lymphedema patients, DeVoogdt et al. also distinguished a number of 
additional items as being important for these patients other than swelling 
alone, such as mental functions, household activities   and social activities 
(30, 31).  
2. ICF Core Sets can facilitate the choice of measurement instruments.  
It must be clear which items, in ICF terms, measurement instruments 
contain. To analyze this, measurement instruments can be linked to the 
ICF with a standard procedure and linking rules (32, 33). The results of the 
linking process can subsequently be compared with the ICF Core Sets, 
creating an image of the extent to which a measurement instrument 
covers one or more items from the ICF Core Sets. Given this information, 
the researcher or clinician can decide whether he will use the instrument 
or not. In conclusion, the patient information registered using the ICF 
Core Sets can help to decide what to measure. This concerns not only 
their use for scientific research but also the choice of outcomes and 
corresponding measurement instruments in clinical practice.  
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In the latest version of the Dutch multidisciplinary guideline for 
lymphedema, the Core Sets are frequently mentioned (15), but only as 
being ‘under construction’. When ICF Core Sets for lymphedema are 
developed and adopted by the field they can be implemented in the 
guideline.  
4. ICF Core Sets for lymphedema can bring structure to the data to be 
recorded and facilitate their incorporation into the files.  
As a result of advancing informatics in health care, electronic patient files 
are used more often and data are recorded in a comprehensive way. 
However, the description of the functioning of lymphedema patients is 
not possible with the existing files. 
5. ICF Core Sets can help to describe the severity of the disability for 
lymphedema patients. 
       For each ICF-category of the Core Sets, so called qualifiers can be 
assigned. One of these qualifiers denotes the severity of the problems. A 
study by Uhlig et al. (34) examining the responsiveness of the ICF Core Set 
for rheumatoid arthritis using this qualifier demonstrated moderate 
responsiveness in the real-life setting of patients where minor changes 
occurred during treatment with a specific medication. 
6. ICF Core Sets can be used to generate lymphedema-specific data.  
As already indicated, data on the incidence and prevalence of 
lymphedema are scarce (4, 15). ICF Core Sets for lymphedema could help 
to generate more information about this health condition, not only about 
the occurrence of the specific components of the ICF but also about the 
impact of the disease on daily life.  
7. Both ICF Core Sets and the ICF scheme can be helpful for patient education 
and for enhancing self-management.  
With the ICF scheme and the ICF Core Sets, it is possible to give the 
patient more insight into his/her functioning and into the factors 
influencing this functioning. Therefore, the ICF can be used in patient 
education and in teaching self-management strategies. The formulation of 
treatment goals by the patients themselves can be facilitated with the ICF 
Core Sets, as they provide an overview of the relevant items. In a study 
about geriatric rehabilitation, the association between goal attainment 
and improved overall functioning underlined the necessity of considering 
the patient’s perspective in the rehabilitation process (35).  
       
              
3. The ICF Core Sets can be used as a framework for guidelines.  
- 25 -
As it is a universal language, the ICF and the ICF Core Sets can not only be 
applied in the conversation with the patient but also in consultation 
settings of different health professionals. The Comprehensive Core Sets 
lend themselves to these multidisciplinary settings, whereas the Brief 
Core Sets can be applied in one on one situations (20, 22). A study by 
Huber et al. showed that the ICF Core Sets can be used to record precise 
information on patients’ functioning in a multidisciplinary setting. Typical 
impairments, limitations and restrictions, intervention goals and methods 
of functioning could be documented (36). Finally, broad information 
about lymphedema can be collected worldwide and compared by using 
the universal framework of the ICF and ICF Core Sets. 
 
 
Aim of the thesis 
 
For the above mentioned reasons, the introduction of specific ICF Core Sets could 
significantly and positively impact care for lymphedema patients. As seen 
previously, lymphedema presents roughly in a consistent manner, but may have 
different causes. ICF Core Sets will cover the whole spectrum of this health 
condition. The purpose of this thesis is to develop ICF Core Sets for lymphedema. 
Because lymphedema can present in different regions of the human body, we 
decided to construct three separate ICF Core Sets: for the upper limb, lower limb, 
and midline lymphedema. This process will result in six Core Sets, as both a Brief 
and a Comprehensive Core Set will be developed for each region. To achieve this 
goal, we followed the method of Stucki and Cieza, who constructed a standard 
method for this development process (20) (figure 7). This method consists of a 
preparatory phase with several studies, phase 1, in which the first versions of the 
Core Sets are concluded, and phase 2, in which the versions are validated and 
implemented. 
 
 
 
 
8.    ICF Core Sets for lymphedema can facilitate the multidisciplinary 
cooperation. 
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Figure 7. Development of the ICF Core Sets for lymphedema: phases of the project (from: Stucki et 
al., 2002 (20)). 
 
 
Contents  
 
In Chapter 2, a position paper is presented about the project in which the 
procedure is discussed.  
The following research questions were asked: 
1.  What are the areas of functioning, disability and health reported in peer 
reviewed studies on patients with lymphedema?  
2.  Which concepts of the ICF can be linked to the ULL27, a French health-related 
quality of life questionnaire for upper limb lymphedema? 
3.  What are the most common problems of patients with lymphedema from the 
clinician’s perspective using the ICF? 
4. What is the perspective of patients on their functioning and health and which 
concepts of functioning and health are important to these patients using the 
ICF? 
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5.  What is the perspective of experts in the field of lymphedema on the 
functioning and health of patients with lymphedema and which concepts of 
functioning and health are important using the ICF? 
6. What is the content of ICF Core Sets for lymphedema, taking into account the 
researcher’s, patient’s and professional’s perspective? 
 
To answer these questions the procedure starts with four preparatory studies: a 
literature review (Chapter 3 and 4), a qualitative study with lymphedema patients 
(Chapter 5), a cross-sectional clinical study (Chapter 6), and an international e-
mail-based survey of lymphedema experts (Chapter 7). The findings of these 
preparatory studies were presented at an international consensus conference 
(phase I), which led to the first versions of the ICF Core Sets for lymphedema 
(Chapter 8).  
In Chapter 9, the results of a translation and validation study of the ULL27 are 
presented. Following the linking rules of Cieza et al. (32, 33), this questionnaire - 
included in the literature study (Chapter 3) - is linked to the ICF and is used as an 
example of the use of the ICF Core Sets in the General Discussion.  
In the General Discussion (Chapter 10), we critically review our research methods 
and our results, and we have given recommendations for the use of the ICF Core 
Sets for lymphedema in practice and for further research, including validation 
(phase II). 
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Abstract 
Background: The description and testing of the different levels of human 
functioning is essential prior to beginning the treatment of patients with 
lymphedema.  
Aims: The International Classification of Functioning, Disability and Health (ICF) 
offers an international framework for the classification of health and health-
related domains. ICF Core Sets are lists of selected ICF categories concerning the 
important aspects of functioning that are most likely to be affected by a specific 
disease. These Core Sets make it easier and faster to describe the patient’s 
problems and to define treatment goals. Furthermore, they are available to 
healthcare providers of all professions, researchers, health insurance companies 
and policymakers. The objective of this document is to outline the development 
process for ICF Core Sets for lymphedema.  
Methods: The ICF Core Sets for lymphedema will be defined at a consensus 
conference, on the basis of data derived from the following preparatory studies: 
a) a systematic review b) a qualitative study c) an expert survey and d) a cross-
sectional study.  
Results: Not available at the time of writing.  
Conclusions: The ICF Core Sets for lymphedema are being designed with the aim 
of providing a useful standard for both research and clinical practice.  
Declaration of interest: None. 
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Introduction 
 
The course of lymphoedema is unpredictable and varies among patients. Various 
types of impairments, activity limitations and restrictions in physical and 
psychosocial participation can have important consequences for each individual 
patient with lymphoedema, influencing the treatment  programme. Describing  
and testing the different levels of human functioning is essential prior to 
embarking on the treatment of patients with lymphoedema, enabling treatment 
goals to be defined and adapted to the functioning of each individual patient. To 
achieve this goal, a framework and classification system is needed, which can 
serve as an objective, universal yet standardised language understood by health 
professionals, researchers, policymakers, patients, and patient organisations. The 
International Classification of Functioning, Disability and Health (ICF), approved by 
the World Health Assembly, offers standard terms and schemes for classifying and 
describing functioning, disability and health in people with lymphoedema. The 
International Society for Lymphology (ISL) mentions The International 
Classification of Functioning, Disability and Health (ICF) in its latest revision of the 
lymphoedema consensus document (2009). 
The ICF framework consists of the following components: 
- Body Structures and Functions 
- Activities and Participation 
- Personal and Environmental factors. 
Personal factors are not yet classified, but the other components contain more 
than 1,400 ICF categories. This is simply not workable in practice and necessitates 
the creation of a practical tool to incorporate such a large number of categories. 
In order to reduce the amount of categories, only those terms/concepts that are 
the most relevant for individuals with a defined health condition are selected by 
the experts attending the consensus conference. 
Core sets 
These summaries are called ICF ‘Core Sets’, which are practical tools designed for 
a range of purposes. They allow health professionals to classify and describe an 
individual’s functioning using a universal and standardised language. Therefore, 
the Core Sets offer a chance for international studies to be conducted and open 
up the possibility of comparing the impact of different conditions. Moreover, the 
ICF Core Sets can be used in electronic healthcare records. 
To date, ICF Core Sets have  been developed for several chronic conditions — see 
Cieza et al (2004), Stucki and Grimby (2004), Üstün et al (2004). For every health 
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condition, both a brief ICF Core Set (for clinical or epidemiological studies), as well 
as a comprehensive ICF Core Set (for multidisciplinary assessments) has been 
established. The development of ICF Core Sets for lymphoedema star ted 
as a cooperative effort  between the Erasmus Medical Centre (Depar tment of 
Dermatology) in Rotterdam and the Dutch Institute of Allied Health Care in 
Amersfoor t, under the auspices of the WHO Collaborating Centre for the Family 
of International Classifications (WHO-FIC) in Bilthoven (all in The Netherlands). 
 
Methods 
There are three phases in the development of the ICF Core Sets for lymphoedema: 
a preparatory phase, phase I and phase II (Figure 1). 
 
Figure 1. The three phases in the development of the ICF Core Sets for lymphoedema. 
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Preparatory  phase 
Within the preparatory phase, studies will be conducted from four different 
perspectives. 
 
Systematic review: researcher perspective. 
A systematic review of English language literature will be performed: (1) to  
identify meaningful concepts reported in studies published between 2005 and 
2010 that involve patients with lymphoedema; and (2) to link these concepts to 
ICF codes and quantify them to indicate their importance in the literature. The 
literature will be retrieved from the Medline, Central, Cinahl, Embase and Pedro 
databases. 
 
Qualitative  study: patient  perspective. 
Focus group interviews will be performed with individuals with lymphoedema to 
identify the aspects of functioning, disability and health that are important to the 
individual in question. These will then be listed using the ICF as a reference. 
Different focus groups will be interviewed, such as those with upper extremity, 
lower extremity, midline lymphoedema and those with lymphoedema that may or 
may not be related to cancer. 
  
Expert survey: expert perspective. 
An internet-based survey will be performed to gather the opinions of an 
international pool of experts across various health professions (for example, 
physicians, nurses, physical therapists  and skin therapists) regarding the most 
relevant aspects to be considered in persons with lymphoedema. 
 
Empirical cross-sectional study: clinical perspective.  
A cross-sectional study with 400 patients  will  be  performed: (1)  to describe 
functioning, disability, health and the relevant personal and environmental factors 
of individuals with lymphoedema and (2) to identify whether problems in 
functioning can be unequivocally classified using the ICF. This study  will be 
executed partly in Australia in cooperation  with  Flinders  University Medical  
Centre  Lymphoedema Assessment Clinic Adelaide (Professor Neil Piller). 
 
Phase I 
The data collected during the preparatory phase will be presented at a 
international ICF Core Set consensus conference and experts in the field of 
lymphoedema will work together to reach a consensus on the most adequate ICF 
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categories to be included in both the comprehensive and the brief ICF Core Sets 
for lymphoedema. 
 
 
Phase II 
In Phase II of the project — the testing and implementation of the ICF Core Sets 
for lymphoedema — an international, cross-sectional, multi-centre validation 
study involving patients with lymphoedema will be performed, to assess the 
content validity and feasibility of the comprehensive and brief ICF Core Sets for 
lymphoedema. 
 
The development of ICF Core Sets for lymphoedema is an inclusive and open 
process and the project will be conducted in accordance with the ethical 
principles of the Declaration of Helsinki. Anyone who wishes to participate 
actively in this process is invited to contact the project co-ordinator  
(p.viehoff@erasmusmc.nl). The project will be guided by a steering committee 
comprising  the authors of this article. 
  
Discussion 
ICF Core Sets for lymphoedema offer a dedicated tool to guide research, with the 
ultimate aim of improving understanding of functioning, disability and health in 
people with lymphoedema. 
Tsauo et al (2010) already proved the usefulness of the ICF in patients suffering 
from lymphoedema due to breast cancer. They found that data classified with the 
ICF could well predict the health-related quality of life for these patients. 
The ICF Core Sets for lymphoedema will also form the basis for the development 
of assessment instruments to quantify the severity of the impact of lymphoedema 
on functioning; to measure change over time; and to measure the effectiveness of 
interventions. They can also serve as the basis for setting clinical significance 
thresholds for diagnostic purposes. Finally, it is hoped that this will lead to 
effective intervention methods that improve functioning and minimise disability 
among people with lymphoedema throughout the world. 
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Abstract 
 
Purpose: To identify and quantify the meaningful concepts within questionnaires 
focusing on lymphedema using the International Classification of Functioning, 
Disability and Health (ICF). 
Methods: Electronic searches of Medline, EMBASE, CINAHL, CENtral and Pedro 
(2005–2010) were conducted. The concepts in the questionnaires were retrieved 
from the included studies and linked to the ICF. 
Results: Of the 2381 abstracts retrieved, 136 studies were included. The study 
population suffered from lymphedema in the upper limb (65%), in the lower limb 
(25%), in the midline (3%) and in combinations of these areas (7%). In total, 12 
lymphedema-specific questionnaires were found (nine  for the upper limb,  two 
for the  lower limb and one  for lymphedema in general). A total of 301 concepts 
were extracted from the questionnaires, of which 271 (90%) could be linked to 
the ICF. There were 45 two-level ICF categories linked to concepts in 2 
questionnaires; 13 in Body Functions, 6 in Body Structures, 16 in Activities and 
Participation and 10 in Environmental Factors. The most frequently measured 
categories were ‘‘Structure of upper extremity’’, ‘‘Immunological system 
functions’’, ‘‘Looking after one’s health’’, ‘‘Sensation of pain’’, ‘‘Touch functions’’, 
‘‘Dressing’’ and ‘‘Health services, systems and policies’’. 
Conclusion: The ICF provides a valuable reference to identify concepts in 
questionnaires focusing on individuals with lymphedema
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Introduction 
 
Lymphedema is a chronic condition resulting in an abnormal accumulation of 
extracellular fluids as a result of disturbed lymphatic flow, primarily in the 
subcutaneous tissues and subfascial compartments. In lymphedema, the 
transport capacity of the lymphatic system is compromised because of less 
activity or less capacity of the lymphatic vessels or obstruction of the lymphatic 
system [1]. Lymphedema can occur in both upper and lower limbs and in the 
midline (head, neck, abdomen and thorax). 
The precise epidemiology of lymphedema is unknown because it is not a regularly 
registered disease. The number of lymphedema patients worldwide  is estimated  
to be approximately  140–250 million [2]. 
Lymphedema is divided into primary lymphedema and secondary lymphedema. 
Primary lymphedema is inherited as it is caused by gene mutations and starts at 
adolescence, or sometimes earlier, and affects mainly the foot and calf. Some 
congenital types are already visible at birth (Milroy’s disease). Secondary 
lymphedema is acquired as a result of an injury or infection of the lymph system. 
In the Western world, 80% of lymphedema cases are acquired after cancer 
treatment as a result of the removal of lymph nodes (mostly in the axilla or groin) 
and/ or radiotherapy [3]. In the developing world, parasites (filariasis) are 
responsible for millions of patients with lymphedema [4]. 
 
Lymphedema after cancer treatment 
Williams et al. [3] stated that the incidence of lymphedema is 30% after axillary 
lymph node dissection. Norman et al. [5] reported a cumulative incidence of 
subject-reported lymphedema 5 years after axillary lymph node dissection in 50% 
of patients younger than 50 years, in 40% of patients between 50 and 70 years 
and in 26% of patients older than 80 years. Eighty percent of lymphedema 
patients developed the condition in the first 2 years after the operation. Lee et al. 
[6] described factors, such as higher age, post-operative wound infections (or 
later infections on the operated side) and obesity as cumulative risk factors  for 
lymphedema after axillary node dissection. Obesity as a risk factor for developing 
lymphedema was described by several authors [7–14]. 
Cormier et al. [15] described an overall incidence of lymphedema of 15.5% after 
cancer treatment beyond breast cancer,  16%  after  cancer  treatment  for  
melanoma,  20%  after cancer treatment for gynaecological cancer, 10% after 
cancer treatment for genitourinary cancer, 4% after cancer treatment for 
head/neck cancer and 30% after cancer treatment for sarcoma. Increased 
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lymphedema risk was described for pelvic dissections (22%) and radiation therapy 
(31%). Incidence reporting has increased  using  objective  measurement  methods  
and  longer follow-up. 
 
Lymphatic filariasis 
According to a WHO report, 120 million people in 72 countries were infected with 
lymphatic  filariasis  in  2010,  of  which 15 million people suffered from the 
stigmatizing and disabling manifestations of lymphedema (elephantiasis) [4]. 
 
 
Symptoms of lymphedema 
Initially lymphedema is non-pitting and the affected skin feels soft. In later stages, 
the skin may feel hard and thickened as a result of fat deposits and fibrosis in the 
swollen area. In severe, long-lasting lymphedema, skin changes are visible as 
keratosis. Lymphedema results in many symptoms such as decreased mobility of 
the limb [16], slower wound healing, increased risk for infection, feelings of 
heaviness and tightness, discomfort and tight fitting of jewelry or clothes on the 
affected body parts [5,17,18]. It leads to impairments such as limited walking 
distance in leg lymphedema and to limitations in personal care, domestic life, 
occupation and socialization. Lymphedema is a chronic condition and its limitation 
on physical functioning can result in distress [7] and loss of quality of life. 
Generally, the activity level of lymphedema patients is lower compared with 
healthy persons of the same age. Altered body shape and the necessity of daily 
use of special garments  or  bandaging  as  a  standard  treatment  for  stabilized 
lymphedema make acceptance of lymphedema difficult for the patient and for his 
family. 
 
Treatment and health classifications 
Lymphedema requires lifelong skin care and precautions to minimize (recurrent) 
swelling. Patients are advised to practice certain regimens, such as daily 
bandaging or the use of special garments, skin care and caution with open 
wounds. 
Today medical treatment of patients with lymphedema is primarily aimed at 
reducing volume, but treatment should most likely be aimed at other problems as 
well. An important basis for the optimal treatment and management of 
lymphedema is an in-depth understanding, systematic consideration and sound 
measurement of its consequences at different levels of a person’s functioning.  To  
achieve  this  goal,  it  is  necessary to  develop a comprehensive framework and 
classification which can serve as a universal language, understood by health 
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professionals, researchers, policy makers, patients and patient organizations. The 
International Classification of Functioning, Disability and Health (ICF) [19] is a 
widely used classification system in which terms and classes are designed to 
describe functioning, disability and health in people with health disorders. The 
terms and classes in the ICF consist of both descriptions and codes. Descriptions 
are culturally tuned and provided in many languages. The pertinent codes (letters 
and numbers) are identical world- wide. The ICF terms can be understood by 
health professionals, researchers, policy makers, patients and patient 
organizations. The International Society for Lymphology  (ISL)  mentioned the 
importance of the use of the ICF in their latest revision of lymphedema consensus 
document (2009) [20]. 
The ICF contains two parts. Part 1 describes Functioning and Disability and 
includes three components: Body Functions, Body Structures and Activities and 
Participation. Part 2 addresses Contextual Factors and includes two components: 
Environmental Factors and Personal Factors. However, ‘‘Personal Factors’’ is not 
elaborated as a classification in the ICF because of the large social and cultural 
variety associated with these factors [19]. 
With the ICF codes, linkage among data across conditions or interventions is 
possible as a necessary step in the development of efficient, transparent and cost-
effective health care [21]. Although the ICF classification system with more than 
1400 categories can serve as a reference, the ICF is not easily applicable in clinical 
practice. Therefore, tools such as ICF Core Sets (health-specific selections of ICF 
categories) [22] are helpful to make the ICF more appealing for the 
implementation in medical/allied health care [23]. Health-specific Core Sets 
choose the appropriate terms and classes to describe the functioning of the 
patient and make the formulation of treatment goals easier, faster and more 
transparent. Therefore, these data are also appropriate for use in electronic 
health records. Core Sets are available to all types of health care providers, 
researchers, health insurance companies and policy makers. Once a Core Set is 
developed, one can select measurement instruments for each code (or 
combination of codes), thereby creating a basic set of measurement instruments 
as well. To date, ICF Core Sets have been developed for various burdensome 
chronic conditions [21,24,25], such as stroke, multiple sclerosis and breast cancer. 
Core Sets have also been developed for an acute hospital and early post-acute 
rehabilitation facilities [26–28]. ICF Core Sets for lymphedema are not yet 
developed. 
Stucki et al. [22] have composed a standard method to develop ICF Core Sets. The 
development of ICF Core Sets for lymphedema will follow this method. The 
method consists of the following component studies: (a) a literature review: a 
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search for meaningful concepts (i.e. a unit of text that conveys a single theme 
[29]) in the literature regarding the outcomes used in clinical trials, qualitative 
research and selected observational studies, representing the researchers’ 
perspective; (b) focus groups of patients with lymphedema (patients’ 
perspective); (c) an expert survey on the outcomes gathered in studies (a) and (b) 
using the Delphi technique (perspectives of various relevant groups); and (d) an 
empirical, cross-sectional study to gather concepts that are named in clinical 
situations (health care providers’ perspectives). The final composition of the ICF 
Core Sets for lymphedema will take place at an ICF Core Set Consensus 
Conference (study e), which will integrate evidence from the previous studies (a–
d). The development of ICF Core Sets on lymphedema (a–e) will be carried out in 3 
years. This article represents the researchers’ view (study a). The literature will be 
systematically searched for meaningful concepts, especially meaningful concepts   
within lymphedema-specific questionnaires. An analysis of meaningful concepts 
within the text of published studies (also part of study a) will be published 
separately. 
 
Objectives 
The objectives of the literature review are as follows: (1) to identify 
questionnaires in studies focusing on patients with lymphedema and (2) to link 
meaningful concepts within these questionnaires to the ICF. 
 
Methods 
 
Search strategy 
Electronic searches were carried out in CINAHL, EMBASE, Medline, CENtral and 
Pedro databases from 2005 to 2010 using the search terms lymphedema, 
elephantiasis, lymphatic edema, lymphostatic edema and Milroy’s disease (the 
detailed search strategy is available upon request). The target population in the 
included studies was patients who were 18 years or older and had a clinical 
diagnosis of lymphedema. Studies with one of the following designs were 
included: (1) randomized clinical trials, (2) controlled clinical trials, (3) 
observational studies, i.e. cohort studies and cross-sectional studies, (4)  
guidelines, and (5) qualitative studies. The publication language was English. If 
a study was described in a number of publications, only the publication in the 
journal with the highest impact factor was included. The exclusion criteria for the 
studies were as follows: (1) studies with exclusively laboratory parameters, (2) 
genetic studies, (3) animal experiments, (4) letters, (5) comments, (6) 
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editorials, (7) systematic reviews, (8) case reports, and (9) meta- analyses. 
 
Data collection procedure 
In the first step, the abstracts of the retrieved studies were checked for the 
inclusion criteria. For the selected abstracts, the whole publication was studied 
and a decision was made as to which of the publications should be included in 
the study. In the second step, measurement methods, including questionnaires, 
were identified. In the third step, meaningful concepts were extracted from the 
selected questionnaires. The identification of meaningful concepts was 
performed separately by two researchers (PV and JH) who are trained in this type 
of identification before the research, using the first specific rule for health-
status measures of Cieza et al. [30] (‘‘Before starting the process of linking 
health-status measures to the ICF categories, identify all meaningful concepts 
within each item of the health status measure under consideration.’’). The 
concepts should be focused only on patients themselves and their surroundings. 
Examples of therapies mentioned were not included. In the fourth step, the 
meaningful concepts were linked to ICF categories using rule 2 (‘‘Each meaningful 
concept is linked to the most precise ICF category’’) of Cieza et al. [30,31]. 
 
Coding principles 
Coding was performed until the fourth level of the ICF. Each defined 
class/category/code was used only once for each questionnaire (e.g. pain has 
been marked as a meaningful concept; when pain in the foot and pain in the leg 
were described in the same questionnaire, only one single ICF code (b28015: pain 
in lower limb) was registered). If a meaningful concept pertained to a personal 
factor, such as ‘‘age’’, ‘‘sex’’ and ‘‘education’’, the concept was coded as ‘‘pf’’ 
because various personal factors are only named as examples but are not yet  
properly classified within the ICF. If a concept described an aspect of functioning 
and health that is not covered by the ICF, such as ‘‘taking up time’’ and 
‘‘suffered’’, the code ‘‘nc’’ (not covered) was attributed. If a concept pertained to 
health conditions, such as ‘‘lymphedema’’ and ‘‘breast cancer’’, which are not 
included in the ICF, the code ‘‘hc’’ (health condition) was attributed. When the 
concept was related to ‘‘quality of life’’, the code ‘‘nd-qol’’ (not definable – 
quality of life) was given. 
 
Inter-coder agreement 
The following steps of the study were performed by two researchers (PV and 
JH) independently: (1) eligibility check of the abstracts, (2) extraction of the 
meaningful concepts of all selected  questionnaires,  (3)  specification  of  the  
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concepts and (4) linking of the concepts to the ICF. After steps 1 and 2, both 
researchers compared their results. Initial disagreement was resolved after the 
discussion. If any disagreement remained, a third person (YH or DVR) was 
consulted. After steps 2, 3 and 4 (taken together), the inter-coder agreement was 
quantified by calculating the kappa with its 95% confidence interval (CI). 
Calculations were performed with the statistical software package SPSS, version 
19.0 (IBM SPSS, Armonk, NY). This was performed for all of the questionnaires. 
After the kappa calculations, disagreement (first on extraction/specification of 
concepts, second on proper ICF code) was also resolved together or by a third 
person. These steps together provided the final codes of the meaningful concepts 
that are presented in this study. 
 
Data analysis 
Frequencies of the linked ICF categories are reported when measured in more 
than two questionnaires. If a concept was linked to a third or fourth level ICF 
category, the corresponding second- level category is reported in this article to 
avoid long lists of ICF categories. This is appropriate because the lower level 
categories share the attributes of the higher level categories [19]. 
 
Results 
 
From the 2381 abstracts retrieved, 149 studies were selected based on the 
inclusion and exclusion criteria. Reading of the publications occurred in 
alphabetical order based on the name of the first author. After the full-text 
articles were read, an additional 13 studies were excluded because they did not 
fit into the inclusion  criteria  (e.g. being  comments, case reports or not 
primarily focusing on lymphedema), which was not evident from the abstracts. In 
the remaining 136 studies, 88 (65%) of the study population consisted of patients 
with lymphedema in the upper limb, 34 (25%) of the study population consisted 
of patients with lymphedema in the lower limb, 5 (3%) of the study population 
consisted of patients with midline lymphedema and 9 (7%) of the study 
population consisted of patients who had lymphedema in combinations of 
locations. The included studies consisted of 46 intervention studies ( 40 for upper 
limb; 4 for lower limb;  1 for midline;  1 for combinations), 67 observational 
studies ( 43 for upper limb; 16 for lower limb;  4 for midline;  4 for combinations), 
19 qualitative studies ( 4 for upper limb; 12 for lower limb; 3 for combinations) 
and there were 4 clinimetric studies (1 for upper limb; 2 for lower limb; 1 for 
combinations). The measurement methods described and used in the 136 
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studies are listed in Table 1. The next step was to filter out the questionnaires 
that were used (Table 2). Finally, only the lymphedema-specific questionnaires 
were selected [5,7,17,32–40] (Table 3). 
In total, 12 lymphedema-specific questionnaires were found (10 for the upper 
limb, 1 for the lower limb and 1 for lymphedema in general). From these 
questionnaires, all meaningful concepts were determined and linked to the ICF. 
 
 
                             Table 1. Measurement methods used in the 136 studies. 
 
Questionnaire 114 
Circumferential measurement 49 
BMI 28 
Water displacement device 23 
VAS 17 
Bio impedance 12 
Perometer 9 
Goniometry 9 
Lymphoscintigraphy 7 
Palpation 4 
Sonography 4 
Tonometry 3 
Blood samples 3 
Grip strength 3 
Diary 2 
Water composition 2 
Duplex Ultrasound 2 
3D Measuring 1 
MRC 1 
Optoelectronic system 1 
Lymphangiography 1 
Pletysmography 1 
Functional Tests 1 
Electrical Impedance Spectrography 1 
Magnetic Resonance Imaging 1 
Computer Tomography 1 
1 RM test 1 
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      Table 2. Questionnaires used in the 136 studies. 
 
Name of questionnaire Number 
of studies 
Short Form-36 14 
Functional Assessment of Cancer Therapy Breast plus 4 subscale 7 
Lymphedema and Breast Cancer Questionnaire 7 
European Organization for Research and Treatment of Cancer –Quality of 
Life Questionnaire –Cancer 30 
5 
Dermatology Life Quality Index 4 
Disabilities of Arm Shoulder and Hand 3 
European Organization for Research and Treatment of Cancer –Quality of 
Life Questionnaire –Breast 23 
3 
Nottingham Health Profile 3 
Upper Limb Lymphedema 27 3 
Borg Rate of Perceived Exertion Scale 2 
Center for Epidemiologic Studies of Depression Scale 2 
General Health Questionnaire -30 2 
McGill Pain Questionnaire 2 
Short Form -12 2 
World Health Organization Disability Assessment Schedule 2 2 
Selfreport (Norman) 2 
Various 51 
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Table 3. Lymphedema-specific questionnaires used in the 136 studies (5, 7, 17, 32-40).  
 
Name Author Location (A = arm, B = 
leg, C = combinations) 
Number of 
studies 
Lymphedema and 
Breast Cancer 
Questionnaire 
Armer et al (32) A 7 
Upper Limb 
Lymphedema 27 
Launois et al (37) A 3 
Arm Symptom Distress 
Scale 
Mak et al (36) A 1 
Edema Scale Belcaro et al (39) C 1 
Gynaecologic Cancer 
Lymphedema 
Questionnaire 
Carter et al (33) A 1 
Lymphedema and Pain 
Questionnaire 
Oliveri et al (35) A 1 
Lymphedema Risk-
Reduction Behaviors 
Fu et al (17) A 1 
Lymphedema Signs and 
Symptoms 
Questionnaire 
Dawes et al (34) A 1 
Measure of Arm 
Symptom Survey-
Lymphedema 
Swenson et al (7) A 1 
Memorial Symptom 
Assessment Scale 
(adapted) 
Norman et al (5) A 1 
Questionnaire for 
Lymphedema-Related 
Subjective Symptoms 
Szolnoky et al (38) A 1 
Supportive Care Needs 
Survey Short Form 
(Lymphedema 
supplement) 
Beesley et al (40) B 1 
 
 
 
Inter-coder reliability 
The inter-coder agreement for the determination of meaningful concepts was 
80% (kappa 0.55; 95% CI 0.48–0.63). For  the  linking  with  the  ICF,  the  inter-
coder  agreement was 63% (kappa 0.28; 95% CI 0.18–0.37). Disagreement 
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originated most often in the same direction by the same differences in coding 
(e.g. when both researchers consistently coded the same meaningful concept in 
different ways. For instance ‘‘Do you have limited movement of your foot’’ was 
coded ‘‘b7100 Mobility of a single joint’’ by one researcher and ‘‘b7101 Mobility 
of several joints’’ by the other continuously). In only three cases, no consensus 
was reached by the two researchers about linking a meaningful concept to the 
ICF. These could be resolved by the third researcher. 
 
Identified concepts and ICF codes 
A total of 301 concepts were extracted from the 12 questionnaires. Out of these, 
4 concepts in a total of 3 questionnaires were considered as ‘‘not covered’’ (‘‘nc’’) 
by the ICF, 13 concepts in a total of 11 questionnaires as ‘‘health condition’’ 
(‘‘hc’’), 1 as ‘‘quality of life’’ (‘‘nd-qol’’) and 12 concepts in a total of 4 
questionnaires as ‘‘personal factor’’ (‘‘pf’’). Examples of Personal Factors found 
were ‘‘Date of birth’’, ‘‘Age’’, ‘‘Lifestyle’’ and ‘‘Race’’. The other 271 concepts 
(representing 90%) could be linked to a total of 117 different ICF categories. In all, 
1 concept was linked at the level of an ICF chapter only, 6 concepts were linked to 
the first level of the ICF categories, 116 concepts were linked to the second level 
and 148 concepts to the third level. Not a single concept was linked to a fourth-
level category. Later, the third- level categories were merged into the 
corresponding second-level categories for purposes of this article. Tables 4–7 list 
the 45 second-level ICF categories representing the concepts contained in two or 
more questionnaires. Of these 45 categories, 13 categories belong to the  
component  ‘‘Body Functions’’, 6 to the component ‘‘Body Structures’’, 16 to the 
component ‘‘Activities and Participation’’ and 10 to the component 
‘‘Environmental Factors’’. The second-level categories of the ‘‘Body Functions’’ 
component  that were found most frequently were ‘‘b435, Immunological system 
functions’’ (10 questionnaires), ‘‘b280, Sensation of pain’’ (9 questionnaires) and   
‘‘b265, Touch Functions’’ (8 questionnaires) (Table 4). Of the ‘‘Body Structures’’ 
component, the most frequently found categories were ‘‘s730, Structure of upper 
extremity’’ (10 questionnaires) and ‘‘s630, Structure of reproductive system’’ (6 
questionnaires) (Table 5). The  most  frequently  found  categories  in  ‘‘Activities  
and Participation’’ were ‘‘d570, Looking after one’s health’’  (9 questionnaires),  
‘‘d540,  Dressing’’ (7 questionnaires),  ‘‘d445, Hand and arm use’’ (6 
questionnaires) and ‘‘d850, Remunerative employment’’ (6 questionnaires as 
well) (Table 6). The most frequently found  ‘‘Environmental  Factors’’ were ‘‘e580, 
Health services, systems and policies’’ (7 questionnaires) and ‘‘e115, Products and 
technology for personal use in daily living’’ (6 questionnaires) (Table 7). 
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Table 4. Frequency of second level categories of the ICF linked to concepts contained in the 12 
questionnaires: component Body Functions ( A = code found in upper limb questionnaire, B = code 
found in lower limb questionnaire, C = code found in lymphedema general questionnaire). 
 
ICF code Description Number of questionnaires 
Chapter 1: mental functions   
b126 (A) Temperament and personality 
functions 
3 
b134 (A,B) Sleep functions 5 
b152 (A,B) Emotional functions 3 
b180 (A,C) Experience of self and time 
functions 
4 
Chapter 2: sensory functions 
and pain 
  
b265 (A,B) Touch functions 8 
b280 (A,B) Sensation of pain 9 
Chapter 4: functions of the 
cardiovascular, 
haematological, 
immunological and 
respiratory systems 
  
b435 (A,B,C) Immunological system 
functions 
10 
Chapter 5: Functions of the 
digestive, metabolic and 
endocrine systems 
  
b550 (A,B) Thermoregulatory functions 2 
Chapter 7: 
neuromusculoskeletal and 
movement-related functions 
  
b710 (A,B) Mobility of joint functions 4 
b730 ((A,B) Muscle power functions 2 
Chapter 8: functions of the 
skin and related structures 
  
b810 (A,B,C) Protective functions of the skin 5 
b820 (A,B) Repair functions of the skin 2 
b840 (A) Sensation related to the skin 3 
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Table 5. Frequency of second-level categories of the ICF linked to concepts contained in the 12 
questionnaires: component Body Structures ( A = code found in upper limb questionnaire, B = code 
found in lower limb questionnaire, C = code found in lymphedema general questionnaire). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ICF code Description Number of 
questionnaires 
Chapter 6: Structures related to the 
genitourinary and reproductive 
systems 
  
s630 (A,B) Structure of reproductive 
system 
6 
Chapter 7: Structures related to 
movement 
  
s720 (A) Structure of shoulder region 2 
s730 (A,C) Structure of upper extremity 10 
s750 (B,C) Structure of lower extremity 3 
s760 (A) Structure of trunk 3 
Chapter 8: skin and related 
structures 
  
s810 (A) Structure of areas of skin 3 
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Table 6. Frequency of second-level categories of the ICF linked to concepts contained in the 12 
questionnaires: component Activities and Participation ( A = code found in upper limb questionnaire, 
B = code found in lower limb questionnaire, C = code found in lymphedema general questionnaire). 
 
ICF code Description Number of 
questionnaires 
Chapter 2: General tasks and 
demands 
  
d230 (A,B) Carrying out daily routine 4 
Chapter 3: Communication   
d325 (A,B) Communicating with –receiving- 
written messages 
2 
d330 (A) Speaking 2 
Chapter 4:  Mobility   
d415 (A) Maintaining a body position 3 
d430 (A) Lifting and carrying objects 2 
d440 (A,B) Fine hand use 3 
d445 (A) Hand and arm use 6 
d450 (A) Walking 2 
d470 (A) Using transportation 4 
Chapter 5: Self-care   
d520 (A) Caring for body parts 2 
d540 (A) Dressing 7 
d570 (A,B,C) Looking after one’s health 9 
Chapter 6: Domestic life   
d640 (A,B) Doing housework 4 
d650 (A) Caring for household objects 2 
Chapter 8: Major life areas   
d850 (A,B) Remunerative employment 6 
Chapter 9: Community, social and 
civic life 
  
d920 (A) Recreation and leisure 5 
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Table 7. Frequency of second-level categories of the ICF linked to concepts contained in the 12 
questionnaires: component Environmental Factors( A = code found in upper limb questionnaire, B = 
code found in lower limb questionnaire, C = code found in lymphedema general questionnaire). 
 
 
 
Discussion 
Using the ICF as a reference, it was possible to identify meaningful concepts in 
questionnaires focusing on patients with lymphedema. Many of these concepts 
could be linked to the ICF. The identification of the ICF categories contributed, 
from the researcher’s point of view, to the development of ICF Core Sets for 
lymphedema. This research covered a period of 5 years. Most literature 
reviews concern the evidence for certain treatments or diagnostic methods,  
ICF code Description  Number of 
questionnaires 
Chapter 1:products and 
technology 
  
e110 (A) Products and substances 
for personal consumption 
4 
e115 (A) Products and technology 
for personal use in daily 
living 
6 
e125 (A,B) Products and technology 
for communication 
2 
e135 (A,B) Products and technology 
for employment 
4 
Chapter 2: Natural environment 
and human-made changes to 
environment 
  
e225 (A) Climate 2 
e245 (A,C) Time-related changes 3 
Chapter 3: Support and 
relationships 
  
e310 (A,B) Immediate family 2 
e325 (A,B) Acquaintances, peers 
colleagues, neighbours 
and community members 
3 
e355 (A) Health professionals 5 
Chapter 5: services, systems and 
policies 
  
e580 (A,B) Health services, systems 
and policies 
7 
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often  using  a  period  of  more  than  5  years.  In  this particular case, the 
review aims at classifying meaningful concepts used in  scientific  literature 
concerning  lymphedema. A 5-year-period is considered to be sufficient for this 
particular goal [41,42]. Coincidentally, between 2005 and 2010 literature about 
lymphedema focused more on other items than only swelling and there was paid 
more attention to lymphedema other than caused by breast cancer than in the 
years before. This enlarged the variety of meaningful concepts in this research. 
Compared to previously published systematic reviews for ICF Core Set 
development [43], this study not only included RCTs but also studies with other 
designs, such as observational studies and qualitative studies. The reason for 
including observational and qualitative studies was that these type of studies 
might be more appropriate to disclose the everyday problems related to 
lymphedema. Expanding the scope of studies included offering a chance to reveal 
more meaningful concepts. 
The ICF codes were summarized into two-level codes to ensure readability and 
practical use. This way of presenting was performed previously in ICF Core Set 
development [41], although this procedure seems to be contrary to Coding Rule 2, 
as described by Cieza et al. [30], which states that the most precise ICF category 
should be identified. More detailed data will be used for the next studies on 
developing the Core Sets (studies b–e). 
The somewhat low kappa of 63% of the inter-coder reliability in comparison to 
other studies (e.g. Geyh et al. [44]; 82%) can be partly explained by the fact that in 
our study kappa values were calculated after a fully independent formulation of 
meaningful concepts by two persons and the linking of the concepts to ICF codes. 
Inter-individual differences can result from differences in the identification of 
meaningful concepts as well as in differences in the selection of ICF codes. In the 
study of Geyh et al. [44] the kappa values were calculated after consensus was 
reached for the meaningful concepts. Furthermore, it was not simple or straight- 
forward to link meaningful concepts derived from the questionnaires to the 
appropriate ICF category because concept wordings are often not very precise as 
to their exact meaning and are not equal to the ICF terms. Thus, the coding 
frequently requires discussion. Recent linkage exercises, however, have 
demonstrated that it is possible to examine and compare the content of measures 
based on the ICF framework and predefined linking rules [30,31,45]. A third  
explanation  might  be that both reviewers had good theoretical knowledge of the 
ICF, but less experience in the linking process. 
In the lymphedema-specific questionnaires, the most frequently measured 
categories were ‘‘s730, Structure of upper extremity’’ (10 questionnaires), 
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‘‘b435, Immunological system functions’’ (10), ‘‘d570, Looking after one’s 
health’’ (9), ‘‘b280, Sensation of pain’’ (9), ‘‘b265, Touch functions’’ (8), ‘‘d540, 
Dressing’’ (7) and ‘‘e580, Health services, systems and policies’’ (7). Because 
most of the measurement instruments concerned about upper extremity 
lymphedema, it is clear that ‘‘s730, Structure of upper extremity’’ was found 
most frequently. Lymphedema is a chronic health condition that presents with 
swollen extremities. This explains the high frequency of ‘‘b435, Immunological 
system functions’’, implying the swelling of arms and legs. Self-management of 
lymphedema seems to be important, considering the high frequencies of 
‘‘d570, Looking after one’s health’’ and ‘‘d540, Dressing’’. Many questionnaires 
contain items related to therapy and caregivers, which can be deduced from 
the high frequency of the category ‘‘e580, Health services, systems and 
policies’’, indicating their importance for patients with lymphedema. 
Concerning the Body Functions category, much lymphedema research still 
focuses on the symptoms, pain and swelling, and little attention is paid to 
other problems, such as skin problems (Chapter 8 – Functions of the skin and 
related  structures). More research from the patient’s, clinician’s and expert’s 
point of view will show whether skin problems really are of less importance. 
Although lymphatic filariasis (a mosquito-transmitted chronic, incurable disease 
often found in Third World  countries) damages mostly the lymphatic  system  of  
the lower extremity  [46–51], most of the questionnaires were found to be 
concerned about lymphedema of the upper extremity. This is the reason why, 
for example, ‘‘d450, Walking’’ has a relative low frequency. There is a need in 
this field of research to provide more insight into these limitations. 
The other measurement methods (not the questionnaires) that were identified 
in the studies were almost always related to the classification ‘‘Body Functions’’ 
of the ICF. These methods are concentrated on clinical symptoms, such as 
swelling  and pain. However, from a more holistic point of view (e.g. using the 
perspective of the ICF), there are other fields important to describe the 
patient’s functioning as well. 
Considering the questionnaires, it is striking that there are 51 different 
questionnaires in the included studies, so it seems that every researcher used 
his/her own questionnaire. To achieve more uniformity in this perspective, the 
ICF, and more specifically the Core Sets for lymphedema, can work as a framework 
in the future. 
Most of the included meaningful concepts could be linked to the ICF (90%), 
but a small proportion could not. Of these, ‘‘Health Conditions’’ can be 
classified with the ICD-10. Unfortunately, the ‘‘Personal Factors’’ component, as  
part of the ICF, is still under development. 
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The selection of studies might have been biased by including only studies and 
questionnaires published in English. The search concerned publication years 
2005–2010, so it is possible that more recent studies would have revealed 
different results. 
Because the large majority of meaningful concepts found in the questionnaires 
concerning lymphedema could be linked to the ICF, this type of classification  
appears workable. Recent publications [52,53] stress the importance of 
implementing the ICF. 
The ICF provides a valuable reference to identify and quantify the meaningful 
concepts focusing on individuals with lymphedema. The findings of this 
literature review indicate a need to define and to agree on ‘‘what should  be   
measured’’ in lymphedema care. This is one of the goals of the ICF Core Set 
development for lymphedema. ICF Core Sets should allow for a comparable 
and comprehensive description of patient populations, their functioning and 
health across studies and interventions. 
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Abstract 
Background: This article is the second arising from a literature research study that 
was conducted as part of the development process of ICF Core Sets (selections 
from the ICF for a specific group of clients) for lymphoedema. In the first article, 
meaningful concepts in lymphoedema-specific questionnaires were explored. 
Objectives: To compare and analyze categories of the WHO’s International 
Classification of Functioning, Disability and Health (ICF) linked to meaningful 
concepts within studies focusing on lymphoedema with ICF categories linked to 
meaningful concepts derived from lymphoedema-specific questionnaires in the 
earlier study.  
Methods: Electronic searches of Medline, EMBASE, CINAHL, CENtral and Pedro 
(2005-2010) were conducted. Meaningful concepts were retrieved from the 
included studies and linked to the ICF, and these were compared with the codes 
given to meaningful concepts derived from lymphoedema-specific questionnaires. 
Results: 2381 studies were retrieved and after reading the abstracts, 149 articles 
were included, of which 136 articles remained after reading the full text . Based 
on saturation in the detection of new concepts concerning upper limb 
lymphoedema, 54 publications were excluded. Publications about combinations 
of regions were also excluded, resulting in 34 studies for upper limb 
lymphoedema, 34 for lower limb lymphoedema and five for midline 
lymphoedema (n = 73). A total of 2488 concepts were extracted, of which 2269 
(91.2%) could be linked to ICF categories. 
Conclusion: Studies of lymphoedema show a greater variety of meaningful 
concepts and ICF categories than do questionnaires, although the most frequently 
found ICF categories in studies and questionnaires are similar. The two methods 
complement each other and can be used together to produce more data than can 
be obtained through the use of either method alone. There is a need for 
lymphoedema-specific questionnaires concerning midline lymphoedema, and 
existing questionnaires should be adapted.  
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Introduction 
In lymphoedema, there is an abnormal accumulation of fluid and protein as a 
result of an imbalance between the flow and discharge of fluid (1). Lymphoedema 
can occur in the upper and lower limbs as well as in the midline (head, neck and 
thorax). It can be subdivided into primary and secondary lymphoedema. Primary 
lymphoedema, which is inherited, can occur in any part of the body but is most 
common in the legs. Secondary lymphoedema is acquired; in this condition, the 
lymph vessels and/or nodes have been removed or infected. Examples of 
secondary lymphoedema are upper limb lymphoedema after axillary lymph node 
dissection, lymphoedema of the lower limb after a gynecological operation with 
inguinal lymph node dissection, and infection with lymphatic filariasis, a 
mosquito-transmitted, chronic, incurable disease often found in third-world 
countries. Patients receiving post-surgical radiotherapy and/or chemotherapy 
have an increased chance of acquiring lymphoedema (2). The epidemiology of 
lymphoedema is not precisely known because it is not a regular registered 
disease. According to a WHO report,(2010) approximately 120 million people in 
72 countries were infected with lymphatic filariasis, of whom 15 million suffered 
from lymphoedema (3). Worldwide, the number of persons with lymphoedema is 
estimated to be 140-250 million (4). 
Symptoms of lymphedema 
Lymphoedema results in decreased mobility of the limb (5), slower wound 
healing, increased risk of infection, feelings of heaviness and tightness, discomfort 
and tight fitting of jewelry or clothing in the affected body parts (6-8). It leads to 
limitations in activities, such as a reduced ability to walk, and limitations in 
personal care, domestic life, occupation and socialization. Lymphoedema is a 
chronic condition, and its influence on physical functioning can result in distress 
(9) and loss of quality of life. Altered body shape and the necessity for daily use of 
specialized garments or bandaging as a standard treatment for stabilized 
lymphoedema make acceptance of the condition difficult for the patient as well as 
for his or her family and environment. In addition, lymphoedema requires lifelong 
self-care: patients must follow prescribed regimens, such as daily bandaging or 
the use of special garments; utilize skin care regimens; and exercise caution with 
open wounds. Generally, the activity and participation levels of persons with 
lymphoedema are lower than those of their healthy peers.  
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ICF 
The International Classification of Functioning, Disability and Health (ICF) (10) is 
accepted by the World Health Assembly as a universal framework for classifying 
and describing functioning in people with specific health conditions. The 
International Society for Lymphology (ISL) emphasized the importance of the 
ICF in the latest revision of its lymphoedema consensus document in 2013 (11). 
The ICF organizes information in two parts. Part 1 addresses functioning and is 
composed of the components ‘Body Functions and Structures’ (divided into two 
classifications) and ‘Activities and Participation’ (a single classification). Part 2 
addresses contextual factors and consists of the components ‘Environmental 
Factors’ (one classification) and ‘Personal Factors’. Personal Factors are not 
used as a classification in the ICF yet, because of the large social and cultural 
variance associated with these factors (10). The ICF makes it possible to link 
data across conditions or interventions with the goal of achieving efficient, 
transparent, and cost-effective health care (12). This article is the second 
arising from a literature research study that was conducted as part of the 
development process of ICF Core Sets (selections from the ICF for a specific 
group of clients) for lymphoedema. In the first article, meaningful concepts in 
lymphoedema-specific questionnaires were explored  (13). One of the 
conclusions indicated a need to define and agree upon ‘what should be 
measured’ in lymphoedema care. In this second article, meaningful concepts in 
the studies themselves were coded with the ICF to define what researchers 
described as important items in lymphoedema. Afterwards, these ICF 
categories were compared with the ICF categories linked to the meaningful 
concepts found in the questionnaires (13) to determine whether researchers 
indeed explored these important items. 
 
Objectives 
The objectives of the literature review were 1) to identify literature describing 
(problems in) functioning of individuals with lymphoedema; 2) to identify 
meaningful concepts within the studies; 3) to link these meaningful concepts to 
the ICF; 4) to quantify these ICF-linked concepts (to count the frequency of 
occurrence of codes/classes); and 5) to compare these codes with those that were 
found in a previous study about lymphoedema-specific questionnaires. 
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Methods 
 
Search strategy 
Electronic searches were carried out in the CINAHL, EMBASE, Medline, CENtral 
and Pedro databases from 2005 to 2010 using the search terms ‘lymphoedema’, 
‘elephantiasis’, ‘lymphatic edema’, ‘lymphostatic edema’ and ‘Milroy’s disease’. 
The detailed search strategy can be obtained from the first author upon request. 
The target population of the included studies consisted of patients over 18 years 
old with a clinical diagnosis of lymphoedema. Studies with the following designs 
were included: 1) randomized clinical trials; 2) controlled clinical trials; 3) 
observational studies, i.e., cohort studies and cross-sectional studies; 4) 
guidelines; and 5) qualitative studies. The publication language was English. If a 
study was described in a number of publications, only the publication in the 
journal with the highest impact factor was included. The exclusion criteria for the 
studies were as follows: 1) studies with exclusively laboratory parameters; 2) 
genetic studies; 3) animal experiments; 4) letters; 5) comments; 6) editorials; 7) 
systematic reviews; 8) case reports; and 9) meta-analyses. 
 
Data collection procedure 
In a first step, the studies were selected based on title. The abstracts of the 
retrieved studies were checked for inclusion. For the selected abstracts, the entire 
publication was studied and a decision was made as to whether the publication 
should be included in the study.  
In a second step, meaningful concepts were extracted from the text of the 
selected publications. In this process, the following criteria were used: only the 
Methods and Results sections were assessed, and the concepts were focused on 
the patients themselves and their surroundings; examples and descriptions of the 
therapies and exclusion criteria used in the studies were not included. The 
measurement instruments used in the studies are described in the previous article 
(13). After data extraction, two researchers (PV, JH) compared their results.  
In a third step, the retrieved meaningful concepts were linked to ICF categories 
using standardized linkage rules (14, 15). Each relevant concept was linked by two 
researchers (PV, JH). Coding took place until the 4th level. Each 
class/category/code was used only once per article to avoid bias. After the linking 
process was complete, the two experts compared their results. Comparison of the 
meaningful concepts and the linking process took place at the same time. Initial 
disagreement was solved by discussion between the two experts. If disagreement 
remained, a third person (YH or DvR) was consulted.  
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If a meaningful concept pertained to a personal factor such as ‘age’, ‘gender’ or 
‘education’, the code ‘pf’ was attributed because personal factors are not coded 
within the ICF. If a concept described an aspect of functioning and health that is 
not covered by the ICF, such as ‘taking up time’ or ‘suffering’, the code ‘nc’ (not 
covered) was attributed. If a concept pertained to health conditions such as 
‘lymphoedema’ or ‘breast cancer’, which are not included in the ICF, the code ‘hc’ 
(health condition) was attributed. When the concept was related to ‘quality of 
life’, the code ‘nd-qol’ (not definable-quality of life) was used. If the information 
provided by the meaningful concept was insufficient to allow the researchers to 
make a decision regarding which ICF category it should be linked to, the 
meaningful concept was assigned ‘nd’ (not definable) (e.g., ‘side effects’ of 
therapy). Meaningful concepts referring to health in general were assigned ‘nd-
gh’ (not definable-general health). 
 
Inter-coder agreement 
The following steps of the study were performed by two researchers (PV and JH) 
independently of each other: 1) eligibility check of the abstracts; 2) data 
extraction of the included full-text articles and specification of the concepts; and 
3) linking of the concepts to the ICF. After each step, the researchers compared 
their results. Initial disagreement was solved after discussion. If disagreement 
remained, a third person (YH or DVR) was consulted.  
 
Data analysis 
The frequencies of the linked ICF categories were reported. All of the resulting ICF 
categories that referred to concepts measured in more than 5% of the studies 
were reported (16). ICF categories are presented at the second level. If a concept 
was linked to a third- or fourth-level ICF category, the corresponding second-level 
category was reported. This is appropriate because the lower-level categories 
share the attributes of the corresponding higher-level categories (10). Finally, the 
percentage frequencies of the codes of the meaningful concepts in the studies 
and the codes of the meaningful concepts in the questionnaires were compared 
to each other. 
 
Results 
 
Of the 2381 titles retrieved, 149 studies were included. After reading the full-text 
articles, the investigators excluded an additional 13 studies because they did not 
meet the inclusion criteria (e.g., they represented comments or case reports or 
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were not primarily focused on lymphoedema). Of the remaining 136 studies, 88 
(65%) concerned individuals with upper limb lymphoedema, 34 (25%) concerned 
individuals with lower limb lymphoedema, five (3%) reported on individuals with 
midline lymphoedema, and nine (7%) described patients with lymphoedema in 
multiple locations.  
After 34 publications concerning patients with lymphoedema of the upper limb 
were assessed, saturation of the noticed meaningful concepts was reached. 
Because no further information was expected, it was decided that the remaining 
54 publications on upper limb lymphoedema would not be considered. Because 
no discrimination of the location was possible in the studies that involved 
combined lymphoedema locations, these studies were excluded. In the end, the 
included research studies included 73 publications (34 on upper limb 
lymphoedema, 34 on lower limb lymphoedema, and five on midline 
lymphoedema). Twenty of the included studies were intervention studies (n = 15 
for upper limb, n = 4 for lower limb, and n = 1 for midline lymphoedema), 37 were 
observational studies (n = 17 for upper limb, n = 16 for lower limb, and n = 4 for 
midline lymphoedema), 13 were qualitative studies (n = 1 for upper limb and n = 
12 for lower limb lymphoedema), and three were clinimetric studies (n = 1 for 
upper limb and n = 2 for lower limb lymphoedema). The studies of upper limb 
lymphoedema were all conducted in Western countries (i.e., Europe, the United 
States of America and Australia), whereas 22 of the 34 studies of lower limb 
lymphoedema were conducted in Africa, Asia or Central America.  
 
Identified concepts and ICF codes 
A total of 2488 concepts were extracted; 8.8% (219) of these concepts could not 
be linked to ICF categories. Of these 219 concepts, 76 concepts were considered 
‘personal factors’, 75 represented ‘health conditions’, 37 were considered ‘not 
covered’, 21 were considered ‘not defined-quality of life’, and 10 were classified 
as ‘not defined-general health’. The remaining 2269 concepts could be linked to 
ICF categories. In all, three concepts (0.2%) were linked to an ICF component; 64 
(2.8%) were linked to the first level of the ICF, 935 (41.3%) were linked to second-
level ICF categories, and 1265 (55.7%) were linked to third-level ICF categories. No 
concepts were linked to fourth-level categories. After the initial classification was 
made, the third-level categories were merged into the corresponding second-level 
categories. 
Tables 1 through 4 list the 93 second-level ICF categories representing the 
meaningful concepts that were classified in four or more studies involving upper 
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limb and/or lower limb lymphoedema. This cutoff was chosen for readability. 
Because the number of midline studies was very small (n = 5), all of those studies 
were taken into account. Thirty of the 93 categories (32.2%) belong to the 
component Body Functions, 12 (12.9%) belong to the component Body Structures, 
27 (29,1%) belong to the component Activities and Participation and 24 (25.8%) 
belong to the component Environmental Factors. Tables 1 through 4 also show 
the division of the ICF categories linked to the meaningful concepts derived from 
the studies as well as the ICF categories linked to the meaningful concepts derived 
from the lymphoedema-specific questionnaires found in the previous study (13). 
For comparison, the results of the questionnaires for the upper extremity (nine 
questionnaires) and for the lower extremity (two questionnaires) are presented 
separately. There were no questionnaires specific for midline lymphoedema. 
 
Body functions 
The most frequently found second-level categories of the Body Functions 
component for the upper limb were ‘b435, Immunological system functions’ (97% 
of the studies, 89% of the questionnaires), ‘b280, Sensation of pain’ (56% of the 
studies, 78% of the questionnaires), and ‘b265, Touch functions’ (32% of the 
studies, 67% of the questionnaires) (see Table 1). For the lower limb, the most 
frequently found categories were ‘b280, Sensation of pain’ (62% of the studies, 
100% of the questionnaires), ‘b435, Immunological system functions’ (82% of the 
studies, 50% of the questionnaires) , and ‘b265, Touch functions’ (32% of the 
studies, 100% of the questionnaires). In studies of midline lymphoedema, the 
categories ‘b640, Sexual functions’( 80% of the studies) and ‘b435, Immunological 
system functions’ (60% of the studies) were most often found. A similar pattern is 
apparent in the questionnaires, although the class ‘b455, Exercise tolerance 
functions’ is not used to code MCs in the questionnaires for either the upper or 
the lower limb. Several other categories also have no representation in the 
questionnaires (e.g., ‘b160, Thought functions’, ‘b164, Higher-level cognitive 
functions’, ‘b270, Sensory functions related to temperature and other stimuli’, 
‘b530, Weight maintenance functions’, and ‘b540, General metabolic functions’). 
Three ICF categories that are present in the questionnaires were not present in at 
least four studies; these are ‘b134, Sleep functions’, ‘b550, Thermoregulatory 
functions’, and ‘b840, Sensation related to the skin’. 
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Table 1 Frequency of second-level categories of the ICF linked to concepts contained in the 73 
studies for the component Body Functions. For the studies of upper and lower limb lymphedema, 
only ICF codes that were present in at least four of the studies are shown. 
( ) = the corresponding percentage of studies or questionnaires.  
Yellow = categories that have a mutual representation in both the studies and the questionnaires. 
Red = categories that are present in the questionnaires but have no representation in the studies. 
Blue = categories that are present in the studies but have no representation in the questionnaires. 
 
 
  ICF 
code Description Upper Limb Lower Limb  
  
Number 
(%) of 
studies 
Number 
(%) of 
question-
naires 
Number 
(%) of 
studies 
Number 
(%) of 
question-
naires 
Number 
(%) of 
studies 
Midline 
Chapter 1: mental functions           
b114 Orientation functions - - 10 (29) - - 
b122 Global psychosocial functions 4 (12) - 7 (21) - - 
b126 Temperament and personality functions 5 (14) 3 (33) 10 (29) - 1 (20) 
b130 Energy and drive functions - - 10 (29) - 1 (20) 
b134 Sleep functions - 4 (44) - 1 (50) - 
b140 Attention functions - - - - 1 (20) 
b152 Emotional functions 8 (24) 2 (22) 19 (56) 1 (50) 2 (40) 
b160 Thought functions - - 8 (24) - - 
b164 Higher-level cognitive functions - - 9 (26) - - 
b180 Experience of self and time functions 6 (18) 3 (33) 8 (24) 1 (50) 1 (20) 
Chapter 2: sensory functions 
and pain           
b210 Seeing functions - - 5 (15) - - 
b265 Touch functions 11 (32) 6 (67) 11 (32) 2 (100) - 
b270 
Sensory functions 
related to temperature 
and other stimuli 
5 (14) - 7 (21) - - 
b280 Sensation of pain 19 (56) 7 (78) 21 (62) 2 (100) 1 (20) 
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Chapter 4: functions of the 
cardiovascular, hematological, 
immunological and respiratory 
systems 
          
b415 Blood vessel functions - - 5 (15) - - 
b430 Hematological system functions - - - - 1 (20) 
b435 Immunological system functions 33 (97) 8 (89) 28 (82) 1 (50) 3 (60) 
b440 Respiration functions - - - - 1 (20) 
b455 Exercise tolerance functions 14 (41) - 13 (38) - - 
Chapter 5: Functions of the 
digestive, metabolic and 
endocrine systems 
          
b530 Weight maintenance functions 4 (12) - 4 (12) - - 
b540 General metabolic functions 4 (12) - - - - 
b550 Thermoregulatory functions - 1 (11) 4 (12) 1 (50) - 
Chapter 6: genitourinary and 
reproductive functions           
b610 Urinary excretory functions - - - - 1 (20) 
b620 Urination functions - - - - 1 (20) 
b640 Sexual functions - - - - 4 (80) 
Chapter 7: 
neuromusculoskeletal and 
movement-related functions 
          
b710 Mobility of joint functions 12 (35) 3 (33) 6 (18) 1 (50) 1 (20) 
b730 Muscle power functions 9 (26) 1 (11) 6 (18) 1 (50) - 
b735 Muscle tone functions - - - - 1 (20) 
Chapter 8: functions of the skin 
and related structures           
b810 Protective functions of the skin 8 (24) 3 (33) 14 (41) 1 (50) 1 (20) 
b820 Repair functions of the skin 8 (24) 1 (11) 18 (53) 1 (50) 2 (40) 
b830 Other functions of the skin - - 4 (12) - - 
b840 Sensation related to the skin - 3 (33) - - - 
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Body structures 
The most frequently found second-level categories of the Body Structures 
component for the upper limb were ‘s730, Structure of upper extremity’ (91% of 
the studies, 100% of the questionnaires), ‘s420, Structure of immune system’ 
(68% of the studies), and ‘s810, Structure of areas of skin’ (38% of the studies, 
33% of the questionnaires) (see Table 2). For the lower limb, the most frequently 
found categories were ‘s750, Structure of lower extremity’(94% of the studies, 
100% of the questionnaires), ‘s810, Structure of reproductive system’ (26% of the 
studies, 50% of the questionnaires), and ‘s420, Structure of immune system’ (35% 
of the studies). In the midline studies, ‘s630, Structure of reproductive system’ 
(80% of the studies), ‘s750, Structure of lower extremity’ ( 60% of the studies), 
and ‘s810, Structure of areas of skin’ (60% of the studies) were the most often 
classified categories. No representation of ‘s420, Structure of immune system’ 
was found in the questionnaires, although this category had a high frequency in 
the studies. The questionnaires also did not mention ‘s410, Structure of 
cardiovascular system’ or ‘s430, Structure of respiratory system’. It is remarkable 
that ‘s730, Structure of upper extremity’ has a representation in studies of the 
lower limb and vice versa that ‘750, Structure of lower extremity’ is represented 
in studies of the upper limb. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Frequency of second-level categories of the ICF linked to the concepts contained in the 73 
studies for the component Body Structures. For the studies of upper and lower limb lymphedema, 
only  ICF codes present in at least 4 of the studies are shown.  
( ) = the corresponding percentage of studies or questionnaires.  
Yellow = categories that have a mutual representation in both the studies and the questionnaires. 
Blue = categories that are present in the studies but have no representation in the questionnaires. 
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 ICF 
code Description Upper limb Lower limb  
  
Number 
(%) of 
studies 
Number 
(%) of 
question-
naires 
Number 
(%) of 
studies 
Number 
(%) of 
question-
naires 
Number 
(%) of 
studies 
Midline 
Chapter 4: structures of the 
cardiovascular, immunological and 
respiratory systems      
s410 Structure of cardiovascular system - - 6 (18) - 1(20) 
s420 Structure of immune system 23 (68) - 12 (35) - 1(20) 
s430 Structure of respiratory system 4 (12) - - - - 
Chapter 6: Structures related to the 
genitourinary and reproductive 
systems      
s610 Structure of urinary system - - - - 2 (40) 
s620 Structure of pelvic floor - - - - 2 (40) 
s630 Structure of reproductive system 6 (18) 5 (56) 9 (26) 1 (50) 4 (80) 
Chapter 7: Structures related to 
movement      
s720 Structure of shoulder region 9 (26) 2 (22) - - 1 (20) 
s730 Structure of upper extremity 31(91) 9 (100) 8 (24) - 1 (20) 
s740 Structure of pelvic region - - 6 (18) - - 
s750 Structure of lower extremity 5 (15) - 32 (94) 2 (100) 3 (60) 
s760 Structure of trunk 6 (18) 3 (33) - - 2 (20) 
Chapter 8: Skin and related 
structures      
s810 Structure of areas of skin 13 (38) 3 (33) 12 (35) - 3 (60) 
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Activities and participation  
In the component Activities and participation, ‘d570, Looking after one’s 
health’(71% of the studies, 78% of the questionnaires), ‘d540, Dressing’ (21% of 
the studies, 78% of the questionnaires), and ‘d455, Hand and arm use’ (21% of the 
studies, 56% of the questionnaires) were most often coded for the upper limb 
(see Table 3). For the lower limb, ‘d570, Looking after one’s health’ (65% of the 
studies, 50% of the questionnaires), ‘d850, Remunerative employment’ (32% of 
the studies, 50% of the questionnaires), and ‘d230, Carrying out daily routine’ 
(29% of the studies, 50% of the questionnaires) were the most frequently found 
categories. In the midline studies, ‘d570, Looking after one’s health’ (40% of the 
studies) was the most frequently found category.  In contrary to the upper 
extremity, the ICF codes of the lower limb ‘d415, Maintaining a body position’ and 
‘d540, Dressing’ are not used in the questionnaires. This is also the case for many 
of the codes in chapters 3, 4, 5, 7, 8, and 9. On the other hand, ‘d325, 
Communicating with-receiving- written messages’, ‘d330, Speaking’, ‘d440, Fine 
hand use’, ‘d445, Hand and arm use’, ‘d470, Using transportation’ and ‘d650, 
Caring for household objects’ are not represented in the studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.Frequency of second-level categories of the ICF linked to concepts contained in the 73 
studies for the component Activities and Participation. For the studies of upper and lower limb 
lymphedema, only ICF codes present in at least 4 of the studies are presented.  
( ) = the corresponding percentage of studies or questionnaires.     
Yellow = categories that have a mutual representation in both the studies and the questionnaires. 
Red = categories that are present in the questionnaires but have no representation in the studies. 
Blue = categories that are present in the studies but have no representation in the questionnaires. 
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 ICF 
code Description Upper limb Lower limb  
  
Number 
(%) of 
studies 
Number 
(%) of 
question-
naires 
Number 
(%) of 
studies 
Number 
(%) of 
question-
naires 
Number 
(%) of 
studies 
Midline 
d155 Acquiring skills - - 5 (15) - - 
Chapter 2: general tasks and demands 
d230 Carrying out daily routine 6 (18) 3 (33) 10 (29) 1 (50) - 
Chapter 3: Communication 
d325 Communicating with-receiving- written messages - 1 (11) - 1 (50) - 
d330 Speaking - 2 (22) - - - 
d335 Producing non-verbal messages - - 7 (21) - 1 (20) 
d340 Producing messages in formal sign language - - 6 (18) - - 
Chapter 4: Mobility 
d410 Changing basic body position - - 7 (21) - - 
d415 Maintaining a body position 6 (18) 3 (33) 16 (47) - 1 (20) 
d430 Lifting and carrying objects 6 (18) 2 (22) - - - 
d440 Fine hand use - 2 (22) - 1 (50) - 
d445 Hand and arm use 7 (21) 5 (56) - 1 (50) - 
d450 Walking - 2 (22) 11 (32) - 1 (20) 
d460 Moving around in different locations - - 5 (15) - - 
d470 Using transportation - 4 (44) - - - 
Chapter 5: Self-care 
d510 Washing oneself - - 8 (24) - - 
d520 Caring for body parts 10 (29) 2 (22) 10 (29) - - 
d530 Toileting - - - - 1 (20) 
d540 Dressing 7 (21) 7 (78) 16 (47) - - 
d570 Looking after one’s health 24 (71) 7 (78) 22 (65) 1 (50) 2 (40) 
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 Chapter 6: Domestic life 
d640 Doing housework 4 (12) 3 (33) 9 (26) 1 (50) - 
d650 Caring for household objects - 2 (22) - - - 
d660 Assisting others - - 6 (18) - - 
Chapter 7: Interpersonal interactions 
and relationships      
d710 Basic interpersonal interactions - - 4 (12) - - 
d720 Complex interpersonal interactions 6 (18) - 8 (24) - - 
d750 Informal social relationships - - 7 (21) - - 
d770 Intimate relationships - - 9 (26) - 1 (20) 
Chapter 8: Major life areas 
d845 Acquiring, keeping and terminating a job - - 7 (21) - - 
d850 Remunerative employment 5 (15) 5 (56) 11 (32)  1 (50) - 
d870 Economic self-efficiency - - 10 (29) - - 
Chapter 9: Community, social and 
civic life      
d910 Community life 7 (21) - 10 (29) - 1 (20) 
d920 Recreation and leisure 5 (15) 5 (56) 11 (32) - 1 (20) 
d930 Religion and spirituality - - 8 (24) - - 
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Environmental factors 
For the component ‘Environmental factors’, the most frequently found categories 
for the upper limb were ‘e580, Health services, systems and policies’ (100% of the 
studies, 67% of the questionnaires), ‘e355, Health professionals’ (85% of the 
studies, 56% of the questionnaires), and ‘e115, Products and technology for 
personal use in daily life’ (68% of the studies, 67% of the questionnaires) (see 
Table 4). For the lower limb, these were ‘e580, Health services, systems and 
policies’ (100% of the studies, 50% of the questionnaires), ‘e325, Acquaintances, 
peers, colleagues, neighbors and community members’ (91% of the studies, 50% 
of the questionnaires), and ‘e355, Health professionals’ (79% of the studies). The 
categories ‘e580, Health services, systems and policies’ (100%), ‘e325, 
Acquaintances, peers, colleagues, neighbors and community members’ (80%), and 
’e110, Products and substances for personal consumption’ (60%) were found in 
three or more studies of midline lymphoedema. Comparison of the ICF codes in 
the studies and those in the questionnaires showed that in the case of ’e110, 
Products and substances for personal consumption’, ‘e115, Products and 
technology for personal use in daily living’, and ‘e355, Health professionals’, there 
is no representation of ICF codes in the questionnaires relating to the lower limb. 
This also applies to several other categories in the chapters concerning 
Environmental Factors (see Table 4). The categories ‘e125, Products and 
technology for communication’, ‘e135, Products and technology for employment’, 
‘e225, Climate’ and ‘e245, Time-related changes’ are present in the 
questionnaires but not in the studies. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Frequency of second-level categories of the ICF linked to the concepts contained in the 73  
studies for the component Environmental Factors. For the studies of upper and lower limb 
lymphedema, only the ICF codes present in at least 4 studies are presented. 
( ) = the corresponding percentage of studies or questionnaires.  
Yellow = categories that have a mutual representation in both the studies and the questionnaires. 
Red = categories that are present in the questionnaires but have no representation in the studies. 
Blue = categories that are present in the studies but have no representation in the questionnaires. 
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 ICF 
code Description Upper limb Lower limb  
  
Number 
(%) of 
studies 
Number 
(%)  
of 
question-
naires 
Number 
(%) of 
studies 
Number 
(%) 
of 
question-
naires 
Number 
(%) of  
Studies 
Midline 
e110 
Products and substances 
for personal 
consumption 
13 (38) 4 (44) 26 (76) - 3 (60) 
e115 
Products and technology 
for personal use in daily 
living 
23 (68) 6 (67) 23 (68) - 2 (40) 
e125 Products and technology for communication - 1 (11) - 1 (50) - 
e135 Products and technology for employment - 3 (33) - 1 (50) - 
e140 
Products and technology 
for culture, recreation 
and sport 
4 (12) - - - - 
e150 
Design, construction and 
building products and 
technology of buildings 
for public use 
- - 5 (15) - - 
e155 
Design, construction and 
building products and 
technology of buildings 
for private use 
- - 9 (26) - 1 (20) 
e165 Assets - - 5 (15) - - 
Chapter 2: Natural environment 
and human-made changes to 
environment      
e210 Physical geography 5 (15) - 13 (38) - - 
e215 Population 4 (12) - 14 (41) - - 
e225 Climate - 2 (22) 4 (12) - - 
e245 Time-related changes - 2 (22) - - - 
e255 Vibration - - - - 1 (20) 
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 Chapter 3: Support and 
relationships      
e310 Immediate family 8 (24) 2 (22) 16 (47) - 1 (20) 
e315 Extended family - - 8 (24) - - 
e320 Friends - - 9 (26) - - 
e325 
Acquaintances, peers 
colleagues, neighbors 
and community 
members 
24 (71) 2 (22) 31 (91) 1 (50) 4 (80) 
e330 People in positions of authority - - 6 (18) - - 
e355 Health professionals 29 (85) 5 (56) 27 (79) - 2 (40) 
Chapter 4: Attitudes 
e425 
Individual attitudes of 
acquaintances, peers, 
colleagues, neighbors 
and community 
members 
- - 4 (12) - - 
e460 Societal attitudes - - 4 (12) - - 
e465 Social norms, practices and ideologies - - 4 (12) - - 
Chapter 5: services, systems 
and policies      
e535 Communication services, systems and policies 5 (15) - - - - 
e555 
Associations and 
organizational services, 
systems and policies 
- - 5 (15) - - 
e570 Social security services, systems and policies 4 (12) - 4 (12) - 2 (20) 
e580 Health services, systems and policies 34 (100) 6 (67) 34 (100) 1 (50) 5 (100) 
e585 
Education and training 
services, systems and 
policies 
4 (12) - 4 (12) - 1 (20) 
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Discussion 
 
Using the ICF as a reference, it was possible to identify and quantify meaningful 
concepts found in published studies that focus on individuals with lymphoedema. 
While a large number of these concepts (2269 out of 2488) could be linked to the 
ICF, a small portion (8,8%) could not. Of these concepts, Health Conditions can be 
classified with the ICD-10 (34%). Unfortunately, Personal Factors (3%), which is a 
component of the ICF, is still under development, although some provisional lists 
for this component have been published (17, 18). The identification of ICF 
categories in the literature contributes to the development process of ICF Core 
Sets for lymphoedema predominantly from the researchers’ point of view. 
Whereas earlier systematic reviews for ICF Core Set development tended to focus 
on health-specific questionnaires (16), in the present study meaningful concepts 
were extracted both from the studies themselves and from the lymphoedema-
specific questionnaires included in these studies. The results obtained using the 
questionnaires have been published separately (13). 
The most frequently found categories were ‘e580, Health Services, systems and 
policies’ (73 studies), ‘b435, Immunological system functions’ (64 studies), ‘e325, 
Acquaintances, peers, colleagues and community members’ (59 studies), ‘e355, 
Health professionals’ (58 studies), and ‘d570, Looking after one’s health’ (48 
studies). 
Lymphoedema is a chronic health condition that presents most often with swollen 
extremities. Since the lymphatic system is part of the immunological system, this 
explains the frequency of the code ‘b435, Immunological system functions’, which 
implies the swelling of arms and legs. Swelling, especially in the genital area and 
breast, can also be a significant burden in midline lymphoedema. The categories 
‘e580, Health services, systems and policies’ and ‘e355, (support of and 
relationships with) Health professionals’ originate from the fact that in almost 
every study, regardless of design, the relevant therapy for lymphoedema was 
mentioned. The high frequency of ‘e325, (support of and relationships with) 
Acquaintances, peers, colleagues and community members’ derives from the fact 
that in the qualitative researches much emphasis is placed on focus groups and 
fellow-sufferer contacts. These were also coded with ‘e325’. For these underlying 
reasons, the classification ‘e325’ has been biased. Future research on the Core 
Sets development process should indicate whether this code is relevant.  
The minor representation of literature concerning midline lymphoedema in this 
review was expected because midline lymphoedema occurs less often than 
lymphoedema of the upper and lower limbs. The resulting codes for midline 
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lymphoedema might have been biased because the study includes four studies 
about genital lymphoedema and one about breast lymphoedema. Because 
lymphoedema of the breast is seen more frequently than genital lymphoedema, 
there is a need for more studies involving this condition. Furthermore, no studies 
concerning head or neck lymphoedema were found, although these conditions 
frequently occur after surgery for cancer in this area. The present research also 
confirms the need for a lymphoedema-specific questionnaire for midline, 
especially genital lymphoedema, and for head and neck lymphoedema because 
no such questionnaires were found in this literature research. 
 
Body functions 
Concerning the Body Functions categories, much lymphoedema research still 
focuses on the symptoms of pain and swelling, whereas other symptoms, such as 
skin problems (Chapter 8, Functions of the skin and related structures), are less 
well represented. If other research for the development of the ICF Core Sets for 
lymphoedema (i.e., the patient’s, clinician’s and expert’s points of view) indicates 
the importance of skin problems, the authors recommend that skin-related items 
be added to lymphoedema-specific questionnaires.  
ICF chapter 1: Mental Functions is less represented in studies of upper limb 
lymphoedema (4 categories) than in studies of lower limb lymphoedema (8 
categories). The surveyed studies involving lower limb lymphoedema were mostly 
qualitative, whereas many of the studies involving upper limb lymphoedema were 
controlled studies in which symptoms such as pain and swelling were measured. 
Mental functions were more often described in qualitative research than in 
controlled studies. This difference can be explained by the fact that qualitative 
research produces more diverse data than controlled studies, which produce only 
predefined data. Mental Functions, as well as Exercise Tolerance Functions, are 
also much better represented in the studies than in the questionnaires. Although 
researchers often describe problems related to mental function and exercise 
tolerance, there seems to be no need to use these areas as outcome parameters 
in questionnaires; the gap concerning these areas can most likely be filled by using 
generic questionnaires or performance tests. The underrepresentation could also 
be the result of the assumption that training is a contraindication for 
lymphoedema. More recent research devotes more attention to muscle power, 
coordination and endurance (17-19). 
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Body structures 
Within the Body Structures component, the codes ‘s730, Structure of upper 
extremity’, ‘s750, Structure of lower extremity’, and ‘s420, Structure of immune 
system’ were found most frequently. This is most likely because the swelling 
caused by the lymphoedema changed the appearance of the relevant body part. 
Code ‘s420, ‘Structure of immune system’ is used often because of the description 
of lymphatic vessels and nodes. Concerning the codes ‘s730, Structure of upper 
extremity’ and ‘s750, Structure of lower extremity’, the same representations can 
be observed in questionnaires. On the other hand, more attention is paid to ‘s630, 
Structures related to the genitourinary and reproductive systems’ in 
questionnaires. The code ‘s420, Structure of immune system’ is lacking in the 
questionnaires. This is quite understandable because it is difficult to ask patients 
about their lymphatic vessels and nodes. Asking about the genitourinary region 
(genital lymphoedema) and the breast seems more appropriate.  
That ‘s730, Structure of upper extremity’ has a representation in studies of the 
lower limb and, conversely, ‘750, Structure of lower extremity’ has one in studies 
of the upper limb can be explained by the fact that some disorders that cause 
lymphoedema (e.g., filariasis) have consequences for the entire body although 
only one body part was examined in the study. 
 
Activities and participation 
In general, treatment of lymphoedema is divided into an extensive and a 
maintenance phase. In the second phase, self-management is of great 
importance. This explains the high frequency of the item ‘d570, Looking after 
one’s health’ in the studies as well as in the questionnaires. Furthermore, 
researchers describe problems with maintaining a body position (‘d415’), e.g., 
lying, sitting and standing, especially for the lower limb (47%), but do not  ask 
about these problems in their questionnaires. This issue could also be relevant in 
upper limb lymphoedema, especially in patients with mastectomy and higher-
grade lymphoedema. If maintaining a body position  seems to be a problem, 
patients should be questioned about it more often.  
Most of the literature found concerned lymphoedema of the upper extremities (n 
= 88), whereas lymphatic filariasis primarily damages the lymphatic system of the 
lower extremities (18-23). The category ‘d450, Walking’ has a rather low 
frequency (32% of the studies about lower limb lymphoedema). Furthermore, 
walking is not mentioned in lymphoedema-specific questionnaires regarding the 
lower limb, although this may have been taken into account by using generic 
questionnaires or performance tests. There is an apparent need for research to 
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provide more insight into the restrictions people with lymphoedema have with 
walking.  
 
Environmental factors 
Although the component Environmental Factors is not frequently used to code 
meaningful concepts, the support of health professionals and the provision of 
therapy (‘e355, Health professionals’ and ‘e580, Health services, systems and 
policies’) seem to be important because they are mentioned in all of the studies 
and half of the questionnaires. The categories ‘e110, Products and substances for 
personal consumption’ (42 studies) and ‘e115, Products and technology for 
personal use in daily living’ (48 studies) have a fairly high representation. The 
need for medication, the use of ointments for skin care and the use of bandages 
and hosiery are examples of the importance of these items to the lymphoedema 
patient. The results obtained from the questionnaires correspond to these 
findings, although in general there is relatively little representation of the ICF 
categories related to environmental factors in questionnaires related to 
lymphoedema of the lower limb (3 categories). This may be because part of the 
research surveyed was conducted in communities in which access to health 
services is difficult. 
 
Strengths and weaknesses of the study 
The authors introduce a new approach of finding ICF categories in literature. 
Besides examining questionnaires, the studies themselves were observed as well. 
The number of ICF categories is much greater than the number of categories 
provided in the questionnaires. This has to be taken into account in the 
comparison of results. Nevertheless, by examining both the questionnaires and 
the studies themselves, a useful selection of ICF categories has been identified. 
The authors recommend the use of both questionnaires and studies because 
these approaches are complementary to each other and because the use of both 
methods yields more data than can be obtained by using either method alone.  
All of the publications on upper limb lymphoedema used in this study originated 
in Western countries. The literature on lower limb lymphoedema came from both 
Western and developing countries. The fact that future Core Sets for 
lymphoedema will be designed primarily based on data produced in the Western 
countries has to be taken in account.  
The selection of studies might have been biased by the inclusion only of studies 
published in English. The literature search covered the period 2005-2010; it is 
possible that including more recent studies would have yielded different results 
(e.g., the Lymph-ICF mentioned by Devoogdt (20)). Furthermore, it was not always 
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simple and straightforward to link concepts reported in clinical studies to the 
appropriate ICF categories, and this process required frequent discussion. More 
information regarding the inter-coder agreement, by calculating kappa, might 
have been useful. Unfortunately, the required data were not recorded. Linkage 
exercises have demonstrated, however, that it is possible to examine and 
compare the content of measures based on the ICF framework and predefined 
linking rules with good reliability (14, 15, 21). 
The fact that the large majority of meaningful concepts found in studies 
concerning lymphoedema could be linked confirms the usefulness of the ICF 
classification. Recent publications (20, 22) stress these findings. Devoogdt et al 
(20) constructed a questionnaire (Lymph-ICF) based on data from interviews with 
patients with breast cancer-related lymphoedema. It consists of 29 meaningful 
concepts and their ICF codes. Although the classifications Body Structures and 
Environmental factors are absent and the linking process remains unclear, their 
findings are in many ways similar to the results of this study. 
 
Conclusion 
The ICF provides a valuable reference for identifying meaningful concepts related 
to individuals with lymphoedema. In this and previous research on lymphoedema-
specific questionnaires, a substantial number of meaningful concepts concerning 
lymphoedema were found, and most of them could be linked to the ICF. The most 
frequently found ICF categories in the studies and questionnaires are similar. 
There is a need for lymphoedema-specific questionnaires concerning midline 
lymphoedema. Questionnaires for the lower limb should be adapted because 
many categories mentioned in the studies do not appear in the few 
questionnaires for the lower limb that were found. The findings of this literature 
review indicate a need to define and to agree on ‘what should be measured’ in 
lymphoedema care. Pusic et al (23) reported a similar conclusion concerning data 
obtained from studies of health-related quality of life for patients with upper limb 
lymphoedema. 
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Abstract 
The health-related quality of life questionnaire for lymphedema of the upper limb 
(ULL27) was translated into Dutch according to international guidelines and 
validated. Eighty-four patients with lymphedema that occurred after axillary 
surgery for breast cancer and subsequent radiotherapy, chemotherapy, or 
hormonal therapy, completed the translated version of the ULL27 and the 
RAND36. Severity of upper limb edema was measured by specialized 
physiotherapists. The internal consistency of the domains of the questionnaire 
was good as were the convergent validity and discriminant ability. Upper limb 
volume and the domains of the ULL27 were not correlated. The Dutch translation 
of the ULL27 questionnaire has good internal consistency and validity but further 
research is needed to determine its responsiveness. 
 
Keywords: validation, lymphedema, health-related quality of life, ULL27, RAND36, 
breast cancer 
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Introduction 
Breast cancer is diagnosed in 9,000 women a year in the Netherlands. The 
prevalence of upper limb lymphedema is 25% after modified radical mastectomy 
and 40% after adjuvant radiotherapy in the axillary region (1). Although upper 
limb lymphedema is sometimes treated surgically, it is usually treated 
conservatively, with manual lymphatic drainage (a mild form of massage), 
ambulant compression, exercise, and advice (2). The aim of such treatment is to 
reduce the edema and to improve the function of the upper limb (especially 
kinesiophobia, pain and limited shoulder function and usage). Functional 
limitations of the affected upper limb have a much greater impact on well-being 
than the increase in the size of the upper limb (3-5). Moreover, impairments such 
as swelling, numbness, and pain are not correlated with upper limb function (6). 
Both Bosompra et al (6) and Johansson et al (7) stressed the importance  of 
assessing patients not only at the level of impairment but also for practical and 
psycho- social problems experienced by patients in daily life. Indeed, most 
investigators stress the importance of using health-related quality of life (HRQOL) 
questionnaires (8-14) to determine patient well-being. Several HRQOL 
questionnaires are being used to assess patients with cancer, and breast cancer in 
particular, such as the European Organization for Research and Treatment of 
Cancer Quality of Life Questionnaire (EORTC QLQ-C30) (15), the Functional 
Assessment of Cancer Therapy-Breast with 4 additional questions about the upper 
limb (FACT-B+4) (8), the Short Form 36 (SF36) (16) and the Nottingham Health 
Profile (17). However, none of these, mostly generic, questionnaires specifically 
focus on lymphedema and its consequences on HRQOL. The only lymphedema-
specific HRQOL questionnaire currently available is the French language Upper 
Limb Lymphedema 27 (ULL27) (9). Cross-cultural validation of an existing specific 
HRQOL scale has the advantage of avoiding the initial stage of development of a 
new questionnaire. The aim of this study was to translate the ULL27 into Dutch 
and to determine its internal consistency and validity for assessing upper limb 
lymphedema in the Dutch population of patients with lymphedema. 
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Patients and methods  
ULL27 
The ULL27 is a self-report questionnaire encompassing 27 questions with answers 
given on a 5-point Likert scale, ranging from “never” to “always” and is considered 
to measure the effects of lymphedema on HRQOL. The questionnaire measures 
three domains: physical (15 items), psychological  (7 items) and social (5 items), 
with scores ranging from 0 to 100 (100 being the best score possible). Internal 
consistency (Cronbach’s alpha) was reported to be > 0.82. Positive correlations 
between the ULL27 subscales and homologous SF-36 domains were significant. 
Sensitivity analysis in patients with active lymphedema demonstrated a significant 
effect size (9). 
 
Translation 
The questionnaire was translated according to established international 
guidelines (18-24). Two translators independently translated the questionnaire 
from French into Dutch, and a first version was established at a consensus 
meeting. The translation took into account the cultural and lifestyle context, 
making use of appropriate idioms [i.e., cross- cultural adaptation (20)]. 
Subsequently, a third translator translated the Dutch questionnaire back into 
French (19). This process of forward and back translation was repeated until a 
satisfactory translation was achieved [model of Brislin (19)]. 
As stipulated by Guillemin (20), the final translation was tested on patients, to 
clarify any ambiguities, in one-to-one interviews. Five patients commented on the 
difficulty, clarity and language of the questionnaire using a Dutch translation of 
the EORTC debriefing questionnaire for this purpose (15). Based on this 
information, a new version of the Dutch questionnaire was generated, which was 
translated into French by a fourth translator. 
The final version of the questionnaire and its back translation, were then sent to 
the originator of the ULL27, Professor Launois (21), for comments. These were 
incorporated in the definitive version of the Dutch translation of the ULL27. 
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RAND36 
The RAND 36-item Health Survey (RAND36) is a generic HRQOL questionnaire. It 
contains 8 domains: Physical Functioning (PF), Social Functioning (SF), Role 
Physical (RP), Role Emotional (RE), Mental Health (MH), Vitality (VT), Pain (P) and 
General Health (GH). Internal consistency was > 0.71 and construct validity, 
compared to similar scales, was significant (25). 
 
Validation 
The questionnaire was validated in twenty-three physiotherapy practices by 
physiotherapists specialized in edema therapy. Patients who matched the 
inclusion criteria were asked to participate in this study. These criteria were (1) 
women only, (2) unilateral edema of the upper limb, (3) no distinction between 
primary and secondary lymphedema, and (4) women should have fluency in 
Dutch, sufficient to understand the questionnaire. Patients with: (1) progressive 
cancer or (2) who had lymphangitis or infections of the upper limb in the past 2 
months were excluded from this study. 
All participants were asked to complete a general questionnaire concerning 
demographic data, the ULL27 and the RAND36. The physiotherapists were asked 
to determine the severity of edema, following a specific protocol in which the size 
difference of both upper limbs was measured in a standardized way. According to 
the protocol of Kühnke (26) with the volume of the hand added to the total of the 
upper limb. Completed questionnaires were returned and data were anonymized. 
Informed consent was not needed, since all measurements were part of good 
clinical practice. 
The discriminant validity was determined in an age-matched group of 61 women 
without symptoms of the neck, shoulder or upper limb and had been recruited by 
the practice, family, and friends. 
 
Statistical Analysis 
The data were checked for normal distribution. Thereafter the internal 
consistency of the three domains was determined with Cronbach’s Alpha, with a 
value of 0.7 or higher being considered adequate. The item internal consistency 
was also determined, with an item-domain correlation of 0.4 or higher being 
considered sufficient. The item-domain discriminant validity was also determined. 
The concurrent validity was established by comparing the scores of the three 
ULL27 domains with the scores of the eight domains of the RAND36, and the 
discriminant ability was tested by comparing the total score and the scores of the 
- 96 -
three domains of the patients with those of the age-matched group of women 
without upper limb lymphedema. A Spearman correlation coefficient of 0.40 or 
higher was considered to indicate a significant correlation (19). Finally, the 
correlation between the mean scores of the ULL27 and the severity of edema was 
determined. 
This research was conducted in accordance with the Declaration of Helsinki. 
 
Results 
The Translation 
Two translation rounds were needed to obtain the definitive version of the 
questionnaire that was tested on patients in the pilot study. During this study, one 
patient commented that questions on psychological topics might raise 
expectations that physiotherapists would also treat these aspects. This can be 
avoided by giving patients adequate information about treatment goals before 
therapy starts. Another patient suggested that the word “restricted” for questions 
24 to 27 should be replaced by “hindered.” She considered that “restricted” 
meant that a person could not perform an action whereas “hindered” implied that 
a person could still perform the action, albeit to a diminished extent. The 
questionnaire was then discussed with Professor Launois, in English. The use  of 
the word “hindered” or “restricted” in questions 24 to 27 was replaced by “are 
you feeling any difficulty,” and the questionnaire was approved. 
 
The Validation Research 
Twenty-nine physiotherapists specialized in edema were recruited between 
February and August 2006. They recruited 84 patients, the characteristics of 
whom are given in Table 1. 
Most patients (mean age 59) were housewives (42.4 %), and 94% had undergone 
axillary surgery with or without surgical dissection of the breast. Three patients 
had not had surgery, and one patient had undergone extirpation of a melanoma 
on the shoulder. 
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Table 1. Characteristics of the Research Population (N=84) 
Characteristic Mean Sd Range 
Age 59 11.79   34-80 
Size difference in ml. 360.4 338.3 -170-1628 
Start of oedema after the  
operation in months
26 56.51   0-360 
Duration of oedema in months 35.51 45.14   0.5-276 
Number of physiotherapy sessions 115 184.74   0-1100 
 
 
 
Fig. 1. Various treatments for breast cancer (%). 
 
 
Surgery involved breast amputation (n=49) and breast-saving techniques (n=31). 
Patients received various postoperative treatments (see Fig. 1); 47 patients wore 
therapeutic hosiery for treatment of their edema. 
Patients were classified by the severity of edema (Table 2), and then the mean 
ULL27 total score and subdomain scores were calculated for each edema severity 
(Fig. 2). 
96,4
9479,8
56 42,9
Surgery
Axillary surgery
Radiotherapy
Chemotherapy
Hormonal therapy
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Kolmogorov-Smirnov analysis showed the data not to be distributed normally. An 
ANOVA with Bonferroni correction showed that there was no significant 
difference between the total and subdomain scores of the ULL27 in each of the 
four grades of edema severity. 
The internal consistency of the Dutch ULL27 was good (all Cronbach’s alpha values 
>0.7; Table 3) and the item-domain internal consistency was considered sufficient 
except in two cases (> 0.4). Question 20 (“Did you feel confident about the future 
during the last 4 weeks?”) was scored 0.29 and question 22 (“Did you feel well 
and at ease during the last 4 weeks?”) was scored 0.25. The item-domain 
discriminant validity was determined by examining the correlations of the items 
with all three domains. In two cases (also questions 20 and 22) the items showed 
a better correlation with a domain other than its corresponding domain. 
 
Table 2. Classification of the Severity of Edema 
Grade  Description Volume 
difference 
Number of patients 
1  Not measurable oedema 150-299 ml                            45 
2  Small-volume oedema 300-499 ml                            17 
3  Medium-volume  
 oedema 
500-800 ml                            15 
4  Large-volume oedema > 800 ml                              7 
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 Fig. 2. Mean ULL27 score by severity of lymphedema. 
 
Table 3. The Internal Consistency of the ULL27 
  
 
 
 
 
The concurrent validity was examined by associating the outcomes of the ULL27 
with the RAND36. The domains of the Dutch ULL27 were significantly correlated 
with most of the corresponding domains of the RAND36 (Table 4). 
Lastly, the total score and subdomain scores of an age- matched group of women 
without symptoms of the neck, shoulder or upper limb (N=61, mean age (SD) 54 
(9.4)) were compared with those of 61 patients, using an unpaired T-test. The 
total score and subdomain scores of the two groups were significantly different 
(p<0.001), with the control group scoring higher on the ULL27. 
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Domain Dutch version French version 
Physical domain 0.92 0.93 
Psychological domain 0.78 0.86 
Social domain 0.79 0.82 
- 100 -
Table 4. Correlations Between RAND36 and ULL27 
RAND36 Physical domain 
ULL27 
Psychological  
domain 
ULL27 
Social 
domain  
ULL27 
Physical Functioning (PF) 0,38 0,21 0,64 
Role Physical (RP) 0,48 0,35 0,32 
Bodily Pain (BP) 0,69 0,38 0,40 
General Health (GH) 0,60 0,54 0,56 
Vitality (VT) 0,47 0,55 0,44 
Social Functioning (SF) 0,55 0,51 0,45 
Role Emotional (RE) 0,39 0,42 0,36 
Mental Health (MH) 0,52 0,66 0,53 
 
 
Discussion 
The purpose of this study was to translate the French ULL27 questionnaire into 
Dutch and to validate it in a Dutch population of patients with lymphedema in the 
upper  limb. The availability of such a questionnaire makes it possible to compare 
the data collected in other international studies. The questionnaire was validated 
in 84 patients but the distribution of edema severity in this population (grade 1 
53.6%, grade 2 20.2%, grade 3 17.9% and grade 4 8.3%) was not similar to that of 
the French population (n=304) used to validate the original questionnaire (grade 1 
13%, grade 2 20%, grade 3 27%, grade 4 40%), which means that it was not 
possible to compare the data directly. 
Edema severity and ULL27 scores were not correlated, as has been found in other 
studies showing a lack of correlation between the difference in size between the 
affected and non-affected upper limbs and HRQOL (3-7). The internal consistency 
of the three domains was good and similar to that of the French study. The item-
domain internal consistency and item-domain validity differed in two cases: 
questions 20 and 22 showed a better correlation with the social domain than with 
their own psychological domain. These two questions have a different direction in 
their presentation than the other 25 questions and serve as control questions. It 
may be appropriate to ask patients to pay special attention to these questions. 
Otherwise, these items may need to be deleted in a future version. The physical 
domain of the ULL27 was poorly correlated with the Physical Functioning domain 
of the RAND36 (r =0.4). This can be explained by the fact that the questions of the 
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RAND36 are focused more on the lower limb and those of the ULL27 more on the 
upper limb. The strongest correlations between the scores of the psychological 
and social domains of the ULL27 were found for the General Health (GH), Vitality 
(VT), Social Functioning (SF), Bodily Pain (BP) and Mental Health (MH) domains of 
the RAND36 and ranged from rs 0.55-0.69, supporting concurrent validity. The 
correlations were less strong for the other domains, as was also found with the 
original French questionnaire (manuscript in preparation). 
Lastly, the Dutch ULL27 showed strong discriminant validity between groups of 
women with and without symptoms of lymphedema of the upper limb. 
However, a distinction in severity of the edema could not be made using the 
ULL27. A potential limitation of this study is that the severity of edema was 
measured according to a written protocol, and the measurements had not been 
practiced in advance. However, since specialized edema physiotherapists 
routinely measure the upper limb volume, it is expected that the measurements 
were accurate, with the only difference from normal practice being the 
measurement of the hand volume as part of the total volume. Moreover, it was 
the difference in hand/arm volume between the two upper limbs that was 
important. 
The finding that HRQOL is not correlated with the difference in volume between 
the two upper limbs is consistent with earlier findings and supports the use of the 
ULL27 to provide additional information about lymphedema of the upper limb, 
because it offers better understanding of the patient in total. A minor limitation of 
the questionnaire is that it does not include information about upper limb 
complaints based on pathology other than edema. Therefore some open 
questions in the French, as well as in the Dutch version, are added to the 27 
questions. 
The design of this study was aimed at the validity of the ULL27. Its sensitivity to 
change in clinical use, however, is not yet determined. Further research is needed 
to establish the responsiveness of the Dutch ULL27. 
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Abstract 
 
Purpose: To identify and quantify meaningful concepts in lymphedema from the 
patients’ perspectives using the International Classification of Functioning, 
Disability and Health (ICF). 
Methods: Six focus group interviews in five different centers were organized, 
audiotaped, transcribed verbatim and analyzed. 
Results: A total of 2681 relevant ICF linkings were performed with the focus group 
data, resulting in 130 different second-level categories. Of these 130 second-level 
categories, 41 (31.5%) categories were categorized as Body Functions, 20 (15.5%) 
as Body Structures, 41 (31.5%) as Activities and Participation, and 28 (21.5%) as 
Environmental Factors. Overall, the most important issues according to the 
patients were the use of hosiery and bandages, support and relationships, and the 
shape of structures related to movement. 
Conclusion: Based on their experiences with lymphedema, patients reported 
activity limitations and participation restrictions combined with impaired body 
functioning. Anatomical changes (Body Structures) were also often mentioned as 
a problem in daily life. Environmental factors may act as a barrier or facilitator for 
patient functioning. The ICF provides a valuable reference to identify concepts in 
statements from lymphedema patients. The results of this research will be used in 
the development of ICF Core Sets for lymphedema. 
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Introduction 
 
Lymphedema is a chronic condition that can lead to physical functioning 
problems, often resulting in distress (1) and loss of quality of life (2, 3). 
Lymphedema presents clinically as swelling given the imbalance between 
interstitial filtration and fluid and protein discharge caused by compromised 
lymphatic system transport capacity. This condition may occur in upper and lower 
limbs as well as the midline (head, neck and thorax) and can be subdivided into 
primary and secondary lymphedema (4). Primary lymphedema, a congenital and 
sometimes hereditary disease, may exist at birth; however, most cases of primary 
lymphedema are manifested during puberty (4). The lymph vessels and/or nodes 
are not well constructed or do not function properly because of gene mutations 
(4). This condition is most commonly observed in the legs but can occur 
throughout the entire body, including the genital region. Secondary lymphedema 
results from lymph vessel and/or node damage, which occurs as a complication of 
oncologic surgery and/or radiotherapy, infections or trauma (5). According to a 
WHO report, approximately 120 million people in 72 countries were infected with 
a parasite (lymphatic filariasis) in 2010 (6). Of these infected individuals, 15 million 
people suffered from the consequent lymphedema manifestations (filarial 
elephantiasis). Podoconiosis is endemic non-filarial elephantiasis due to long-term 
barefoot exposure to irritant volcanic soils in tropical Africa (7). Lymphedema 
epidemiology is not exactly known because it is not a well-registered disease. The 
number of patients worldwide is estimated to be approximately 140-250 million 
(5). 
 
Symptoms of lymphedema 
If untreated, lymphedema leads to irreversible tissue changes, a high risk of 
infection and feelings of heaviness and tightness; in addition, patients report that 
jewelry or clothes feel uncomfortable or tight on the affected body parts (8-10). 
These features lead to impairments, such as a decreased range of movement of 
the limb involved, as well as to limitations in walking, personal care, domestic life, 
occupation and socialization (7). Altered body shape, often leading to 
stigmatization, as well as the need to use garments or bandaging daily, make 
acceptance difficult for the patient as well as his/her family (11).  
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Treatment  
Lymphedema therapeutic options include conservative and operative modalities 
and should be fine-tuned to the patient’s living circumstances, including work and 
home environments, as well as to personal factors, such as age, co-morbidities, 
(malignant) disease prognosis, psychosocial aspects, and physical potential. The 
general goal of conservative treatment is to eliminate edema;  by compression 
therapy in combination with manual lymph drainage (MLD) (12), exercises, proper 
weight reduction and weight control (13), and special skin care to prevent 
infection (14). When maximal initial therapeutic result is achieved, the emphasis 
of the treatment will be on enhancing patient self-management, including strict 
compliance in wearing compression garments (bandages, wraps or hosiery) (12). 
In severe lymphedema stages, circumferential suction-assisted lipectomy can be 
applied to alleviate irreversible alterations, such as adipose tissue formation and 
fibrosis (15). In 2012, the International Lymphedema Framework (ILF) published 
the ‘best practice document’ for the management of lymphedema (16). It 
proposes a comprehensive lymphedema service based on the chronic care model 
and use of the International Classification of Functioning, Disability and Health 
(ICF) as a vehicle for determining and delivering a patient’s needs (16). 
 
ICF 
The ICF provides a comprehensive framework of human functioning as well as a 
classification system, based on a bio-psychosocial model (17, 18). In addition, it 
offers a universal language understood by health professionals, researchers, 
policy makers, patients, and patient organizations.  
The ICF consists of two separate parts. Part 1 addresses functioning and is 
composed of three components: ‘Body Functions’, ‘Body Structures’, and 
‘Activities and Participation’. Part 2 addresses contextual factors and is composed 
of two components: ‘Environmental Factors’ and ‘Personal Factors’. However, 
‘Personal Factors’ are not described as a classification in the ICF yet, because of 
the significant social and cultural variation (11). 
Each ICF category is assigned an alphanumerical code, a letter that refers to the 
classification components (b: Body Functions, s: Body Structures, d: Activities and 
Participation, and e: Environmental Factors). Each letter is followed by a number 
or numbers starting with the chapter number (one digit) and followed by second-
level specifications (three digits) and further third- and fourth-level specifications 
(four and five digits), where applicable. 
Although its classifications with more than 1400 categories can serve as a 
reference, the ICF is not easily applicable in clinical practice. For this reason, tools, 
such as ICF Core Sets (17, 18) (a core set is an ICF selection developed for a 
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specific diagnostic group), make the ICF useful for health care providers (19). The 
Core Sets facilitate the use of ICF-terminology to describe the functioning profile 
of a patient (a ‘functional’ diagnosis) and the formulation of treatment goals. 
Description uniformity is needed to compare data for the evaluation of treatment 
efficacy and to collect data for research. The ICF Core Sets may be used during the 
process of clinical reasoning and to record the results of clinical reasoning and 
treatment in electronic health care records.  
Today, ICF Core Sets have been developed for various burdensome chronic 
conditions (18, 20-22) and since lymphedema is a serious, chronic and worldwide 
problem in health care, there is a great need for specific Core Sets for this disease 
(3, 23, 24) . The development of Core Sets for lymphedema consists of several 
preparatory studies leading to an international consensus conference. To obtain a 
complete spectrum of the effects of lymphedema, these studies have different 
points of view, i.e. the researcher, the clinician, the patient and the international 
expert.  
 
Aim of the study 
The aim of this study is to determine relevant aspects of functioning as well as 
relevant environmental and personal factors from the lymphedema patients’ 
perspective and to quantify these, using the ICF. 
 
Methods 
 
Design 
A Dutch multicenter qualitative study using focus group interviews was conducted 
as part of a larger project on the development of ICF Core Sets for lymphedema 
(25). Patients were recruited from five different centers during 2012-2013. Stucki 
and Cieza (17) developed a method to establish ICF Core Sets for specific 
conditions. The development of ICF Core Sets for lymphedema follows this 
procedure. The study was approved by the Ethics Committee of the Erasmus 
Medical Centre in the Netherlands and performed in accordance with the 
Declaration of Helsinki. 
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Participants 
To obtain a comprehensive understanding of the continuum of clinical care, 
patients from various treatment stages (control, after first contact, during initial 
treatment phase and maintenance phase) were included. Because lymphedema 
occurs in various locations and results from various causes, six different focus 
groups were used, each with 3-8 participants. These groups consisted of patients 
with: (A) lymphedema with non-oncology background (mixed locations), (B) 
lymphedema with oncology background (mixed locations), (C) lymphedema of the 
upper limb (mixed causes), (D) lymphedema of the lower limb (mixed causes), (E) 
lymphedema in the genital region (mixed causes), and (F) lymphedema in the 
head and neck region caused by cancer-treatment. 
All participants had to meet the following inclusion criteria: the individual (1) had 
a diagnosis of lymphedema determined by a physician, (2) was older than 18 
years, (3) was informed of and understood the purpose and rationale of the study, 
and (4) signed the patient consent form. Before they participated, patients had to 
fill in a form with questions about socio-demographic items and comorbidities and 
they had to range their perceived lymphedema severity on a scale from zero to 
ten. 
 
Questions 
The following open-ended questions, based on ICF components, were used in the 
focus groups (26-28): 
1. If you think about your body and mind, what does not work the way it is 
supposed to? (Body Functions) 
2. If you think about your body, in which parts are your problems located? 
(Body Structures) 
3. If you think about your daily life, which problems do you experience 
performing the activities or things you want or are necessary? (Activities 
and Participation) 
4. If you think about your environment and living conditions, what do you find 
helpful or supportive? (Environmental Factors-facilitators) 
5. If you think about your environment and living conditions, what barriers do 
you experience? (Environmental Factors-barriers) 
6. If you think about yourself, what is important about you and the way you 
handle your disease or the problems associated with your disease? 
(Personal Factors) 
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Data collection 
The same moderator (a member of the Dutch Society for Physical Therapists 
within Lymphology (NVFL)) led the focus groups. When collecting information 
about the nature and course of the study, the moderator emphasized that the 
individual retained the right to refuse participation at any time without any 
treatment consequences. Each focus group discussion was digitally recorded and 
transcribed verbatim. When the transcription was completed, the members of 
each focus group were asked – by email - if they agreed with the contents of the 
transcription (member check). If not, alterations were made until there was 
agreement. 
 
Data analysis 
The data analysis was conducted in four steps and followed the method of 
‘meaning condensation’ (29). In the first step, the transcribed focus group data 
were read to obtain an overview of the collected data. In the second step, the 
data were divided into ‘meaning units’, and the theme that dominated a meaning 
unit was determined. A ‘meaning unit’ was defined as a specific unit of text, either 
a few words or a few sentences, with a common theme (30). The text was divided 
as soon as the researcher discerned a shift in the meaning (29). In the third step, 
‘meaningful concepts’ contained in the meaning units were identified. A 
‘meaningful concept’(MC) was defined as a unit of text that conveys a single 
theme (31). A meaning unit could contain more than one MC. This procedure was 
conducted using the Kwalitan software program, version 6.02. 
In step four, each MC was linked to one or more ICF categories according to 
published linking rules (32, 33). Linked ICF categories are defined as relevant 
concepts of functioning for individuals with lymphedema. The following concepts 
cannot be classified using the ICF: personal factors (indicated with ‘pf’), health 
conditions (‘hc’), concepts related to the ICF but cannot be assigned a particular 
component or code (not definable ‘nd’), and concepts beyond the ICF framework 
(not covered ‘nc’). The MCs were linked independently of the six questions (e.g., 
codes referring to the Body Functions component could also arise when the group 
answered one of the five other questions). After each focus group, the linked ICF 
categories were added to a list of ICF categories selected so far from earlier 
studies (34)  
 
Quality of data 
To assure reliability, two health professionals (PV and PG) separately performed 
step three and four in the first focus group to achieve agreement concerning the 
implementation of the linking rules for this specific health condition. The 
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procedure was performed according to the method proposed by Stucki and Cieza 
for the development of ICF Core Sets (32, 33). Afterwards, the MCs and linking 
processes identified by the two health professionals were compared. The degree 
of agreement between the two health professionals (PV and PG) regarding the 
identified MCs as well as the linked ICF categories in the first focus group was 
calculated by kappa statistics. The kappa coefficient values generally range from 0 
to 1, where 1 indicates perfect agreement and 0 indicates no agreement beyond 
what is expected by chance alone. A kappa value of 0.6 or greater is considered 
sufficient (35). Disagreement was resolved by structured discussion. 
 
The data analysis for all focus groups 
After analyzing data from the first focus group and ICF linking, three individuals 
independently linked all MCs from all focus groups to the ICF (PV, YH, DvR). 
Disagreement was resolved after structured discussion to create consensus for a 
final version of the linked ICF categories. This extra ICF coding (agreement) was 
performed to obtain the best possible ICF linking from the patients’ perspectives. 
The degree of agreement concerning the linking of all MCs between the main 
researcher (PV) and the other researchers (YH, DR) was subsequently assessed by 
kappa statistics.  
 
Results 
 
Description of the focus groups patients 
A total of 31 patients with a mean age of 55 years participated in six focus groups; 
the majority of the participants were female (67.7%). Of the 31 patients, the 
lymphedema location included seven exclusive upper limb cases, 11 exclusive 
lower limb cases, five exclusive midline cases and eight cases displaying a 
combination of locations (6 lower limb-genital region cases and two upper limb-
breast cases). In total, 18 patients reported a history of cancer, and 13 reported 
no history of cancer (i.e. primary lymphedema). Lymphedema severity, as judged 
by the participants themselves, was the highest in the lymphedema group with an 
oncologic cause (6.5 on a scale of 0 to 10) and the genital lymphedema group 
(6.0). Further details of the patient characteristics are shown in Table 1.  
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Table 1. Patient characteristics. [( ) = standard deviation.]  
(A) Lymphedema with non-oncology background (mixed locations), (B) lymphedema with oncology 
background (mixed locations), (C) lymphedema of the upper limb (mixed backgrounds), (D) 
lymphedema of the lower limb (mixed backgrounds), (E) lymphedema in the genital region (mixed 
backgrounds) and (F) lymphedema in the head and neck region.   
 
Variables Total 
(n = 31) 
A  
(n = 5) 
B  
(n = 6) 
C 
(n = 5) 
D  
(n = 6) 
E  
(n = 6) 
F  
(n = 3) 
Age in years 
 
55  
(13.6) 
37.8  
(8.5) 
61.1  
(13) 
61.6 
(12.9) 
51.5 
(12.2) 
56.2 
(11.9) 
65.3  
(3) 
Women : men 21 : 10 5 : 0 6 : 0 5 : 0 5 : 1 0 : 6 0 : 3 
Duration of 
lymphedema 
in months 
124  
(160) 
186 
(132.9) 
39  
(20.1) 
49.4 
(50.2) 
218.5 
(231.8) 
184.3 
(205.2) 
5.3  
(1.5) 
Upper limb : 
lower limb : 
midline : 
combination 
7 : 
11 :  
5 : 
8 
0 :  
5 : 
0 : 
0 
2 :  
2 : 
0 : 
2 
5 :  
0 : 
0 : 
0 
0 :  
4 : 
0 : 
2 
0 :  
0 : 
2 : 
4 
0 : 
0 : 
3 : 
0 
Seriousness of 
lymphedema 
on a 11-point 
scale 
5.7 (2.3) 5 (1.2) 6.5 (0.5) 5.6 (3) 5.5 (2.3) 6 (4) 5.3 (2) 
Employment 15 4 2 3 3 2 1 
 
Data analysis and meaning units  
The following meaning units were observed in most of the groups:  
- Lymphedema is accepted as a burden that one has to learn to live with. 
- Hosiery and bandages are viewed as barriers to daily life that also alleviate 
the disability. 
- Persons with lymphedema experience problems with clothing choices. 
- Swimming is an activity that provides relief during the activity itself. 
However, patients do not choose to go to the beach or swimming pool, 
due to either feelings of shame or problems with their stockings.  
- Most lymphedema (swelling) problems are experienced during summer. 
However, some patients report fewer problems in summer compared 
with winter. 
- Contact with health professionals is rather ambivalent. The patients 
report good and bad experiences. In addition, the patients feel as if health 
professionals are ignorant and downplay lymphedema, because they do 
not really know what it means to have lymphedema.  
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- Numbness and hardened skin are the most frequently mentioned 
problems concerning the skin.  
- Patients report that distress has a negative effect on lymphedema; stress 
worsens lymphedema and is a risk factor for erysipelas. 
- Contact with fellow sufferers is worthwhile. 
-  Patients with lymphedema localized in the genital area as well as in the 
head and neck region are most likely to discuss the impact and 
consequences of operations compared with the other groups.  
- Patients with lower limb lymphedema experience swelling that always 
begins in the feet and expands up the leg, whereas patients with upper 
limb lymphedema describe swelling at various sites of the arm.  
- Individuals with lymphedema in the lower limbs mentioned pain more 
often than those with lymphedema in other locations. 
- The group with genital lymphedema uses specific devices, such as general 
lymphedema devices or devices that support urination (e.g., the 
Whittaker pouch and self-made constructions to regulate urination), most 
often compared with other groups.  
 
Linking MCs to the ICF  
Based on the focus group data, a total of 2681 relevant ICF linkings were 
performed. In total, 12 first-level categories, 78 second-level categories, 146 third-
level categories, and 7 fourth-level categories for ICF linkings were identified. For 
clarity and readability, the third- and fourth-level categories were merged into the 
second-level categories, resulting in 130 different second-level categories. Of the 
130 second-level categories, 41 (31.5%) categories were identified as Body 
Functions, 20 (15.5%) as Body Structures, 41 (31.5%) as Activities and 
Participation, and 28 (21.5%) as Environmental Factors. Of the 282 MCs that could 
not be given an ICF code (9.5% of all MCs), 135 (48%; 4.6% of all MCs) were coded 
as Personal Factors, 9 (3%; 0.3% of all MCs) were coded as ‘nc’, 12 (4%; 0.4% of all 
MCs) were coded as ‘nd’, 7 (2%; 0.2% of all MCs) were coded as ‘nd-gh’, and 119 
(43%; 4% of all MCs) were coded as ‘hc’. 
 
Body Functions 
Table 2 (tables 2-5 published on the Acta Oncologica website) shows the first- and 
second-level categories identified for the Body Functions component. The top five 
frequently mentioned categories were ‘b435, Immunological system functions’ 
(impairments in the lymphatic system); ‘b152, Emotional functions’ (emotions 
such as fear, anger, joy); ‘b280, Sensation of pain’; ‘b126, Temperament and 
personality functions’ (including psychic stability, confidence and optimism); and 
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‘b840, Sensations related to the skin’ (including itching and tingling). This pattern 
is observed in most of the groups, with a few differences. In the group with 
lymphedema in the head and neck region (F), the most mentioned category is 
‘b510, Ingestion functions’. In the group with upper limb lymphedema (C), the 
most frequent category is ‘b455, Exercise tolerance functions’. Various quotes 
from patients describing some of these categories are found below.  
“ … heavy feeling and tiredness. Especially in the summer when it is hot, you get 
the feeling that your leg is swelling and you can’t move forward. Previously I did 
not have that problem but ever since the edema it bothers me” (patient from 
group B lymphedema with oncology background (mixed locations)).  
“…it looks as if mental things have more influence on the edema than physical. 
When, for instance, I witness a funeral the edema gets worse” (patient from 
group B lymphedema with oncology background (mixed locations)). 
 
Body Structures 
Table 3 displays the first- and second-level categories identified for the Body 
Structures component. In this component, the top five mentioned categories 
were ‘s750, Structure of lower extremity’; ‘s730, Structure of upper extremity’; 
‘s630, Structure of reproductive system’; ‘s710, Structure of head and neck 
region’; and ‘s760, Structure of trunk’. In the genital lymphedema (E) group, the 
most mentioned category was ‘s630, Structure of reproductive system’. In group F 
(head and neck lymphedema), the most mentioned category was ‘s710, Structure 
of head and neck region’. The following quotes illustrate the Body Structures 
component: 
“...but in fact I already have thick feet and swollen legs since 1978” (patient from 
group D lymphedema of the lower limb (mixed causes)). 
“…but it is especially the deformation of my face. That is very annoying. It does 
not bother me much, except that my lips get swollen. They do not occlude enough 
and you make a mess when drinking” (patient from group F lymphedema in the 
head and neck region). 
“…when I was being operated and my lymph nodes were removed, they told me 
that there was a chance I could get swollen legs. But about genital lymphedema 
they did not say anything. You had to find that out afterwards by yourself” 
(patient from group E lymphedema in the genital region). 
 
Activities and Participation 
Table 4 indicates the first- and second-level categories identified for the Activities 
and Participation component. The top five categories identified were ‘d920, 
Recreation and leisure’; ‘d415, Maintaining a body position’ (lying, sitting, 
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standing, etc.), ‘d570, Looking after one’s health’ (ensuring comfort, maintaining 
health and managing diet and fitness); ‘d450, Walking’; and ‘d475, Driving’. In 
focus group C (upper limb lymphedema with mixed backgrounds), ‘d640, Doing 
housework’ occurred most frequently, whereas ‘d415, Maintaining a body 
position’ occurred most frequently in the genital lymphedema group (E).  
Typical quotes from the Activities and Participation component are found below: 
“…you are always busy considering your legs. Because you can’t work and practice 
a sport and doing things at home as well” (patient from group A lymphedema with 
non-oncology background (mixed locations)). 
 “…the problem with driving is the pain in your legs. But since I have a car with 
cruise control it doesn’t bother me anymore” (patient from group D lymphedema 
of the lower limb (mixed causes)).  
Some statements regarding the impact of genital lymphedema (group E patients) 
are:  
“…I can’t walk very far, I can’t sit for a long time, I can’t lay down and I can’t bend 
over because I lose my balance and then I fall down on the ground. This is 
hindering my daily activities, although I try to make the best out of it”.  
“…I also can’t urinate in a normal way. At home I use an urinal and when I leave 
home I always take little cups with me because it sprinkles everywhere. I use a 
diaper and every morning I bandage my scrotum”.  
 
Environmental Factors 
Table 5 displays the first- and second-level categories identified for the 
Environmental Factors component. The categories that occurred most often were 
‘e115, Products and technology for personal use in daily living’ (non-adapted 
items include clothes, shoes, textiles, furniture, and tools; adapted items include 
stockings and prostheses); ‘e580, Health services, systems and policies’ (all 
services, systems and policies for the prevention and treatment of health 
problems that provide medical rehabilitation and promote a healthy life style); 
’e355, Health professionals’; ‘e310, Immediate family’; and ‘e110, Products and 
substances for personal consumption’. The examples below illustrate these 
findings:  
 “…what really works is a hula-hoop. It helps draining the lymphedema in my legs 
when I use it daily” (patient from group D lymphedema of the lower limb (mixed 
causes)).  
“…the insurance company does not always co-operate. They compensate two 
pairs of stockings within 12 months, which is not sufficient at all. I just have to pay 
them myself” (patient from group E lymphedema in the genital region (mixed 
causes)). 
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Personal Factors 
Personal factors can be broadly divided into socio-demographic factors (including 
gender and race), personal living situations and coping strategies.  
Various quotes applicable to these factors are found below: 
“…I don’t know how to explain it. Everybody would like to assist you but in some 
sort of way you live in a cocoon. You go your own way and you seclude yourself 
from them. There will be a moment in time that you will realize that you can’t do 
it alone, but I am not at that point yet” (patient from group A lymphedema with 
non-oncology background (mixed locations)). 
 “...always being busy. With a group of friends practicing sports and afterwards 
drinking a pint. Not sitting at home and thinking about the problems” (patient 
from group E lymphedema in the genital region (mixed causes)). 
 
Not covered or definable items 
Statements that were not covered or definable by the ICF were for instance: “daily 
life”, “handicap”, ”dead”, ”tissue” and “being sickly”.  
 
Quality of data 
Inter-coder reliability in the first focus group (PV and PG). 
The inter-coder agreement for the determination of MCs was 63.8% (kappa 0.31). 
Regarding the linking of MCs to the ICF, the inter-coder agreement was 73% 
(kappa 0.46). As previously mentioned, the MCs determination and the ICF linking 
process were performed simultaneously. Disagreements most often originated 
from the fact that both researchers possess different points of view (e.g., both 
researchers consistently coded the same MC in different ways).  
 
Inter-coder reliability for all focus groups (PV, YH and DvR). 
The inter-coder agreement for ICF linking of the meaningful concepts between PV 
and YH was 75% (kappa 0.72) and 55% (kappa 0.49) between PV and DR. In this 
case, YH and DR linked MCs with unknown contexts (i.e., the coders did not know 
which focus groups supplied the MCs). These MCs could be interpreted in various 
ways. Examples are MCs like: “I am not a man anymore”, “Visit” and “Stress”. In 
addition, these statements are also examples of the previously cited problem of 
coding the same MC in different ways. 
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Discussion 
 
As part of the development process for ICF Core sets for lymphedema, the 
purpose of this study was to determine relevant aspects of functioning as well as 
environmental and personal factors from the perspective of lymphedema 
patients. Based on their experiences with lymphedema, patients predominantly 
faced activity limitations and participation restrictions (31.5% of MCs) combined 
with impaired body functions (also 31.5% of MCs). Environmental factors were 
indicated in 21.5% of MCs, and these factors were considered to act as barriers 
(e.g., hosiery) or facilitators (e.g., spouses). 
Anatomical changes (body structure impairments) were given less attention and 
identified in 15.5% of MCs. 
From the focus groups it can be derived that lymphedema is a chronic health 
condition, which needs constant medical care and attention. In many parts of the 
world lymphedema is treated in rehabilitation settings. A common complaint of 
patients is that they have a chronic medical problem and need ongoing medical 
care and not only one period of treatment in a rehabilitation setting. The findings 
in this study support this patients’ point of view. Although recent guidelines(12, 
36) put more emphasis on self-management and education of the patient to 
become less dependent on health care, regular monitoring and support is advised. 
Depending on the severity of the condition and the level of self-management, 
patients will need more or less frequent treatment and lifelong monitoring. 
 
Meaning units  
Problems with accepting lymphedema were mentioned in every group; however, 
these problems were cited less frequently in primary lymphedema patients. This 
finding is likely attributable to the fact that these patients have had more time to 
accept their disease as they have experienced lymphedema longer than the other 
groups. Many patients stated that movement, particularly swimming, relieves 
lymphedema symptoms during the activity itself. Consistent with this finding, 
Tidhar et al. (37, 38) designed a water exercise program to improve mobility and 
lymphatic drainage. Most swelling problems occur during summer; however, 
some patients experience fewer problems in summer than winter. Higher summer 
temperatures, resulting in greater subcutaneous fluid in the suprafascial 
compartments  by enhanced capillary filtration, leads to more swelling. The 
available literature does not explain why warm weather provides relief to some 
patients.  
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The most frequently mentioned skin complaints consist of a hardened and numb 
feeling. This complaint could be a negative side effect of radiotherapy; however, 
various patients with primary lymphedema who have not received radiotherapy 
cite similar problems.  
Patients with lower limb lymphedema complain more about pain than people 
with lymphedema in other locations. This observation can be explained by the fact 
that, due to gravitation, more pressure exists in the lower vs. upper limbs.   
 
Body Functions 
The focus group participants reported a variety of impairments in Body Functions. 
All of the chapters in this component were covered, especially the chapters 
regarding mental functions as well as functions of cardiovascular, hematological, 
immunological and respiratory systems. The mental effects of lymphedema 
pertain to topics that were also reported in previous studies, such as impairments 
in body image (39, 40), distress (41, 42), and more fatigue (42). Person et al. (43) 
recommended that physiological distress management should serve as a 
significant component of lymphedema management programs in developing 
countries. Although impairments in sexual functions can play an important role 
(44), these problems were only mentioned in the genital lymphedema group. It is 
possible that these sexual problems are underreported and will be more easily 
expressed in one-to-one interviews. 
 
Body Structures 
Altered body shape is a problem discussed in the groups and found in the Body 
Structures component. The shape of the lower limb was particularly cited as 
problematic. This finding was also mentioned in earlier publications. (39, 40, 42). 
 
Activities and Participation 
All categories of the Activities and Participation component were mentioned. 
Mobility items were mentioned most often, followed by self-care, recreation and 
leisure, and domestic life. Other studies partially support these findings. Self-
management to prevent lymphedema worsening is emphasized in the focus 
groups (11, 45); however, the impact on recreation and leisure was not found in 
earlier literature. The patients also stated that they had problems with creating 
and maintaining interpersonal relationships, which made them isolated in society. 
This isolation was described in various studies(41, 46, 47). In the focus groups, 
remunerative employment was only partially discussed; this observation is likely 
because half of the patient population was not working at the time of the 
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interview. It appears that lymphedema has a minor impact on work in Western 
countries compared with developing countries (47, 48).   
 
Environmental Factors 
The top three mentioned environmental factors are Products and technology, 
Support and relationships, and Health services, systems and policies. The 
literature supports these findings.  
The impact of bandages and hosiery is reported in the literature.  Although studies 
on compression garments are scarce or only described using small patient groups, 
Janda et al. (49) highlighted the financial burden of compression garments (only 
15 patients). Frid et al. (39) mentioned the loss of autonomy as patients are 
dependent on nursing staff for dressing. Sawan et al. (50) concluded that the use 
of hosiery had no impact on health-related quality of life (14 patients). The 
findings of Sawan et al. are not supported by the patients of these focus groups. 
In every focus group bandaging and hosiery were discussed in detail and it was a 
recurring topic. Overall the conclusion is that it is a burden, but one with which 
they cannot live without. Presumably it does affect their health-related quality of 
life. Thus, the influence of this environmental factor should be more broadly 
examined in the future.  
In the search for a correct diagnosis and effective treatment (45), interactions 
with other persons are perceived as both positive and negative, often leading to 
stigmatization (39, 40, 47, 48, 51). Although stigmatization was mentioned in 
some Western studies, the impact of its consequences likely plays a greater role in 
developing countries (48). 
Health professionals are perceived as lacking education in this respect and give 
too less post-intervention support (40, 46, 48, 51). From these patients’ 
observations it can be derived that lymphedema is not well-known and 
sometimes underestimated by health professionals. So there is a need for more 
education for those who could encounter lymphedema (e.g. general practitioners 
and surgeons), especially when working with oncology patients. Financial support 
from government and insurance companies is however lacking (51).  
Personal Factors 
In the qualitative research literature, personal factors play an important role in 
describing the coping strategies of lymphedema patients (11, 39, 46, 48). The 
outcomes of this study support these findings. Unfortunately, personal factors 
cannot be coded with the ICF; however, various suggestions on the subdivision  
and classification of personal factors have been made (52-54). 
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Limitations of the research 
Although several meaning units were identified and most of the ICF domains were 
addressed, various limitations to this study exist. By merging the third and fourth 
ICF levels into the second level, some specific codes (corresponding with MCs) are 
not expressed in the analysis. These codes were presented at the concluding 
consensus conference, which is the last step in the Core Sets development. Based 
on the findings of this research, it cannot be concluded that all of the ICF 
categories that were identified are equally relevant and represent all forms of 
lymphedema because the focus groups were comprised of lymphedema patients 
with various etiologies and clinical locations. Although the researchers attempted 
to obtain data on a variety of health conditions, the predominance of cancer-
related lymphedema (18 of the 31 patients) can serve as a bias. Cross-cultural 
variation was not considered because the study was conducted in one (Western) 
country, the Netherlands. Only one person with a different cultural background 
was part of the focus group. Lymphedema can be inborn; by excluding individuals 
younger than 18 years, some age-related issues were potentially missed.  
This research is part of the preparatory studies for the development of ICF Core 
Sets for lymphedema and provides quantitative data for the consensus 
conference, where the final version of the Core Sets was formulated (25). This 
study uses a qualitative approach, seeming the best method to determine the 
patients’ point of view. For the presentation at the international consensus 
conference, being the final part of the development of the ICF Core Sets, the 
qualitative data had to be made quantitative. This study followed the method of 
Stucki and Cieza (14) in which this is stated. Many researches followed this 
procedure ever since (21, 28-30).  
Furthermore, the research bias could result from the fact that the six open 
questions are leading, referring to specific ICF components. However, all 
participants could freely speak about issues important for them during the focus 
group discussions. Above all, it is important to take into account that the 
qualitative approach in this study was performed to identify the broadest possible 
range of problems, also to provide a decision base for the consensus process in 
the development of ICF Core Sets for lymphedema.  
The low kappa value of the inter-coder reliability between PV and PG (0.46) and 
PV and DvR (0.49) compared with other studies (e.g., Geyh et al. (55); range: 0.46-
0.84) can be partly explained by the fact that the Kappa values were calculated 
after a fully independent formulation of MCs by two persons and concept linking 
to ICF-codes. Inter-individual differences can result from variation in the 
identification of MCs as well as the selection of ICF-codes. In the study of Geyh et 
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al. (55), the kappa values were calculated after consensus was reached for the 
MCs. 
Compared to the literature review (34), which was conducted as part of the 
lymphedema ICF Core set development, some points of interest are worth 
mentioning. Although Randomized Clinical Trials (RCTs) and qualitative research 
are commonly considered the most valuable type of research , qualitative 
lymphedema research is limited. Furthermore, in the existing lymphedema RCTs, 
little attention is given to the following ICF chapters: Functions of the skin and 
related structures, Recreation and leisure, and Support and relationships. 
However, patients indicated that they consider these topics important. These 
findings should be considered when composing the first version of the 
lymphedema Core Sets. They also should be respected by health care providers 
and should be considered as variables in future RCTs. 
 
Conclusion 
 
Systematic research on the effects of lymphedema from a patient’s point of view 
using the ICF has not been previously performed. This study provides sufficient 
data for the development of Core Sets for lymphedema using the bio-psychosocial 
model. The data help to describe the functioning of lymphedema patients using 
international standards. Various lymphedema locations were examined, indicating 
outcome differences and similarities between the groups. Patients with lower 
limb lymphedema tend to have more pain than other patients. Overall, the most 
important issues to the patient were the use of hosiery and bandages, support 
and relationships, and the shape of structures related with movement. The impact 
of hosiery and bandages on daily life in particular needs more attention in clinical 
practice and therefore further investigation is needed to obtain objective 
measurements on this topic. 
Finally, from these focus groups it appeared that lymphedema is a chronic health 
condition which needs ongoing medical care and attention.  
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Table 2. Frequency of the 44 first- and second-level categories of the Body Function component.  
(A) Lymphedema with non-oncology background (mixed locations), (B) lymphedema with oncology 
background (mixed locations), (C) lymphedema of the upper limb (mixed backgrounds), (D) 
lymphedema of the lower limb (mixed backgrounds), (E) lymphedema in the genital region (mixed 
backgrounds) and (F) lymphedema in the head and neck region.   
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ICF code Description Total (A) (B) (C) (D) (E) (F) 
b  4      4 
Chapter 1:  
Mental functions 
        
b114 Orientation functions 1     1  
b126 Temperament and 
personality functions 
58 3 21 9 8 13 4 
b130 Energy and drive 
functions 
17 4 2 3  7 1 
b134 Sleep functions 12 2 5 2   3 
b140 Attention functions 2    1 1  
b144 Memory functions 1   1    
b147 Psychomotor functions 1   1    
b152 Emotional functions 83 6 17 19 13 7 21 
b160 Thought functions 1   1    
b164 Higher-level cognitive 
functions 
14 3 6 2  3  
b180 Experience of self and 
time functions 
7 2  2   3 
Chapter 2:  
Sensory functions 
and pain 
        
b230 Hearing functions 1      1 
b235 Vestibular functions 4  3   1  
b240 Sensations associated 
with hearing and 
vestibular function 
2   1   1 
b250 Taste functions 1      1 
b255 Smell function 1      1 
b260 Proprioceptive function 6 5 1     
b265 Touch functions 18 2 4 6 2 3 5 
b270 Sensory functions related 
to temperature and other 
stimuli 
3 1  2    
b280 Sensation of pain 65 16 11 6 22 4 6 
Chapter 4: 
Functions of the 
cardiovascular, 
hematological, 
immunological and 
respiratory systems 
        
b4  1      1 
b415 Blood vessel functions 8 4 4     
b435 Immunological system 
functions 
159 34 36 17 38 23 11 
b440 Respiration functions 5 2 2    1 
b450 Additional respiratory 
functions 
4      4 
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b455 Exercise tolerance 
functions 
42 6 6 20 4 4 2 
b460 Sensations associated 
with cardiovascular and 
respiratory functions 
4      4 
Chapter 5: 
Functions of the 
digestive, 
metabolic and 
endocrine systems 
        
b510 Ingestion functions 26      26 
b530 Weight maintenance 
functions 
11 4  2 3 1 1 
b535 Sensations associated 
with the digestive system 
3      3 
b555 Endocrine gland functions 1   1    
Chapter 6: 
Genitourinary and 
reproductive 
functions 
        
b620 Urination functions 5     5  
b640 Sexual functions 5     2 3 
b660 Procreation functions 5 4   1   
Chapter 7: 
Neuromusculoskele
tal and movement-
related functions 
        
b710 Mobility of joint functions 11 6 5     
b730 Muscle power functions 6  1  3 1 1 
b735 Muscle tone functions 2      2 
b760 Control of voluntary 
movement functions 
23 4 3 9 2 4 1 
b780 Sensations related to 
muscles and movement 
functions 
26 6 6 5 6  3 
Chapter 8: 
Functions of the 
skin and related 
structures 
        
b8  1    1   
b810 Protective functions of 
the skin 
18 2 3  3 4 6 
b820 Repair functions of the 
skin 
2    1 1  
b840 Sensations related to the 
skin 
47 5 8 3 8 3 20 
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Table 3. Frequency of the 23 first- and second-level categories of the Body Structures component. 
(A) Lymphedema with non-oncology background (mixed locations), (B) lymphedema with oncology 
background (mixed locations), (C) lymphedema of the upper limb (mixed backgrounds), (D) 
lymphedema of the lower limb (mixed backgrounds), (E) lymphedema in the genital region (mixed 
backgrounds) and (F) lymphedema in the head and neck region.   
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ICF code Description Total (A) (B) (C) (D) (E) (F) 
s  2      2 
Chapter 1: 
Structures of the 
nervous system 
        
s1  1  1     
Chapter 2:  
The eye, ear and 
related structures  
        
s2  1      1 
s220 Structures of eyeball 2    2   
Chapter 3: 
Structures 
involved in voice 
and speech 
        
s320 Structure of mouth 11      11 
s330 Structure of pharynx 3      3 
s340 Structure of larynx 2      2 
Chapter 4: 
Structures of the 
cardiovascular, 
immunological 
and respiratory 
systems 
        
s410 Structure of cardiovascular 
system 
3     1 2 
s420 Structure of immune system 9 1  3 2 3  
s430 Structure of respiratory 
system 
2  1    1 
Chapter 5: 
structures related 
to the digestive, 
metabolic and 
endocrine system  
        
s510 Structure of salivary glands 1      1 
s540 Structure of intestine 1     1  
Chapter 6: 
Structures 
related to the 
genitourinary and 
reproductive 
systems 
        
s610 Structure of urinary system 2     2  
s630 Structure of reproductive 
system 
35 2 4 6 1 22  
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Table 4. Frequency of the 43 first- and second-level categories of the Activities and Participation 
component. 
(A) Lymphedema with non-oncology background (mixed locations), (B) lymphedema with oncology 
background (mixed locations), (C) lymphedema of the upper limb (mixed backgrounds), (D) 
lymphedema of the lower limb (mixed backgrounds), (E) lymphedema in the genital region (mixed 
backgrounds) and (F) lymphedema in the head and neck region. 
Chapter 7: 
Structures 
related to 
movement 
        
s710 Structure of head and neck 
region 
20   5 3  12 
s720 Structure of shoulder region 12  6 3   3 
s730 Structure of upper extremity 58  25 29 1 2 1 
s740 Structure of pelvic region 10    1 9  
s750 Structure of lower extremity 179 54 25 7 82 11  
s760 Structure of trunk 19 2 2 3 8 4  
s770 Additional musculoskeletal 
structures related to 
movement 
3   1 1  1 
Chapter 8:  
Skin and related 
structures 
        
s810 Structure of areas of skin 11   1 1 7 2 
s840 Structure of hair 1   1    
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ICF code Description Total (A) (B) (C) (D) (E) (F) 
d  3  1 1  1  
Chapter 1: 
Learning and 
applying 
knowledge 
        
d115 Listening 2     2  
d166 Reading 2 1     1 
d170 Writing 2   1   1 
Chapter 2:  
General tasks and 
demands 
        
d230 Carrying out daily 
routine 
10  2 2 1 4 1 
d240 Handling stress and 
other psychological 
demands 
1      1 
Chapter 3: 
Communication 
        
d325 Communicating with –
receiving- written 
messages 
1 1      
d330 Speaking 8  1   1 6 
d335 Producing non-verbal 
messages 
2  2     
d350 Conversation 1     1  
d355 Discussion 1      1 
d360 Using communication 
devices and techniques 
11 1 4 2 2  2 
Chapter 4:  
Mobility 
        
d410 Changing basic body 
position 
26 8 4 3 4 4 3 
d415 Maintaining a body 
position 
59 11 15 9 13 11  
d430 Lifting and carrying 
objects 
22  5 13 1 1 2 
d440 Fine hand use 1  1     
d445 Hand and arm use 6 1  3  1 1 
d450 Walking 45 8 8 5 18 6  
d455 Moving around 32 12 4 6 10   
d470 Using transportation 4  1  2  1 
d475 Driving 38 7 4 8 12 4 3 
Chapter 5:  
Self-care 
        
d510 Washing oneself 6 1 3   2  
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d520 Caring for body parts 3    1  2 
d530 Toileting 4 1 1   2  
d540 Dressing 2  1 1    
d550 Eating 11      11 
d560 Drinking 5    1  4 
d570 Looking after one’s 
health 
57 5 12 3 16 5 16 
Chapter 6: 
Domestic life 
        
d610 Acquiring a place to live 2  2     
d620 Acquisition of goods 
and services 
15 3 4 2 6   
d630 Preparing meals 9  1 1 3  4 
d640 Doing housework 33 1 5 24 3   
d650 Caring for household 
objects 
2 1  1    
d660 Assisting others 2   2    
Chapter 7: 
Interpersonal 
interactions and 
relationships 
        
d7  5   1 1 2 1 
d710 Basic interpersonal 
interactions 
2  1   1  
d750 Informal social 
relationships 
8 1  5 2   
d760 Family relationships 1     1  
d770 Intimate relationships 1      1 
Chapter 8:  
Major life areas 
        
d850 Remunerative 
employment 
31 2 6 12 4 4 3 
d860 Basic economic 
transactions 
1     1  
Chapter 9: 
Community, 
social and civic 
life 
        
d910 Community life 2     1 1 
d920 Recreation and leisure 100 22 22 12 21 8 15 
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Table 5. Frequency of the 32 first- and second-level categories of the component Environmental 
Factors.  
(A) Lymphedema with non-oncology background (mixed locations), (B) Lymphedema with oncology 
background (mixed locations), (C)  Lymphedema of the upper limb (mixed backgrounds), (D) 
Lymphedema of the lower limb (mixed backgrounds), (E) Lymphedema in the genital region (mixed 
backgrounds) and (F) Lymphedema in the head and neck region. 
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 ICF code Description Total (A) (B) (C) (D) (E) (F) 
e  2      2 
Chapter 1: 
products and 
technology 
        
e110 Products and 
substances for personal 
consumption 
64 10 3 9 5 9 28 
e115 Products and 
technology for personal 
use in daily living 
288 64 60 17 97 36 14 
e120 Products and 
technology for personal 
indoor and outdoor 
mobility and 
transportation 
6   1 2 1 2 
e130 Products and 
technology for 
education 
5   1   4 
e135 Products and 
technology for 
employment 
3 1 1  1   
e140 Products and 
technology for culture, 
recreation and sport 
3  3     
e155 Design, construction 
and building products 
and technology of 
buildings for private use 
1  1     
Chapter 2: 
Natural environment 
and human-made 
changes to 
environment 
        
e2  3  3     
e210 Physical geography 1  1     
e220 Flora and fauna 1    1   
e225 Climate 44 13 20 1 1 2 7 
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Chapter 3:  
Support and 
relationships 
        
e3  6     4 2 
e310 Immediate family 88 10 4 35 19 14 6 
e315 Extended family 1 1      
e320 Friends 17 2 3 6 0 4 2 
e325 Acquaintances, peers 
colleagues, neighbours 
and community 
members 
23 2 3 12 4 1 1 
e330 People in positions of 
authority 
6   3  2 1 
e335 People in subordinate 
positions 
6  1 2 2 1  
e345 Strangers 3  2 1    
e350 Domesticated animals 3  1 2    
e355 Health professionals 156 15 26 27 34 14 40 
Chapter 4:  
Attitudes 
        
e4  1     1  
e410 Individual attitudes of 
immediate family 
members 
22  1  5  16 
e425 Individual attitudes of 
acquintances, peers, 
colleagues, neighbours 
and community 
members 
1 1      
e450 Individual attitudes of 
health professionals 
10 3 7     
e460 Societal attitudes 19 1 6 6 4  2 
Chapter 5:  
services, systems and 
policies 
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 e540 Transportation services, 
systems and policies 
1     1  
e555 Associations and 
organizational services, 
systems and policies 
9 1 1 5 1  1 
e565 Economic services, 
systems and policies 
4 2 2     
e580 Health services, 
systems and policies 
199 29 24 32 22 30 62 
e585 Education and training 
services, systems and 
policies 
1  1     
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Abstract 
Background: To describe functioning and health of lymphedema patients and to 
identify their most common problems using the International Classification of 
Functioning, Disability and Health (ICF) as part of the preparatory studies for the 
development of ICF Core Sets for lymphedema. 
Methods: Cross-sectional study in a population of lymphedema patients (n = 200), 
undergoing treatment in a Dutch lymphedema-specialised hospital. The second-
level categories of the ICF were used to collect information on patients’ problems 
in daily functioning.  
Results: The mean age of  the study group was 56 years (22-84). 78.5% of the 
patients were female. The most frequent mentioned items were: In the Body 
Functions component: muscle power and mobility of joints , in the Activities and 
Participation component: doing housework, and changing and maintaining a body 
position , in the Environmental Factors: Health professionals, who can act as both 
facilitators and barriers. Interestingly, patients assessed their health more 
positively than health professionals do. 
Conclusion: By using the ICF, a considerable part of the broad spectrum of 
problems in functioning of lymphedema patients was reported. 
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Introduction 
Congenital (primary) or acquired (secondary) lymphedema can affect patient’s 
quality of life both physically and psychosocially (1). It is a chronic condition which 
is often progressive in time (2). Factors influencing the quality of life are pain, 
swelling and disturbed feelings in the affected body parts (2). Patients can 
experience a change in body image or psychological stability, limitations in 
activities and restrictions in participation and all this can depend on the 
localization of the lymphedema as well as on personal and environmental factors 
(3).  
Describing the functioning, disability and health of a lymphedema patient, 
including facilitators and barriers, is an important part of understanding the life of 
a lymphedema patient and will help to define treatment goals.  
The International Classification of Functioning, Disability and Health (ICF), is the 
World Health Organization (WHO) framework for measuring functioning and 
disability at both individual and population levels and is approved by the World 
Health Assembly (4). 
The ICF can be used for many different purposes such as: 
- a scientific basis for understanding and studying health and health-related 
states, outcomes and determinants 
- a common language for describing health and health-related states in order to 
improve communication between different users, such as health care workers, 
researchers, policy-makers and the public, including people with disabilities 
- a tool for comparison of data across countries, health care disciplines, services 
and time 
- a systematic coding scheme for health information systems (4).  
More than 1400 categories are described in the ICF, which is not very applicable in 
daily practice. Working with ICF Core Sets for a specific health condition 
(Comprehensive Core Set of 75-150 categories; Brief Core Set of 10-15 categories) 
allows the ICF to be a practical tool for health professionals (5).  
Since there are no ICF Core Sets for lymphedema, a project was started, following 
the procedures of Cieza et al (6). According to these procedures, four preparatory 
studies were performed from: 1) the researchers’ perspective (systematic review); 
2) the patients’ perspective (qualitative study); 3) the expert perspective (expert 
survey); and 4) the clinical perspective (cross-sectional study). These preparatory 
studies were followed by an international consensus conference, meant for 
experts in the field of lymphedema to decide on the ICF categories to be included 
in the ICF Core Sets for lymphedema. This article reports on the results of the 
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cross-sectional study. The objective was to describe the functioning and disability 
of lymphedema patients and to identify the most common problems in 
lymphedema using the ICF. 
Methods 
Study design 
The study design was a cross-sectional study among lymphedema patients. 
Patients were recruited from the department of the Dutch expert centre of 
lymphovascular medicine Nij Smellinghe Hospital, Drachten, the Netherlands 
between March 2013 and March 2014. This hospital is specialized in the 
treatment of lymphedema and the patients recruited were either inpatients or 
outpatients. In accordance with the declaration of Helsinki, a positive vote of the 
ethics committee was obtained prior to start and informed consent was obtained 
from all the patients. 
 
Assessment 
The ICF has two parts, each containing two separate components. Part 1 covers 
functioning and disability and includes the components Body Functions (b), Body 
Structures (s), and Activities and Participation (d). Part 2 covers contextual factors 
and includes the components Environmental Factors (e) and (non-classified) 
Personal Factors. In the ICF classification, the letters b, s, d, and e, that refer to 
the components of the classification, are followed by a numeric code starting with 
the chapter number (one digit) followed by the second level categories (two 
digits), and the more detailed third and fourth level categories (one digit each). 
For this study, the second level categories of the ICF were used. The ICF provides 
qualifiers which range from 0 – 4 for each category. Each category of the 
components Body Functions, Body Structures and Activities and Participation was 
graded with the qualifiers:  
0 for ‘no impairment/limitation/restriction’,  
1 for ‘mild impairment/limitation/restriction’, 
2 for ‘ moderate impairment/limitation/restriction’,  
3 for ‘severe impairment/limitation/restriction’ and  
4 for ‘complete impairment/limitation/restriction’.  
The categories of the component Environmental Factors were graded with  
0 for ‘No facilitator/no barrier’,  
+ 1 for ‘ mild facilitator’ and – 1 for ‘mild barrier’,  
+ 2 or – 2 for ‘moderate facilitator or barrier’,  
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+3 or – 3 for ‘severe facilitator or barrier’ and  
+ 4 or – 4  for ‘complete facilitator or barrier’.  
Additionally the qualifier ‘8’ had to be used if the available information was not 
sufficient and ‘9’ if the category was not applicable (7).  
The interviewers were instructed to report only limitations and impairment due to 
the lymphedema. If a patient had a limitation due to comorbidity that was not 
associated with lymphedema, this did not contribute to the prevalence of the 
corresponding ICF category and was given the qualifier ‘C’. Because it was not 
patient-friendly to question all categories of the ICF only those second-level ICF 
categories, that came forward from a previous literature study of lymphedema-
specific questionnaires (8) were used for this study (i.e. 102 categories). A 
standardized form collected socio-demographic variables and comorbidities. 
Additionally, health professionals had to rank the patients’ health and the 
magnitude of the problems of the functioning of the patient in everyday life on a 
scale ranging from 0 ( no problem ) to 10 (complete problem).  Patients rated 
their health status in the same way as well. 
 
Data collection procedures  
Patients were recruited and interviewed by health professionals from several 
specialities trained in the principles of the ICF. Each health professional was given 
a personal training how to obtain the best information by performing a patient  
interview. Before an interview started, each patient’s medical record sheet was 
checked and relevant information on socio-demographic variables and diagnoses 
was extracted. During the interview the information was recorded using the 
online database Parantion (Parantion Web Survey 6.8), patient data being 
anonymous.  
 
Data processing 
For the ICF components Body Functions, Body Structures and Activities and 
Participation absolute frequencies of impairments/limitations mentioned by the 
study population were reported. For Environmental Factors absolute frequencies 
of specific categories that were named to be a barrier or facilitator were reported. 
ICF categories that were not mentioned by at least 10% of the study population 
were considered not relevant, except for the midline lymphedema items, because 
this condition is relatively rare. Responses of patients with combinations of 
lymphedema locations were excluded from the analysis. 
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Results 
Two hundred patients were included in the study. Patients’ ages ranged from 22 
to 84 years, with a mean age of 56. Most patients were female (87,5%). The mean 
duration of lymphedema was 11 years ( range of three months to 77 years). There 
were 88 patients with upper limb lymphedema, 89 patients with lower limb 
lymphedema and 8 patients with midline lymphedema (i.e. 2 patients with 
lymphedema of the thorax, 1 with lymphedema in the head and neck region and 5 
patients with genital lymphedema). In addition, there were 15 patients with 
combinations of locations with lymphedema, who were excluded from the study.  
Table 1. Characteristics of the patients (ULL = Upper Limb Lymphedema, LLL = Lower Limb 
Lymphedema) 
Characteristic Total (n=185) ULL (n=88) LLL (n=89) Midline (n=8) 
Mean age (range) 55 (22-83) 60 (23-83) 50 (22-78) 57 (42-72) 
Female (%) 81% 98.9% 69.7% 12.5% 
Duration 
lymphedema (years) 
11.6 7.5 15.8 8.9 
Employment (%) 44.8% 26.1% 60.7% 75% 
 
There were 142 outpatients and 58 inpatients ( treated for lymphedema). 27% 
had primary lymphedema. 20 health professionals interviewed the 200 patients: 
56 by physicians (28%), 71 by nurses (35%), 57 by physical therapists (29%), and 
16 by skin therapists (8%). These professionals rated the patients’ health with a 
mean of 4.2 and the magnitude of the problems in functioning of the patient in 
everyday life with 4.4  on a scale ranging from 0 ( no problem ) to 10 (complete 
problem). Patients themselves rated their health at a mean of  2.5 and 38% (76 
patients) reported no problems in daily life (mean 4.6). 
Tables 2-5 show the most mentioned  ICF categories with impairments, 
limitations, barriers or facilitators for the four ICF components. 
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Table 2 Most mentioned impairments in the component Body Functions.                                                
N = 88 patients with lymphedema of the upper extremity (U; white coloured columns), N= 89 
patients with lymphedema of the lower extremity (L; yellow coloured columns). N= 8 patients with 
midline lymphedema (M; blue coloured columns). 8 = not specified; 9 = not applicable; C = 
Comorbidity. The numbers for 8, 9 and C are added (Total 8,9,C). 
 
 
 
 
 
                                                              
  
U L M U L M U L M U L M U L M U L M
b126
Tempera-
ment and 
personal i ty 
functions
82 76 62 14 13 13 3 7 25 0 1 0  0 1  0 1 2  0
b152
Emotional  
functions
65 62 50 22 24 37.5 8 7  0 3 3 12.5 0 1 0 2 3  0
b530
Weight 
mainte-
nance 
functions
51 64 75 35.5 26 25 10.5 9 0 2 1 0 0 0 0 1 0 0 
b640
Sexual  
functions
72 79 50 8 10 12.5  0 4  0 1 0 12.5 2 0 12.5 17 7 12.5
b710
Mobi l i ty of 
joint 
functions
41 49.5 75 26.5 21.5 0 18.5 26 12.5 5 0 0 1  0 0 7 3 12.5
b730
Muscle 
power 
functions
43 58 75 24 25 12.5 20 14  0 5 2  0  0 0 0 7 1 12.5
Location 
impairmentimpairmentICF code Description
Tota l
8 + 9 + C
0 = no
impairment
2 = moderate
impairment
3 = severe
impairment
4 = complete1 = mi ld
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Table 3 Most mentioned impairments in the component Body Structures. 
N = 88 patients with lymphedema of the upper extremity (U; white coloured columns), N= 89 
patients with lymphedema of the lower extremity (L; yellow coloured columns). N= 8 patients with 
midline lymphedema (M; blue coloured columns). 8 = not specified; 9 = not applicable; C = 
Comorbidity. The numbers for 8, 9 and C are added (Total 8,9,C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U L M U L M U L M U L M U L U L M
s420
Structure of 
immune 
system
88 87.5 6 12.5 5 1 0 0
s720
Structure of 
shoulder 
region
48 75 22 12.5 16 12.5 7 2 5 0
s730
Structure of 
upper 
extremity
56 87.5 18 12.5 15 8 3 0
s740
Structure of 
pelvic 
region
68 18 3 11
s750
Structure of 
lower 
extremity
30.3 30.3 30.3 6.1 1 2
s810
Structure of 
areas  of 
skin
84 74 75 7 18 12.5 8 6 1 2 12.5 0 0 0
Location 
4 = complete 
impairment
Tota l  
8 + 9 + C
M
3 = severe 
impairment
ICF code Description
0 = no 
impairment
1 = mi ld 
impairment
2 = moderate 
impairment
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Table 4 Most mentioned limitations and restrictions in the component Activities and Participation. 
N = 88 patients with lymphedema of the upper extremity (U; white coloured columns), N= 89 
patients with lymphedema of the lower extremity (L; yellow coloured columns). N= 8 patients with 
midline lymphedema (M; blue coloured columns). 8 = not specified; 9 = not applicable; C = 
Comorbidity. The numbers for 8, 9 and C are added (Total 8,9,C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ICF 
code
Description
U L M U L M U L M U L M U L M U L M
d410
Changing 
bas ic body 
pos i tion
68 49.5 4 16 30.5 12.5 11 16 12.5 1 12.5 5 3 12.5
d415
Mainta ining 
a  body 
pos i tion
50 66.3 62.5 28 21.7 14 10 12.5 5 12.5 3 2 12.5
d430
Li fting and 
carrying 
objects
27 59 62.5 32 19 30 9 12.5 5 12.5 3 3 2 12.5
d445
Hand and 
arm use
26 87.5 32 24 12.5 14 1 3 0
d450 Walking 67 36 62.5 10 36 8 18 12.5 6 12.5 1 14 4 12.5
d640
Doing 
housework
24 64.3 50 35 27.7 12.5 30 4 37.5 10 1 1 3 0
d920
Recreation 
and leisure
61.3 57.3 5 17 22.4 2 12.7 13.4 1 5 4.5 2 2 2.4 0
Location
Tota l          
8 + 9 + C
0 = no 
l imitation/  
restriction
1 = mi ld 
l imitation/  
restriction
2 = moderate 
l imitation/  
restriction
3 = severe 
l imitation/  
restriction
4 = complete 
l imitation/  
restriction
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The complete tables with all categories that were reported by at least 10% of the 
study sample are provided as Supplementary material online (Tables 6-9).  
 
Body Functions 
Most mentioned categories in Body Functions were for both the upper and lower 
limb affected patients: ‘b710, Mobility of joint functions’, ‘b730, Muscle power 
functions’, and ‘b530, Weight maintenance functions’. For the midline location 
the most mentioned categories were: ‘b152, Emotional functions’, ‘b126, 
Temperament and personality functions’, and ‘b640, Sexual functions’. 
 
Body structures 
For the upper limb the most mentioned categories were: ‘s720, Structure of 
shoulder region’, ‘s730, Structure of upper extremity’, and ‘s810, Structure of 
areas of skin’. The most mentioned categories in the lower limb were: ‘s750, 
Structure of lower extremity’, ‘s810, Structure of areas of skin’, and ‘s740, 
Structure of pelvic region’. For midline lymphedema patients the following 
categories were the most important: ‘s810, Structure of areas of skin’, ‘s720, 
Structure of shoulder region’, and ‘s420, Structure of immune system’. 
 
Activities and Participation 
In this component the most mentioned items for the upper extremity were: 
‘d640, Doing housework’, ‘d445, Hand and arm use’, and ‘d430, Lifting and 
carrying objects’. For the lower limb these were: ‘d415, Maintaining a body 
position’, ‘d450, Walking’, and ‘d410, Changing basic body position’. For midline 
patients the most important categories were: ‘d640, Doing housework’,  in‘d410, 
Changing basic body position’, and ‘d920, Recreation and leisure’.  
 
Environmental factors 
In this component there was a division in facilitators and barriers. The following 
categories for the upper extremity were most mentioned as facilitators: ‘e355, 
Health professionals’, ‘e310, Immediate family’, and ‘e320, Friends’. Whereas 
‘e125, Products and technology for communication’, ‘e355, Health professionals’, 
and ‘e225, Climate’ were seen as barriers. Facilitators for the lower limb were the 
same as for the upper limb. For the barriers there was a slight difference: ‘e225, 
Climate’, ‘e460, Societal attitudes’, and  ‘e355, Health professionals’ were most 
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mentioned. Most mentioned facilitators for the midline region were: ‘e310, 
Immediate family’, ‘e355, Health professionals’, and ‘e580, Health services, 
systems and policies’. Barriers were: ‘e225, Climate’, ‘e355, Health professionals’, 
and ‘e460, Societal attitudes’. 
 
Discussion 
In this cross-sectional study the most common problems of lymphedema patients 
were explored using the ICF. The findings of this research make clear that all four 
components of the ICF (Body Functions, Body Structures, Activities and 
Participation, and Environmental factors) are relevant for patients with 
lymphedema.  
In the component Body Functions, functions of joint mobility, muscle power, and 
weight maintenance were impaired most frequently for upper and lower 
extremity. A literature study about lymphedema-specific questionnaires 
presented impairments of the immunological system (swelling), pain and touch 
functions as most measured categories (8). Furthermore in another study using 
focus groups the most frequently mentioned categories were: immunological 
system functions, emotional functions (emotions such as fear, anger, joy); pain, 
temperament and personality functions (including psychic stability, confidence 
and optimism), and sensations related to the skin (including itching and tingling) 
(9). The results of these two studies show a rather broad spectrum of 
impairments, but the findings of this study are slightly different with more 
attention to mobility and muscle strength. Weight maintenance is of great 
importance, because overweight is one of the risk factors for developing 
lymphedema. This is in line with previous studies (10, 11). In this study 74.5% of 
the patients considered pain as no problem and 78.9% had no problems 
concerning swelling. In the focus groups all patients mentioned pain and swelling 
as problems, whereas in the lymphedema-specific questionnaires 75% contained 
questions about pain and 83% about swelling.  This could be related to the specific 
treatment the patients received with more focus on mobility and muscle strength 
and the fact that most of the patients were in the maintenance phase (when the 
lymphedema has stabilized), in which swelling was no limitation any more. In the 
maintenance phase the lymphedema already exists for a longer period. Since the 
mean duration of the lymphedema was 11.6 years (see Table 1), it may be 
concluded that most of the patients were in this phase. In addition, midline 
patients have more problems mentally and with sexual functions. Although the 
patients with upper limb and lower limb lymphedema also mentioned problems 
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with sexual functions (11.3% and 14.6% respectively), it is quite understandable 
that patients with lymphedema in the genital region had more problems (37.5%), 
considering the impact of having lymphedema in that region. 
In the component Activities and Participation, most relevant categories pertained 
to recreation and leisure, doing housework and maintaining a body position. 
These are also the results of the focus group research (9), whereas in the 
literature review these items are less prominent (8). In the lymphedema-specific 
questionnaires the most occurring item is ‘looking after one’s health’. In the focus 
group research, all patients mentioned problems with self-management, which is 
no or only a small problem (6.5%) for the patients of this study. Probably this is a 
result of the self-management training as part of the treatment policy of the 
participating hospital.  
Family, health professionals and friends were perceived as facilitators for the 
upper and lower limb in the component Environmental factors. For midline 
patients health services, systems and policies were also important facilitators. This 
emphasizes the importance of patients’ social network and the influence of the 
health professionals. Although no discrimination was made between facilitators 
and barriers in the literature review as well as the qualitative review with focus 
groups, the same categories are important with one exception: ‘Products and 
technology for personal use in daily living’ was the most mentioned item in these 
studies (8, 9). This category contains items like bandaging and hosiery; which are 
important items for lymphedema patients. It remains unclear why these items 
play a less important role in this present study. Perhaps the patients in this study 
are more adapted to the use of these assistive products. Health professionals are 
also mentioned as important barrier. Patients describe the ignorance and play 
down of the health professionals when speaking of lymphedema during cancer 
treatment. In one of the interviews a patient gave an example of how the surgeon 
reacted, when she mentioned her problems with her swollen limb: “Why are you 
complaining about swelling in your arm? You are lucky to be alive.” This is in line 
with the previous qualitative research. Consequently, there is a need for more 
education and a change in attitude concerning lymphedema among health 
professionals.  
The participating health professionals rated the patients’ health with a mean of 
4.2 and the magnitude of the problems of the functioning of the patient with 4.4. 
Whereas the patients themselves rated their health with 2.5 and the problems of 
their daily living with 2.4. It seems that the health professionals overrate the level 
of problems that patients experience. The data of the patients are not in line with 
the previous qualitative research. In the latter, patients experience more 
problems than in this present research. This could be a result of the fact that in 
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the focus groups the topics were  discussed more profound and the rather small 
sample (n = 31). 
This study has some potential weaknesses. All patients were recruited from one 
single hospital. This could serve as a bias, because of the policy of treatment of 
lymphedema (focus on self-management) brings forward special attitudes of 
health professionals and patients, which cannot be generalised for the whole 
population. On the other hand this can be of advantage when patient groups from 
several institutes will be compared in future research; either from a therapeutic 
approach or demographic point of view. Furthermore, the recruitment was not 
performed at random or blinded. Although both limitations are obvious, the data 
of this study represent a considerable part of the distribution of problems in 
functioning of patients with lymphedema.  
 
Conclusion 
The purpose of this cross-sectional study was to provide data of patients with 
lymphedema as one of the preparatory studies for the development of ICF Core 
Sets for lymphedema. This resulted in a representation of the assessment of the 
patients’ perspective by health professionals, using the ICF. The in-depth 
knowledge of the typical spectrum of problems encountered in lymphedema 
patients can contribute to the optimal management of lymphedema patients, the 
teaching of professionals, the planning of studies and the development of 
assessment instruments. 
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Abstract 
Purpose: To capture the views of different health care providers involved in the 
treatment of patients with lymphoedema from various countries around the 
world on the functioning of lymphoedema patients and the factors influencing 
functioning of these patients using the International Classification of Functioning, 
Disability and Health (ICF). 
Method: A world-wide e-mail survey with questions based on components of the 
ICF. 
Results: In total, 142 health professionals from seven different health professions 
and 20 different countries answered the questions. The  aspects of functioning 
that were named by the health professionals could be linked to 359 different ICF 
categories. Of these categories, 109 belonged to body functions (30.4%), 55 to 
body structures (15.3%), 121 to activities and participation (33.7%), and 74 to 
environmental factors (20.6%). Overall, the most mentioned items were: Health 
services, systems and policies, Immunological system functions, Looking after 
one’s health, Products and technology for personal use in daily life, and Dressing . 
Conclusions: The ICF provided a valuable reference for identifying concepts in 
statements from international health care professionals experienced in the 
treatment of lymphoedema patients. The results of this research will be used in 
the development of ICF Core Sets for lymphoedema. 
- 173 -
Introduction 
Lymphoedema is a chronic condition that is characterised by abnormal 
accumulation of lymph fluid in the body. It occurs when the lymph vessels are 
unable to drain this fluid. It is caused by damage to or the absence of lymph 
vessels and/or excessive production of extracellular fluid. Lymphoedema can 
occur in both the upper and lower limbs as well as in the midline (head, neck, 
abdomen, and thorax). There are two types of lymphoedema: primary and 
secondary (1). 
Primary lymphoedema  
Sometimes lymphoedema is genetic, which is called primary lymphoedema. Either 
there are fewer lymphatic vessels or lymph nodes or the lymphatic vessels/nodes 
work less effectively. Some genetic types are visible at birth (Milroy’s disease), 
others  can occur later in life (Lymphedema Tarda). Primary lymphoedema can 
occur in any part of the body, but it is most common in the legs, and it starts 
during adolescence or sometimes earlier (2-7). 
 
Secondary lymphoedema  
Secondary lymphoedema is more common than primary lymphoedema. 
Secondary lymphoedema is caused by damage to the lymph vessels or lymph 
nodes; it can occur after an injury such as surgery or due to infection. In the 
Western world,  lymphoedema is well-known  after cancer treatment as a result 
of the removal of lymph nodes (mostly in the axilla or groin) and/or radiotherapy 
(8). Besides the result of cancer treatment in the pelvic organs, lymphoedema in 
the legs can also be caused by  past infections (erysipelas). In the developing 
world, parasites (filariasis) are responsible for millions of cases of patients with 
lymphoedema (9). Patients with lymphoedema experience slower wound healing 
and heaviness and tightness of the limbs, and they have a higher risk of infection 
(10-12), all of which can lead to loss of quality of life because of the limitations in 
activities related to personal care, occupations, domestic life and socialisation 
(13). Lymphoedema requires lifelong skin care and precautions to minimise 
swelling or recurrent swelling. Patients are advised to practice certain regimes, 
such as daily bandaging or the use of special garments, caution with open 
wounds, and skin care. 
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ICF 
An important basis for the optimal treatment and management of lymphoedema 
consists of an in-depth understanding, systematic consideration, and sound 
measurement of the consequences of lymphoedema at different levels of a 
person’s functioning. To obtain this basis, it is necessary to develop a 
comprehensive framework and classification that can serve as a universal 
language, understood by health professionals, researchers, policy makers, 
patients, and patient organisations. The International Classification of 
Functioning, Disability and Health (ICF) (14, 15) is an international  classification 
system in which the terms and classes have been designed to describe the 
functioning, disability and health of people. The classes/categories of the ICF 
consist of a title, a description and a code. The ICF organises information into two 
parts. Part 1 describes functioning and consists of the components ‘Body 
Functions and Structures’ and ‘Activities and Participation’. Part 2 addresses 
contextual factors and consists of ‘Environmental Factors’ and ‘Personal Factors’. 
There is not yet a list of Personal Factors in the ICF because of the large social and 
cultural variations associated with these factors. The ICF has a hierarchical 
structure of different levels (1 to 4). Each component contains four levels that can 
be used to describe items more detailed. So how higher the level , the more 
detailed the description of the item. The ICF has made it possible to link data 
across conditions or interventions with the goal of achieving efficient and cost-
effective health care (16). The ICF classification system contains all items to 
describe functioning of patients, regardless their health condition. For every 
health condition health-specific selections of ICF categories (ICF Core Sets)  (17)  
can be determined, making the ICF easier to implement in medical/allied health 
care (18). ICF Core Sets include the correct terms and classes to describe the 
functioning of persons with specific health problems, making the formulation of 
treatment goals easier, more transparent, and faster. ICF Core Sets for 
lymphoedema have not yet been developed. Stucki et al. introduced a standard 
method (see Figure 1) to develop ICF Core Sets (17). The expert research 
described in this article is one of the ‘preparatory studies’, which results will be 
incorporated into the international consensus conference to construct the first 
versions of ICF Core Sets for lymphoedema. The objective of this expert survey 
was to explore expert perspectives regarding the relevant problems of individuals 
with lymphoedema. The specific aims were as follows: (1) to identify problems in 
functioning that are important to patients with lymphoedema; and (2) to quantify 
these problems using the ICF.  
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Figure 1. Development of ICF Core Sets for lymphedema: phases of the project. 
 
Methods 
Design 
In an international Internet-based survey, health professionals from different 
health professions, who were experts in the treatment of lymphoedema, were 
asked five open-ended questions about factors relevant to describe the 
functioning of patients suffering from lymphoedema. In addition, basic socio-
demographic characteristics of the experts were recorded. The questions and 
answers were provided in plain English and were subsequently linked to ICF 
categories by two independent researchers (PV, LP) according to the linking rules 
of Cieza et al. (19, 20).  
 
Participants 
Health professionals from all six WHO world regions were included: Africa, North 
and South America, the Eastern Mediterranean region, Europe, Southeast Asia, 
and Western Pacific. The following health professions were included in the study: 
physical therapists, nurses, occupational therapists, skin therapists, psychologists, 
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phlebologists, dermatologists, and lymphologists. These health care providers are 
considered relevant for the treatment of lymphoedema. The inclusion criteria 
required experience with lymphoedema patients for at least one year and 
mastery of the English language. 
During the preparatory phase of the study, professional associations of health 
professions engaged in the treatment of lymphoedema worldwide were identified 
and contacted by means of an Internet search. Furthermore, another Internet 
search and personal recommendations were used to identify health professionals 
experienced in the treatment of patients with lymphoedema. Finally, an 
informative recruitment presentation was given at the international congress of 
the International Society for Lymphoedema (ISL) in Rome in September 2013. All 
associations were asked to distribute a letter among their members with 
information about the study and how to participate. Each association that did not 
respond within two weeks received a reminder, as well as a second reminder after 
four weeks. 
Data collection 
All health professionals who were willing to participate were invited to enter an 
Internet-based survey platform with a password. They were asked to answer five 
open-ended questions that asked them to name relevant changes due to 
lymphoedema and its treatment. The questions covered the ICF chapters on Body 
Functions, Body Structures, Activities and Participation, and contextual 
Environmental and Personal Factors that affect life (Table 1). For each question, a 
health professional could write as many items as he or she considered relevant. 
The participants could not see each other’s answers. Open-ended questions were 
applied to avoid any bias included in predetermined closed-ended questions and 
to obtain as much information as possible. Furthermore, the participants were 
asked to provide some (socio-demographic) information about their age, gender, 
health profession, country of practice, and years of professional expertise.  
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Table 1 Questions presented in the survey. 
 
 
Linking process 
After receiving answers in plain English from all of the participating health 
professionals, the answers were transmitted (linked) to the ICF, based on the 
linking rules of Cieza et al (19, 20). This survey followed rule 1 (“Before starting 
the process of linking to the ICF categories, identify all meaningful concepts within 
the answers under consideration.”) and 2 (“Each meaningful concept is linked to 
the most precise ICF category”. An answer could contain several meaningful 
concepts, depending on the number of themes contained in the answer, and each 
meaningful concept could be linked to one or more ICF categories.  Linking was 
performed using all levels (1 to 4). To overcome the possible bias of any health 
profession, the linking was performed by two different health professionals: a 
physical therapist (PV) and a skin therapy student (LP). The linking was 
independently performed, and when the professionals could not agree, an expert 
in ICF (YH or DvR) was consulted. 
 
Analyses of answers not linked to detailed ICF categories 
Some indicated concepts could not be classified within the ICF, namely personal 
factors (‘pf’), health condition (‘hc’), concepts that related to the ICF but could not 
be assigned a particular component or code (‘nd’), concepts referring to health-
related quality of life (‘qol’), concepts related to general health (‘gh’), concepts 
related to physical health (‘ph’), and concepts outside of the ICF framework (‘nc’). 
 
ICF component Survey question 
Body functions If you think about the body and mind of individuals with 
lymphedema, what does not work the way it is supposed to? 
Body structures If you think about the body of individuals with lymphedema, in 
which parts are their problems ? 
Activities and 
participation 
If you think about the daily life of individuals with lymphedema, 
what are their problems? 
Environmental factors If you think about the environment and the living conditions of 
individuals with lymphedema, what is supportive and/or what is 
hindering for them? 
Personal factors If you think about individuals with lymphedema, what is important 
about them and the way they handle their condition? 
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Accuracy of the linking process 
The degree of agreement between the two health professionals regarding the 
linked ICF categories was calculated using kappa statistics, with 95% bootstrap 
confidence intervals. The kappa coefficient values generally range from 0 to 1, 
where 1 indicates perfect agreement and 0 indicates no agreement beyond what 
is expected by chance alone. A kappa value of 0.6 or greater is considered 
sufficient (21). 
 
Results 
Participants 
All of the data were obtained between November 2013 and March 2014. One 
hundred four associations were approached, of which nine responded to the first 
letter and one after the first reminder (9.6%). The other associations did not 
respond, although it is possible that they sent the information letter to their 
members without responding to the invitation e-mail. The reasons for not 
answering are unknown but might include faulty e-mail addresses, spam filters, 
and a lack of interest in the survey.  
In total, 142 health professionals answered the questions. The participating health 
professionals had a median age of 49 years (age range, 26-74 years) and had been 
working in the field of lymphoedema for a median of 13 years (range, 1-40 years). 
The male to female ratio was 19:123. The 142 health professionals belonged to 
seven different health professions: 86 (60.6%) were physical therapists, 19 
(13.4%) were nurses, 17 (12.0%) were lymphologists, 10 (7.0%) were occupational 
therapists, six (4.2%) were dermatologists, three (2.1%) were skin therapists, and 
one (0.7%) was a phlebologist. In terms of the WHO world regions in which the 
respondents practiced, four of the six regions were represented: there were 86 
participants (60.6%) from the European region (Austria, Denmark, France, 
Germany, Ireland, Israel, Italy, the Netherlands, Portugal, Romania, Spain, 
Sweden, Switzerland, Turkey, and the United Kingdom), 32 (22.5%) from the 
Western Pacific region (Australia and New Zealand), 21 (14.8%) from North 
America (Canada and the United States), and three (2.1%) from Southeast Asia 
(India). There were no participants from Africa, the Eastern Mediterranean region 
or South America. Of the participants, 73 (51.4%) were working in hospitals, 69 
(48.6%) in private practices, 16 (11.3%) in rehabilitation centres, 11 (7.7%) in 
university settings, eight (5.6%) in inpatient practices, six (4.2%) in homes for the 
elderly, and five (3.5%) in nursing homes. Some of the participants worked in 
more than one location. 
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Linking process 
In total, the answers provided by the health professionals included 7373 aspects 
of functioning, of which 6296 (85.4%) could be linked to 359 different ICF 
categories. Of the 359 identified ICF categories, 109 were body functions (30.4%), 
55 were body structures (15.3%), 121 were activities and participation (33.7%), 
and 74 were environmental factors (20.6%). 
One thousand seventy-seven answers (14.6%) could not be linked to ICF 
categories, of which 472 answers (6.4%) referred to the Personal Factor 
components, and 267 answers (3.6%) covered aspects of the underlying health 
condition and, consequently, were labelled ‘health condition’. All of the answers 
that were too general to be linked to an ICF category but that belonged to 
domains of the ICF (n=158) were labelled ‘not definable’ (2%). Nineteen were 
labelled ‘not definable-general health’ (0.25%), sixteen were labelled ‘not 
definable-quality of life’ (0.2%), and fifty-six were labelled ‘not definable-physical 
health’ (0.76%). Eighty-nine answers (1.2%) were labelled ‘not covered’ (see Table 
2). 
 
  Table 2. Categories not linked to the ICF. 
Code Meaning N 
nc Not covered 89 
nd Not definable 158 
nd-gh Not definable- general health 19 
nd-hc Not definable-health condition 267 
nd-ph Not definable –physical health 56 
nd-qol Not definable-quality of Life 16 
pf Personal factor 472 
Total  1077 
 
 
The final inter-linker concordance was 0.619 (95% confidence interval, 0.606-
0.632). After the linking process of every 20th expert, there was consultation 
between the two health professionals. 
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Frequency analysis of ICF categories 
There were a total of 359 different ICF categories. Of these, 26 (7.2%) pertained to 
first-level categories (that is on the level of ICF chapters, not further detailed), 120 
(33.5%) to second-level categories, 201 (56%) to third-level categories, and 12 
(3.3%) to fourth-level categories. For reasons of readability, all of third and fourth 
categories (the more detailed descriptions) were merged into the second-level 
categories, resulting in 181 first- and second-level categories. Tables 3 through 6 
list the first- and second-level ICF categories, linked to ten or more meaningful 
concepts. This cut-off was also chosen for readability. 
 
Body functions 
After merging the third and fourth levels into the second-level categories, there 
were 54 first- and second-level Body Functions categories, of which 24 categories 
were used more than 10 times. The five most frequently used second-level 
categories of the Body Functions component were:  
1) Immunological system functions (b435), e.g., impairments of the 
lymphatic function leading to swelling 
2) Temperament and personality functions (b126), e.g., openness to trying 
different or new treatments, optimism and psychological and emotional 
stability 
3) Emotional functions (b152), e.g., fear, anger, sadness and happiness 
4) Experience of self and time functions (b180), e.g., body image, feeling too 
heavy, and  
5) Sensation of pain (b280).  
The most used first-level category was Chapter 7 ‘Neuromusculoskeletal and 
movement-related functions’. 
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Table 3. First and second-ůĞǀĞů/&ĐĂƚĞŐŽƌŝĞƐŽĚǇ&ƵŶĐƚŝŽŶƐ;ŶшϭϬ)  
ICF Code Description Total 
b1  CHAPTER 1 MENTAL FUNCTIONS 24 
b126  Temperament and personality functions 197 
b130  Energy and drive functions 59 
b152  Emotional functions 127 
b160  Thought functions 10 
b164  Higher-level cognitive functions 62 
b180  Experience of self and time functions 122 
b280  Sensation of pain 99 
b415  Blood vessel functions 26 
b435  Immunological system functions 563 
b440  Respiration functions 11 
b455  Exercise tolerance functions 28 
b530  Weight maintenance functions 35 
b540  General metabolic functions 13 
b640  Sexual functions 19 
b7  CHAPTER 7 NEUROMUSCULOSKELETAL AND MOVEMENT-RELATED 
FUNCTIONS 
54 
b710  Mobility of joint functions 44 
b730  Muscle power functions 15 
b755  Involuntary movement reaction functions 15 
b780  Sensations related to muscles and movement functions 14 
b8  CHAPTER 8 FUNCTIONS OF THE SKIN AND RELATED STRUCTURES 39 
b810  Protective functions of the skin 35 
b820  Repair functions of the skin 22 
b840 Sensation related to the skin 57 
Total  1690 
 
Body structures 
There were 23 first- and second-level Body Structures categories, of which 10 
were used more than 10 times. In this component, the five most frequently used 
second-level categories were: 
1) Structure of lower extremity (s750) 
2) Structure of upper extremity (s730), both because of altered 
representation of the limb 
3) Structure of reproductive system (s630), e.g., breasts and genital regions 
4) Structure of trunk (s760), and  
5) Structure of immune system (s420), lymphatic vessels and nodes.  
Of the first-level categories Chapter 7 ‘Structures related to movement’ was the 
most frequently used. 
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Table 4. First and second-level ICF categories Body Structures ( n шϭϬͿ 
ICF 
code 
Description Total 
s BODY STRUCTURES 39 
s420 Structure of immune system 72 
s630 Structure of reproductive system 85 
s7 CHAPTER 7 STRUCTURES RELATED TO MOVEMENT 62 
s710 Structure of head and neck region 63 
s730 Structure of upper extremity 135 
s750 Structure of lower extremity 150 
s760 Structure of trunk 77 
s8 CHAPTER 8 SKIN AND RELATED STRUCTURES 13 
s810 Structure of areas of skin 48 
Total  744 
 
Activities and participation  
In the component Activities and Participation, there were 53 first- and second-
level categories, of which 26 were used more than 10 times. The five most 
frequently used second-level categories in this component were: 
1) Looking after one’s health (d570), e.g., maintaining one’s health and 
managing diet and fitness 
2) Dressing (d540), e.g., finding appropriate clothing and shoes 
3) Recreation and leisure (d920) 
4) Remunerative employment (d850), and  
5) Doing housework (d640).  
The most frequently used first-level category was Chapter 4 ‘Mobility’. 
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Table 5. First and second-level ICF categories Activities and Participation (n шϭϬͿ͘ 
ICF 
code 
Description Total 
d230 Carrying out daily routine 63 
d360 Using communication devices and techniques 13 
d4 CHAPTER 4 MOBILITY 72 
d410 Changing basic body position 23 
d415 Maintaining a body position 50 
d430 Lifting and carrying objects 22 
d440 Fine hand use 11 
d445 Hand and arm use 25 
d450 Walking 48 
d455 Moving around 36 
d470 Using transportation 19 
d475 Driving 29 
d5 CHAPTER 5 SELF-CARE 44 
d510 Washing oneself 18 
d520 Caring for body parts 54 
d540 Dressing 285 
d570 Looking after one’s health 385 
d620 Acquisition of goods and services 12 
d640 Doing housework 66 
d650 Caring for household objects 13 
d7 CHAPTER 7 INTERPERSONAL INTERACTIONS AND 
RELATIONSHIPS 
35 
d770 Intimate relationships 14 
d845 Acquiring, keeping and terminating a job 13 
d850 Remunerative employment 118 
d870 Economic self-sufficiency 35 
d920 Recreation and leisure 176 
Total  1679 
 
Environmental factors 
Of the 51 first- and second-level categories belonging to the component 
‘Environmental factors’, 24 were used more than 10 times. The five most 
frequently used categories were: 
1) Health services, systems and policies (e580), e.g., all medical treatments 
and institutions 
2) Products and technology for personal use in daily life (e115), e.g., 
bandages and hosiery 
3) Health professionals (e355) 
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4) Acquaintances, peers, colleagues, neighbours and community members 
(e325), and 
5) Climate (e225).  
The most frequently used first-level category was Chapter 3 ‘Support and 
relationships’. Environmental factors can be both inhibiting and facilitating. 
Table 6. First and second-level ICF categories Environmental factors ( n шϭϬͿ͘ 
ICF 
code 
Description Total 
e ENVIRONMENTAL FACTORS 10 
e110 Products or substances for personal consumption 14 
e115 Products and technology for personal use in daily living 299 
e120 Products and technology for personal indoor and outdoor 
mobility and transportation 
15 
e135 Products and technology for employment 12 
e155 Design, construction and building products and technology of 
buildings for private use 
42 
e165 Assets 12 
e210 Physical geography 19 
e225 Climate 64 
e3 CHAPTER 3 SUPPORT AND RELATIONSHIPS 109 
e310 Immediate family 32 
e320 Friends 24 
e325 Acquaintances, peers, colleagues, neighbours and community 
members 
109 
e340 Personal care providers and personal assistants 22 
e355 Health professionals 135 
e4 CHAPTER 4 ATTITUDES 12 
e450 Individual attitudes of health professionals 58 
e460 Societal attitudes 53 
e535 Communication services, systems and policies 11 
e540 Transportation services, systems and policies 10 
e555 Associations and organizational services, systems and policies 11 
e570 Social security services, systems and policies 27 
e580 Health services, systems and policies 686 
e585 Education and training services, systems and policies 35 
Total  1789 
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Overall, the most frequently used second-level items were:  
1) Health services, systems and policies (e580): 686 times 
2) Immunological system functions (b435): 563 times 
3) Looking after one’s health(d570): 385 times 
4) Products and technology for personal use in daily life (e115): 299 times, 
and  
5) Dressing (d540): 285 times. 
 
Discussion 
In this research, experiences with the treatment of lymphoedema from the 
perspective of health professionals were collected. In this procedure, the ICF was 
used to translate multiple answers into one standard (WHO) language. Most of 
the aspects of functioning of the lymphoedema patient, valued by the health 
professionals, were covered by the ICF. This is in line with previous studies in the 
field of lymphoedema (22-24). By linking to the ICF it is possible to compare study 
results obtained from different regions of the world, regardless of the study 
designs and outcome measures (18, 20, 25).  
A very small portion of the answers (1.2%) referred to aspects that are labelled 
‘not covered’  by the ICF, because they are outside of the ICF framework. This 
finding emphasises the relevance of the ICF for lymphoedema. Examples of these 
aspects included life, morbidity, cosmetics and pathophysiology.  
Personal factors are not yet covered by the ICF, although they belong to the 
contextual factors of the WHO bio-psychosocial model of functioning (15, 26). In 
this survey, 6.4% of the mentioned aspects referred to personal factors. 
Frequently mentioned personal factors were comorbidities, lifestyle, and coping 
style. Including a list of personal factors within the ICF framework seems 
appropriate and will increase the relevance of the ICF classifications for describing 
functioning of clients with different health conditions, including clients with 
lymphoedema (27). Some attempts to make such a list have already been 
undertaken (28-30).  
Most of the health professionals were physical therapists (n=86; 60.6%), whereas 
24 physicians (16.9%) participated. The very high response rate of physical 
therapists compared with physicians can be partly explained by the high 
involvement of physical therapists in the treatment of clients with lymphoedema. 
Another reason for the high response rate of the physical therapists could be that 
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they are more used to the ICF and perhaps had more time to participate. The 
overrepresentation of physical therapists can be considered a limitation of the 
present study. On the other hand, the answers of the physicians were not very 
different compared to those of the physical therapists and the distribution of the 
population reflects the real-life distribution of disciplines working in the field of 
lymphoedema. A limitation was that psychologists are not included in the survey, 
which might have underestimated the value of psychological categories. 
Comparable problems were also seen in similar other studies (31, 32). 
This study was also designed to cover perspectives from different cultural 
backgrounds. However, equal distribution in terms of WHO regions could not be 
attained. Although health professionals in various countries were initially 
contacted, in the final sample there was a predominance of respondents from the 
Western world (Europe, Australia and North America). There were no experts 
involved from the Eastern Mediterranean region, South America and Africa. The 
distribution across the WHO world regions however is consistent with that of 
previous ICF Core Set projects (33, 34). A reason for this might be the inclusion 
criterion of ‘mastery of the English language’ in countries where English is not the 
first language. Other reasons could be related to the health care infrastructure for 
lymphoedema and the accessibility of the Internet. For these reasons, the 
conclusions drawn from this study are only applicable to the Western world. The 
value of this study for the other WHO regions could therefore be low, although 
many aspects could be of importance for those regions also.  
The response to the mail directed at the professional organisations was low. As 
the reasons for not answering are unknown, this could serve as a bias. However, it 
could well be that the associations did indeed disseminate the invitations among 
their members, but the members did not cooperate. The most plausible reason, 
besides language, in this study for the low response seems to be the time 
required to read all of the information sent and to answer the questions. 
Frequently, the health professionals described the concepts in more detail than 
the corresponding categories in the ICF; e.g., hyperaesthesia (b2702, Sensitivity to 
pressure) and driving a bicycle (d4750, Driving human-powered transportation). 
Regarding this difference, one should bear in mind that the ICF is a reference 
classification to be used worldwide in all health care situations. It forms the basis 
for the description of the functioning of the patient, but additional information - 
information specific to the health condition, the setting and/or personal situation 
of the patient - must be added. Earlier, Weigl et al (25) described these findings as 
well. With regard to the concepts that were not able to be linked to an ICF 
category or domain, it is important to note that the ICF is a classification of 
functioning not of disease (25% of the non-ICF-linkable concepts are health 
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conditions). For health conditions or diseases the International Classification of 
Diseases (ICD) can be used. The fact that the experts respond to the question 
about functioning by bringing up the health condition indicates perhaps that there 
is still great potential to convince experts in the field that functioning is 
complementary to the health condition and not solely as a consequence of a 
health condition. Moreover, ICF and ICD can be used complementary (35, 36). 
The authors have presented the five most frequently mentioned categories for 
the second-level categories of the ICF. Also presented in Tables 3-6 are the 
categories of the first level of the ICF  that were used more than 10 times. These 
categories have been used to code meaningful concepts that were too broad to 
classify in detail but that represented a significant proportion of the results. The 
five most frequently used first levels were Support and relationships (d7), Mobility 
(d4), Structures related to movement (s7), Neuromusculoskeletal and movement-
related functions (b7), and Self-care (d5). Topics related to first levels ‘Support 
and relationships’ and ‘Self-care’ were also prominently represented in the top 
five most frequently found second-level categories. In contrast, the remaining first 
levels -- ‘Mobility’, ‘Structures related to movement’ and ‘Neuromusculoskeletal 
and movement-related functions’ (all related to movement and not represented 
in the top five of the second-level categories) --- emphasised the importance of 
these items to the contributing health professionals, although they provided 
rather vague descriptions.  
The results of the present study resemble the findings of a literature review of ICF 
categories on lymphoedema-specific questionnaires, which was also a part of the 
project to develop ICF Core Sets for lymphoedema (22). In this review, the second-
level categories of the ‘Body Functions’ component that were found most 
frequently were ‘( Immunological system functions (b435)’ (10 questionnaires), ‘ 
Sensation of pain (b280)’ (9 questionnaires) and ‘ Touch functions (b265)’ (8 
questionnaires). In the ‘Body Structures’ component, the most frequently found 
categories were ‘ Structure of upper extremity (s730)’ (10 questionnaires) and ‘ 
Structure of reproductive system (s630)’ (6 questionnaires). The most frequently 
found categories in ‘Activities and Participation’ were: ‘ Looking after one’s health 
(d570)’ (9 questionnaires), ‘ Dressing (d540)’ (7 questionnaires), ‘ Hand and arm 
use (d445)’ (6 questionnaires) and ‘ Remunerative employment (d850)’ (6 
questionnaires as well). The most frequently found ‘Environmental Factors’ were: 
‘ Health services, systems and policies (e580)’ (7 questionnaires) and ‘ Products 
and technology for personal use in daily living (e115)’ (6 questionnaires). Except 
for the items related to movement, one can see that all of the categories 
important to the experts were represented in the questionnaires. Thus, it is 
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advisable to insert some questions about mobility into future questionnaires as 
well. 
In a qualitative research study, also part of the project on ICF Core Sets for 
lymphoedema (publication in preparation), important categories from the patient 
perspective were studied. The results correspond to the findings of this expert 
research. However, the following categories were more valued by patients than 
by health professionals: Sensations related to the skin (b840) (including itching 
and tingling), Maintaining a body position (d415) (lying, sitting, standing, etc.), 
Walking (d450), Driving (d475), Immediate family (e310), and Products and 
substances for personal consumption (e110). The category Experience of self and 
time functions (b180) (body image) was not mentioned often by the patients but 
was frequently noted by the health professionals. Most likely, the patients in this 
research did not have many difficulties with their body image. 
This survey was one of the preparatory studies in the development of ICF core 
sets for lymphoedema and it tried to capture the views of different health care 
providers involved in the treatment of patients with lymphoedema from various 
countries around the world on the functioning of lymphoedema patients and the 
factors influencing functioning of these patients. The ICF has proven to be a 
practical tool for the translation of problems encountered in lymphoedema, and it 
is sufficiently comprehensive, although not always detailed enough, to address 
the points of view of different health professionals involved in the treatment of 
patients with lymphoedema. 
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ABSTRACT 
 
To understand the challenges of patients with lymphedema it is important to 
describe functioning and to measure the effectiveness of treatment in changing 
functioning. The International Classification of Functioning, Disability and Health 
(ICF) offers an international framework to classify functioning of persons in their 
personal environment. ICF Core Sets are lists of selected ICF categories concerning 
those important aspects of functioning that are most likely to be affected by a 
specific health problem or disease. These Core Sets make it easier and faster to 
describe and communicate the patient's problems and to define treatment goals. 
Furthermore, they are available to health care providers of all professions, 
researchers, health insurance companies and policy-makers. The objective of this 
document is to present the outcomes of a consensus conference held to 
determine the first versions of the ICF Core Sets for lymphedema. Frequency 
rankings were made of the ICF categories derived from four preparatory studies, 
being: a) a systematic review; b) a qualitative study; c) an expert survey; and d) a 
cross-sectional study. By means of working group discussions and plenary 
sessions, a final consensus on ICF categories was achieved and Comprehensive 
and Brief Core Sets for lymphedema for the upper limb, lower limb, and midline 
lymphedema were defined. These ICF Core Sets contain different items in each 
region. Future validation of these Core Sets for health professions and for 
countries is needed.  
 
Keywords: International Classification of Functioning, Disability and Health (ICF), 
ICF Core Set, lymphedema, function, disability, consensus  
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Introduction 
Professionals working in lymphology (e.g., health professionals, researchers, 
health insurance companies and policy makers) often have different 
terminologies, frameworks, and approaches, which can make the communication 
regarding health problems challenging. A common generally accepted framework 
and terminology (term sets) could facilitate comparability of research findings and 
clinical outcomes (1) and improve the communication process among health 
professionals, researchers, health insurance companies, the government, and 
patient organizations (2). Such a framework can be provided by the International 
Classification of Functioning, Disability and Health (ICF) developed by the World 
Health Organization (WHO) (3). The approval of the ICF in 2001, provides a 
universal conceptual framework of domains and classifications to describe the 
functioning of individuals suffering from lymphedema. The ICF describes 
functioning and disability of a patient as a result of the interaction between 
different components: body functions (b), body structures (s), activities and 
participation (d), environmental factors (e), and personal factors (4). The system 
contains a hierarchical structure, using first, second, third, and fourth levels. 
However, using the entire ICF with over 1,400 categories is very time-consuming, 
and its use in daily practice is not very practical. Therefore, focused lists of items 
(categories) that are relevant and important for patients with lymphedema (Core 
Sets) are needed (5,6). There are two versions of the ICF Core Sets: a 
Comprehensive and a Brief Set of categories and codes. The Comprehensive Core 
Set is a list of ICF categories that describes the problems in functioning of patients 
with lymphedema in a multidisciplinary assessment. The Brief ICF Core Set is a list 
of ICF categories that are essential to describe the impairments, limitations, and 
restrictions in functioning and the environment of patients with lymphedema, and 
at the same time short enough to be practical in clinical studies or trials (4,7). 
These sets of ICF categories allow health professionals to classify and describe an 
individual's functioning using a universal and standardized language. In this way 
the Core Sets offer a chance for international studies and the possibility to 
compare the impact of different conditions, especially if used in electronic health 
care records. 
To date, ICF Core Sets have been developed for several chronic conditions (4,7-9). 
The objectives of this paper are: (1) to describe the consensus process, and (2) to 
present the lists of ICF categories and codes within the Comprehensive and Brief 
ICF Core Sets for lymphedema. 
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METHODS 
 
The development of ICF Core Sets for lymphedema started as a cooperative effort 
in a Steering group of the Erasmus Medical Centre (Department of Dermatology) 
in Rotterdam and the Dutch Institute of Allied Health Care in Amersfoort, under 
guidance of the Dutch WHO Collaborating Centre for the Family of International 
Classifications (WHO-FIC) in Bilthoven (all in the Netherlands) (Fig. 1). 
Figure 1. Development of ICF Core Sets for lymphedema: phases of the project. 
 
Overview of the Process 
The ICF Consensus Conference took place on the 4th of June, 2014 preceding the 
5th congress of the International Lymphedema Framework in Glasgow, United 
Kingdom. Data from four preparatory studies were sent to experts before the 
conference, and outcomes of the preparatory studies were briefly reported at the 
beginning of the process. Preparatory studies included a systematic review of 
questionnaires used in lymphedema studies (10), a survey of international experts 
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involved in lymphedema (n = 142) (publication in preparation), a study of focus 
groups  of patients with lymphedema (qualitative study) (11), and a cross 
sectional study which took place in both The Netherlands (n= 200) (12) and in 
Australia (n = 93) (publication in preparation). A division in three regions was 
made: upper limb, lower limb, and midline lymphedema, because each of these 
lymphedema regions might cause specific functioning problems. Afterwards, the 
frequencies of every occurring ICF category were ranked for each study region, 
with the most occurring frequency given the lowest rank (number 1) and so on. 
The frequencies of registered ICF categories from the Netherlands and Australian 
cross sectional studies were combined to obtain a total data set. Next, the total 
ranking numbers between the separate studies were equalized due to different 
numbers of ICF categories per study. Then, frequency rankings of the defined ICF 
category of all studies were summed up resulting in a final list of ranked ICF 
categories for each region separately. These ranking lists were divided into three 
parts: the first 100 and second 100 categories (divided by a red line) and the 
remaining categories (divided by a blue line). Finally, these rankings of ICF 
categories were presented to the consensus participants (experts) as an Excel file. 
In column 1, the ICF code was provided and the title of the code was shown under 
column 2. In column 3 the total frequency was provided and in column 4 the 
ranking of the total. The frequency of the ICF categories, as well as the rankings 
found in each separate study (empirical study, expert survey, systematic review 
and qualitative study) were also presented (columns 5 to 12).  
 
Recruitment of Conference Participants 
Experts in the field of lymphedema were invited to participate in the consensus. 
No remuneration or honorarium was paid to the experts who agreed to attend. In 
order to identify the most active experts, a steering committee formed before 
development of ICF Core sets was consulted. Furthermore, invitation was based 
on scientific publications, professional background, informal network, and region 
of residence. (13). 
 
Consensus Process 
Four weeks preceding the conference, the expert participants were provided with 
information on the ICF and the Excel documents were sent by email. At the 
beginning of the conference, results of the four preparatory studies were 
presented and printed copies were given to the participants. Afterwards, the 
procedural steps of the consensus meeting were explained and the participants 
were divided into three expert groups (i.e. upper limb, lower limb, and midline). 
Each group was moderated by a member of the Steering Group and a secretary 
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was allocated to each group. Both the moderator and the secretary were not 
allowed to participate in the discussion and voting process. In each group, experts 
openly discussed arguments in favor of or against the uptake of the ICF category 
in the Comprehensive Core Set. In a first step, each group had to come to a 
Comprehensive Core Set. Experts had to choose from the first 100 rankings (above 
the red line) those ICF categories that they considered essential. They could argue 
to add ICF categories from the second 100 rankings (above the blue line) and - 
only with very strong arguments - from the categories below the blue line. When 
the group came to consensus (i.e., when more than 50% of the members of the 
working group were in favor), a first version of the Comprehensive Core Set was 
defined. In a second step, experts individually had to choose 10 categories from 
the Comprehensive Core Set which they felt to be important in lymphedema, 
being a part of the Brief Core Set. Afterwards, these categories were discussed in 
the working group and consensus had to be reached. When both the 
Comprehensive and the Brief Core Set were defined in each working group, a 
plenary session took place. In this session, experts had the opportunity to discuss 
the Core Sets findings of the other working groups as the final consensus 
discussion. After the conference, the Steering Group discussed both the process 
as well as the results and had the opportunity for small alterations to the final 
versions. 
 
 
 
RESULTS 
 
Twenty-three experts participated in the consensus conference. Six were 
physicians, seven physical therapists, three nurses, five stocking suppliers, one 
occupational therapist, and one skin therapist. The countries where they practiced 
were: Australia, Belgium, Canada, Germany, Israel, Italy, The Netherlands, 
Sweden, the United Kingdom, and United States. These countries represent WHO 
regions: North America, Europe, and Western Pacific. Based on results for the 
three lymphedema regions using first, second, third, and fourth level 
classifications from the four preparatory studies, Comprehensive and Brief ICF 
Core Set for lymphedema were developed.  
The numbers of categories in the Comprehensive Core Sets were for the upper 
and lower extremity and midline  101, 111 and 89 respectively. For the Brief Core 
Sets they were 23, 18 and 20, respectively. Table 1 shows the ICF categories that 
were included in the Comprehensive and Brief Core Sets.  
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Table 1 Comprehensive and Brief Core Sets for the upper limb (UL in black colours), lower limb (LL in 
red colours) and midline region (M in green colours).In  bold = categories of the common part of the 
Comprehensive Core Set; Arabic = categories of the common part of the Brief Core Set; (B) = Part of 
the Brief Core Set; (M) = categories of the common part of the midline region; (G) = categories of the 
genital region; (H) = categories of the head and neck region; (Breast) = category of the breast region.  
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ICF 
code Description 
UL LL M 
b1 CHAPTER 1  MENTAL FUNCTIONS X   
b126 Temperament and personality functions    X (M) 
b1261 Agreeableness   X  
b1263 Psychic stability  X (B) X  
b1264 Openness to experience  X   
b1265 Optimism X   
b1266 Confidence X X  
b130 Energy and drive functions    X (M) 
b1301 Motivation  X X (B)  
b134 Sleep functions X X X 
b152 Emotional functions  X X (B) X 
b164 Higher-level cognitive functions  X (B)  X 
b1644 Insight  X X X 
b1646 Problem-solving  X  
b1670 Reception of written language   X  
b180 Experience of self and time functions    X (M) 
b1801 Body image  X(B) X(B) X(B) 
b260 Proprioceptive function X X  
b265 Touch function  X  X (M) 
b2702 Sensitivity to pressure  X X  
b280 Sensation of pain  X(B) X(B) X(B) 
b415 Blood vessel functions  X  
b4150 Functions of arteries   X  
b435 Immunological system functions   X X (B) X (B)(M) 
b4350 Immune response   X X (M) 
b4352 Functions of lymphatic vessels  X X X 
b4353 Functions of lymph nodes   X  
b440 Respiration functions    X (M) 
b455 Exercise tolerance functions    X (B) X (B)(M) 
b4550 General physical endurance  X (B)   
b4552 Fatiguability  X (B) X X 
b5104 Salivation    X (H) 
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b5105 Swallowing    X (H) 
b530 Weight maintenance functions X X X 
b540 General metabolic functions   X X (M) 
b5403 Fat metabolism  X   
b550 Thermoregulatory functions  X  
b620 Urination functions   X (G) 
b640 Sexual functions  X X X (B)(M) 
b7 CHAPTER 7 NEUROMUSCULOSKELETAL AND MOVEMENT-RELATED FUNCTIONS 
X   
b710 Mobility of joint functions   X (B)  X (M) 
b7101 Mobility of several joints   X (B)  
b730 Muscle power functions   X (B)  X (M) 
b7303 Power of muscles in lower half of the body   X (B)  
b770 Gait pattern functions   X X (G) 
b780 Sensations related to muscles and movement functions 
X X X 
b810 Protective functions of the skin X X X 
b820 Repair functions of the skin X X X 
b840 Sensation related to the skin X X X 
d155 Acquiring skills  X X X (B)(M) 
d170 Writing X   
d230 Carrying out daily routine  X(B) X(B) X(B) 
d240 Handling stress and other psychological demands  
  X (B)(M) 
d2400 Handling responsibilities X   
d3 CHAPTER 3  COMMUNICATION   X   
d330 Speaking    X (H) 
d350 Conversation    X (H) 
d360 Using communication devices and techniques 
X   
d4 CHAPTER 4  MOBILITY   X   
d410 Changing basic body position X X X 
d4100 Lying down   X X (G) 
d4101 Squatting  X  
d4102 Kneeling  X  
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d4103 Sitting   X  
d4104 Standing  X  
d4105 Bending  X  
d415 Maintaining a body position X   
d4153 Maintaining a sitting position   X X (G) 
d4154 Maintaining a standing position   X X (G) 
d430 Lifting and carrying objects    X X X 
d4401 Grasping  X   
d445 Hand and arm use  X (B)   
d4452 Reaching X   
d450 Walking  X X (B) X 
d4500 Walking short distances   X  
d4501 Walking long distances   X  
d455 Moving around      X (B)(G) 
d4551 Climbing  X  
d4552 Running   X  
d4554 Swimming  X   
d4600 Moving around within the home  X  
d4602 Moving around outside the home and other buildings 
 X  
d470 Using transportation    X (G) 
d4702 Using public motorized transportation  X X  
d475 Driving  X  X (G) 
d4750 Driving human-powered transportation   X  
d4751 Driving motorized vehicles  X  
d5 CHAPTER 5  SELF-CARE  X (B)   
d510 Washing oneself X X X 
d520 Caring for body parts   X X (B)(M) 
d5200 Caring for skin  X X  
d5202 Caring for hair X   
d530 Toileting  X X X 
d540 Dressing    X X X 
d5402 Putting on footwear  X  
d5404 Choosing appropriate clothing  X   
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d550 Eating    X (H) 
d560 Drinking    X (H) 
d570 Looking after one’s health  X(B) X(B) X(B) 
d5700 Ensuring one’s physical comfort  X   
d5701 Managing diet and fitness  X (B) X  
d5702 Maintaining one's health  X X  
d620 Acquisition of goods and services    X (M) 
d6200 Shopping  X X  
d630 Preparing meals X X  
d640 Doing housework    X (B) X X 
d6400 Washing and drying clothes and garments X   
d6505 Taking care of plants, indoors and outdoors  X   
d660 Assisting others X X  
d7 CHAPTER 7  INTERPERSONAL INTERACTIONS AND RELATIONSHIPS 
X   
d750 Informal social relationships    X (M) 
d770 Intimate relationships  X (B) X X 
d845 Acquiring, keeping and terminating a job  X (B)  
d850 Remunerative employment  X (B) X X (B)(M) 
d870 Economic self-sufficiency  X  X (M) 
d920 Recreation and leisure   X (B) X X (B)(M) 
d9201 Sports  X  X (M) 
d9205 Socializing X X X 
e1101 Drugs  X X X 
e1150 General products and technology for personal use in daily living 
X X X 
e1151 Assistive products and technology for personal use in daily living  
X(B) X(B) X(B) 
e1201 
Assistive products and technology for 
personal indoor and outdoor mobility and 
transportation  
 X  
e1300 General products and technology for education  
X   
e135 Products and technology for employment  X  
e150 Design, construction and building products and technology of buildings for public use 
X X  
- 204 -
e155 Design, construction and building products and technology of buildings for private use 
X X X 
e1650 Financial assets  X  
e210 Physical geography  X  
e225 Climate X X X 
e2250 Temperature  X  X (M) 
e3 CHAPTER 3  SUPPORT AND RELATIONSHIPS X   
e310 Immediate family  X(B) X(B) X(B) 
e320 Friends   X (B) X X (B)(M) 
e325 Acquaintances, peers, colleagues, neighbours and community members 
X X X 
e330 People in positions of authority X X X 
e340 Personal care providers and personal assistants 
X X X 
e355 Health professionals  X(B) X(B) X (B) 
e410 Individual attitudes of immediate family members  
 X X (M) 
e420 Individual attitudes of friends X X X 
e425 
Individual attitudes of acquaintances, 
peers, colleagues, neighbours and 
community members  
X (B) X X 
e450 Individual attitudes of health professionals  X  X (M) 
e460 Societal attitudes X X X 
e465 Social norms, practices and ideologies    X (M) 
e555 Associations and organizational services, systems and policies  
  X (M) 
e5550 Associations and organizational services X X  
e5600 Media services  X  
e570 Social security services, systems and policies X   
e580 Health services, systems and policies    X (B) X (M) 
e5800 Health services  X  
e5801 Health systems X   
e5850 Education and training services  X X (B) X 
s330 Structure of pharynx    X (H) 
s340 Structure of larynx    X (H) 
s420 Structure of immune system X X X 
s4200 Lymphatic vessels  X X  
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s4201 Lymphatic nodes  X X  
s630 Structure of reproductive system   X X (M) 
s6303 Structure of vagina and external genitalia   X  
s7 CHAPTER 7 STRUCTURES RELATED TO MOVEMENT 
X   
s710 Structure of head and neck region  X  X (B)(H) 
s720 Structure of shoulder region  X  X (H) 
s730 Structure of upper extremity X (B)   
s7300 Structure of upper arm  X   
s7302 Structure of hand  X   
s740 Structure of pelvic region   X X (B)(G) 
s750 Structure of lower extremity   X (B)  
s7500 Structure of thigh   X  
s7501 Structure of lower leg   X  
s75011 Knee joint   X  
s7502 Structure of ankle and foot  X  
s760 Structure of trunk   X X X (B)(Breast) 
s7701 Joints  X  
s810 Structure of areas of skin X X X 
 
 
In Table 2 the division of the ICF components is shown. Table 3 shows the division 
of ICF levels in the different Core Sets. No first levels were selected, except for the 
Core 
third level. Only 1 fourth level (in the Comprehensive Core Set for the lower limb) 
was included.  
Sets for the upper limb. Most of the categories came from the second and 
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Table 2.  Division of ICF components in the Core Sets for lymphedema(UL = Upper Limb, LL = 
Lower Limb, M = Midline) 
 
                                                                 ICF components 
Core Set for 
lymphedema 
Body 
functions 
Body 
structures 
Activities and 
Participation 
Environmental 
factors 
Total 
Comprehensive UL 29 8 41 23 101 
Comprehensive LL 32 14 40 25 111 
Comprehensive M 29 9 30 21 89 
Brief UL 8 2 9 4 23 
Brief LL 8 1 4 5 18 
Brief M 5 3 8 4 20 
Total 111 37 132 82 362 
 
 
 
Table 3. Division of ICF levels in the Core Sets for lymphedema (UL = upper limb, LL = lower limb, M = 
midline) 
 
Number of levels of the ICF 
Core Set for  
lymphedema 
1 2 3 4 Total 
Comprehensive UL 8 56 40 0 104 
Comprehensive LL 0 55 55 1 111 
Comprehensive M 0 71 17 0 88 
Brief UL 1 16 6 0 23 
Brief LL 0 12 6 0 18 
Brief M 0 18 2 0 20 
Total 9 228 126 1 364 
 
Concerning the Comprehensive Core Sets, some categories are mentioned in all 
Core Sets: 14 from the component Body Functions, three from Body Structure, 14 
from Activities and Participation, and 15 from Environmental Factors. For the Brief 
Core Set the division is: two from Body Functions, two from Activities and 
Participation, and three from Environmental Factors. Because midline 
lymphedema can occur in different body parts (i.e. head and neck , breast and 
genital region ), some categories for the Midline Core Sets concern all body parts 
and some are only applicable for those particular regions. For the Comprehensive 
Core Sets, 23 categories are applicable for all regions, 11 for the head and neck, 
and nine for the genital region. For the Brief Core Set, nine are applicable for all 
regions, one for the head and neck, one for the breast, and two for the genital 
region (see Fig. 2).  
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Figure 2 Flow chart of the Comprehensive and Brief core sets 
 
 
 
 
 
 
 Common ICF categories   of 
Comprehensive (n = 46) and Brief 
Core Sets (n = 7) for the 3 regions 
Added specific items in 
Comprehensive  (n = 58)    
and Brief  Core Set 
                  (n = 16)  
Upper limb 
Added items, common for 
all midline regions 
Comprehensive  ( n = 23) 
and Brief  Core Set (n = 9) 
Midline 
Added specific items in 
Comprehensive  (n = 
65) and Brief  Core Set 
(n = 11)                   
Lower limb 
Head and neck region  
Added specific items in 
Comprehensive (n = 11) and 
Brief (n = 1) Core Set 
Breast region  
Added specific items in 
Brief (n = 1) Core Set 
Genital region   
Added specific items in 
Comprehensive (n = 9) 
and Brief (n = 2) Core 
Set
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DISCUSSION 
 
Lymphedema is a complex health condition which presents itself in several ways. 
It can affect functioning of a patient in various ways, areas, and levels, and it 
involves different health professions, organizations, and policies. The ICF is a 
conceptual framework and classification system by the WHO with which this 
complexity can be addressed. With the use of the ICF, the consensus conference 
succeeded to identify Core Sets of variables that are important in lymphedema, 
with integrated data from preparatory studies. The results of this international 
consensus were: Comprehensive Core Sets for Upper limb lymphedema (104 ICF 
categories), Lower limb lymphedema (111 ICF categories), and Midline 
lymphedema (89 ICF categories), and Brief Core Sets for upper limb (23 
categories), Lower limb (8 categories), and Midline (20 categories) lymphedema.  
The use of the ICF in patients with lymphedema is challenging because the ICF, 
which is based on the bio-psycho-social model, contains terms which can be used 
to describe not only functioning of the individual itself, but also the context in 
which he or she is living (3). Furthermore, the ICF provides a universal language 
and since lymphedema is a health condition which presents itself both in 
developed and on a large scale also in under-developed countries (14), its 
applicability in both cases is multifaceted. 
The Core Sets contain all ICF components, stressing the variety and complexity of 
lymphedema. Unfortunately, personal factors, as part of the contextual factors, 
are not yet classified within the ICF, although various attempts have been made 
recently (15,16). Seven categories were mentioned in all Core Sets leading to the 
most relevant topics in lymphedema, according to this group of experts: Body 
Image, Pain, Daily Routine, Hosiery, Family, Health Professionals, and Self-
management. These items contain two categories from Body Functions, one from 
Activities and Participation, four from Environmental Factors and none of Body 
Structures. Although the shape of extremities and the midline region is important 
in lymphedema, experts seem to value the function of the lymphatics more than 
the form, which evidently is the outcome of the malfunction of the lymphatics. It 
is obvious that Environmental Factors are important, although the outcomes of 
the literature review show that these items are not examined on a large scale and 
are scarcely used in lymphedema specific questionnaires (10). 
The Brief Core Sets are developed to define a standard that can be used as the 
minimum dataset to be collected in patient evaluation or in clinical studies. When 
a minimum dataset in lymphedema is available, this could help in performing 
comparison across settings which would eventually enhance standardization of 
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reporting evidence (e.g., treatment outcomes) (4). Currently the International 
Lymphedema Framework (ILF) is running a study to develop a minimal dataset as 
well (17). The Brief Core Sets could be implemented in this study. 
Compared to other consensus conferences to develop ICF Core Sets (4,5), there 
are some points of special interest. Whereas other conferences lasted two or 
three days, this conference lasted only one day because of lack of financial 
support. The organization managed to collect a representative group of experts 
for one day, preceding the 5th congress of the ILF in Glasgow. Despite the short 
time frame, it is expected that the developed Core Sets encompass a large 
proportion of the problems that patients with lymphedema encounter. Although 
other consensus procedures excluded first level categories in the Core Sets, in this 
Core Set first level categories appear in the Upper limb Core Sets. It was the 
definite will of this working group to include these first level categories. Future 
validation research will determine whether these categories will keep their place 
in the Core Sets. Another issue concerns the sample of experts being composed 
only from developed countries. This distribution of experts was quite similar to 
the pool of experts from the worldwide expert survey which was also conducted 
as part of the Core Set development. The implication is that the Core Sets are 
developed with the focus on the health care systems in these countries. Future 
validation is needed in the under-developed countries to examine the usability of 
the Core Sets in these regions. Furthermore, the country of origin and skew 
distribution of the professional experts could be a confounder. Perhaps a greater 
number of skin therapists and occupational therapists could have led to more 
contribution from this point of view. Another limitation is the potential bias 
regarding patient selection in the preparatory qualitative and cross-sectional 
studies in The Netherlands (11,12). To compensate for this problem somewhat, 
one of the studies was also performed in Australia. Finally, a last bias can be the 
fact that quite a large proportion (9% of the Comprehensive Core Sets and 0.6% of 
the Brief Core Sets) of the ICF categories of below the blue line (rankings higher 
than 200, meaning these categories were scarcely mentioned in the preparatory 
studies), were included in the Core Sets. This could be due to the individual 
attitudes of experts in the working groups or to the fact that the working group 
decided to choose a higher level category to include a broader scope related to a 
health problem, leading to a subjective impact in these Core Sets. The 
Comprehensive ICF Core Sets for lymphedema integrate the experiences and 
needs of different health professions. The domains of the Core Sets can guide the 
patient-centered goal setting process in multidisciplinary settings, where 
resources and problems could be identified and profession-specific treatment 
goals can be identified. The identified categories help in multidisciplinary settings 
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to assign patients to specific areas of expertise for evaluation and treatment, and 
for clinical-decision making (4). The categories of the Brief ICF Core Set can be 
used as a minimum set of domains to report in trials or intervention studies. It can 
also be used in independent clinical practice setting which would help clinicians 
compare results and weigh the evidence of their results. (4). In the future, 
validation studies will be helpful in determining if there are subsets of the Core 
Sets that could be more meaningful given a certain setting and to investigate the 
Core Set's applicability across a range of health professions and cultures. 
International and national frameworks in lymphology should be involved to 
implement the ICF Core Sets for lymphedema.  
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Introduction 
The purpose of this thesis is to develop International Classification of Functioning, 
Disability and Health (ICF) Core Sets for lymphedema. Specific core sets for 
lymphedema should result in a better understanding of the problems of the 
individual lymphedema patient and a more tailor made therapy.  
Lymphedema is a chronic health condition, which gives sincere problems in daily 
life and has a negative effect on the health-related quality of life of these patients. 
In many cases lymphedema is a result of cancer treatment and as such 
lymphedema can be seen as the ‘price of survival’. In the under-developed 
countries lymphedema can be caused by parasitic infections. The problems 
associated with lymphedema can be divided in impairments (like pain, swelling, all 
kinds of sensitivity problems, skin problems and problems in emotional functions), 
limitations in activities (like walking and household), and restrictions in 
participation (such as employment and sports). The occurrence and severity of 
these functioning problems are influenced by environmental factors (such as 
health care systems, treatments and attitudes of others) and personal factors 
(such as age, comorbidity, coping, and life style).  
The project and its overall results 
The development of the ICF Core Sets for lymphedema was performed according 
to the rules of a WHO (World Health Organization) accepted system (1) and 
contained several phases (2). In the preparatory phase five studies were 
performed from four perspectives; the researchers’ perspective (two studies), the 
clients’ perspective (one study), the health professionals’ clinical perspective (one 
study), and the mondial experts’ perspective (one study). The results of the 
preparatory studies were expressed in meaningful concepts and these concepts 
were linked to ICF categories. The final results of these studies are lists of items 
within: Body Structures, Body Functions, Activities and Participation, 
Environmental Factors, and Personal factors. 
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Body Functions 
All preparatory studies reveal the same results with respect to the categories 
most mentioned. These were always ‘b435, Immunological system functions’ 
(because swelling is one of the major problems in lymphedema and lymph vessels 
and nodes are part of the immunological system), ‘b280, Sensation of pain’ (most 
of the patients complain about pain; patients with lower limb lymphedema more 
than patients with upper limb lymphedema), ‘b265,Touch functions’ (the 
sensation of the skin is often altered because of the edema), ‘b152, Emotional 
functions’, and ‘b126, Temperament and personality functions’ (both categories 
are important because of the psycho-social impact of lymphedema). There is one 
exception: in the cross-sectional study, representing the health professionals’ 
clinical perspective, ‘b710, Mobility of joint functions’, ‘b730, Muscle power 
functions’, and ‘b530, Weight maintenance functions’ were most frequently 
mentioned. Probably this is a result of the policy (more focus on self-
management) of the hospital where the study was performed. Currently, risk-
factors, muscle power and mobility are being integrated in treatment more and 
more. Although a substantial proportion of the literature describes these items, 
most of the literature we found focused on swelling and pain. 
 
Body Structures 
In all studies ‘s730, Structure of upper extremity’, ‘s750, Structure of lower 
extremity’, and ‘s630, Structure of reproductive system’ were the most 
mentioned categories. Category ’s810, Structure of areas of skin’ was only 
mentioned in the cross-sectional study representing the health professionals’ 
clinical perspective and in the literature study concerning lymphedema-specific 
questionnaires (one of the two studies representing the researchers’ perspective). 
The questionnaires often are developed by health professionals and one of the 
conclusions of the cross-sectional health professionals’ perspective study was that 
health professionals lay more emphasis on body structures than the patients 
themselves. However, in the qualitative research with patient focus groups 
(representing the clients’ perspective), the structure of the skin area is mentioned 
in the genital lymphedema group as an item of major concern. 
 
- 216 -
Activities and Participation 
Most mentioned categories for all studies were: ‘d415, Maintaining a body 
position’, ‘d570, Looking after one’s health’, ‘d450, Walking’, ‘d640, Doing 
housework’, and ‘d850, Remunerative employment’. Patients themselves as well 
as health professionals consider ‘d920, Recreation and leisure’ as of great 
importance, whereas in the lymphedema-specific questionnaires this category is 
only mentioned in questionnaires concerning the upper limb. 
 
Environmental Factors 
In all studies ‘e580, Health services, systems and policies’, ‘e355, Health 
professionals’, ‘e310, Immediate family’, and ‘e115, Products and technology for 
personal use in daily life’ were mentioned most frequently. The last category 
relates dominantly to the prescribed use of hosiery and bandages, being a 
substantial part of the treatment of lymphedema. In the questionnaires this is 
only a topic in those concerning the upper limb, although stockings have a high 
influence on the quality of life of patients with lower limb lymphedema as well (8-
11). So there is a need to involve questions on this topic in future questionnaires 
for lower limb lymphedema.  
Environmental factors can act as a barrier or a facilitator. The categories ‘e580, 
Health services, systems and policies’ and ‘e355, Health professionals’ are of great 
importance, but quite often it appears that they are predominantly named as a 
barrier. Especially the qualitative research revealed the ambivalence of the 
patient with respect to the health professional. Often seen as of major assistance, 
but many times also someone who underestimates the impact of lymphedema 
and the related prescribed lifestyle for the patient. These problems might be 
attenuated by providing more qualitative patient information about the impact of 
lymphedema to the health professionals. 
Personal factors 
Personal factors are not part of the ICF yet; however, several suggestions on the 
subdivision and classification of personal factors have been made (12-14). In the 
various surveys of this thesis, items on personal factors have been listed. Coping 
strategies of lymphedema patients, comorbidity, lifestyle, age, and race were the 
most frequently mentioned personal factors. Coping strategies are the most 
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important personal factor, because the lymphedema patient, as every patient, 
seeks the best way to deal with his/her health condition. Coping strategies vary 
from mental solutions (thinking of nice things, being pro-active, and trying to act 
as common as they did before the lymphedema) to (self-constructed) material  
(for example for support of urination by genital lymphedema patients,  or using a 
hoola-hoop for more drainage of lymphedema). 
 
Consensus conference 
An international consensus conference was organized for which various health 
professionals, being  lymphedema experts from different countries were invited. 
The data of four (one literature review excluded, because we only used the data 
of the lymphedema-specific questionnaires and followed the method proposed by 
Cieza and Stucki (1))  preparatory studies were subjects for consensus on the most 
important categories. The consensus process resulted in the first versions of six 
ICF Core Sets for lymphedema. A Comprehensive (C) and a Brief (B) Core Set were 
defined, each for three regions: upper limb (101 (C) and 23 (B)  items), lower limb 
(111 (C)  and 18 (B) items) and midline (89 (C) and 20 (B) items) lymphedema. 
These Core Sets appeared to contain different items in relation with the region of 
the edema. However, the comprehensive core sets of the three regions had 46 
categories in common and the Brief Core Sets seven categories. These categories 
appear to represent the core problems of the lymphedema patient. As the Brief 
Core Sets are derived from the Comprehensive sets, it can be concluded that the 
following seven items are the most important for the lymphedema patient: Body 
Image, Pain, Daily Routine, Hosiery, Family, Health Professionals, and Self-
management. These items contain two categories from Body Functions, two from 
the Activities and Participation domain and three from Environmental Factors. 
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ICF Core Sets for lymphedema 
The ICF  offers a conceptual framework to describe the functioning of a patient 
and the factors influencing his/her functioning. To make the connections between 
the different components during the process of clinical reasoning more visible, 
Steiner et al. constructed a so called Rehabilitation Problem Solving (RPS) form as 
a tool for physical therapists (3). Although already published in 2002, not many 
Dutch physical therapists are using this form in daily practice.  The administration 
of the data of clinical examination and treatment mostly happens  with the use of 
electronic patient files. Although these files address the division of patient 
problems as proposed by the ICF, the use in daily practice is not user-friendly. 
Many items have to be filled in, which makes this administration very time-
consuming. Moreover, the examination and results of the treatment of 
lymphedema patients sometimes requires a special way of administrating, which 
cannot easily be performed with the general format of physical therapy 
administration. For instance, palpation and judgement of the swelling need a 
more detailed description than is possible with the present format and the 
volume measurements are not implemented in the electronic patient files. 
Despite the comprehensive format, there is often no space for clinical reasoning, 
let alone a RPS form. With the introduction of ICF Core Sets for lymphedema, 
there is an opportunity for physical therapists to streamline both the 
administration and clinical reasoning of the lymphedema patient. By offering 
more clarity in the possible problems in functioning and the factors influencing 
the functioning of the lymphedema patient as well as the use of a decision tree 
structure, the Core Sets can act as a tool for the clinical administration. By using 
the presented sets these will come  to more refinement and eventually reduction. 
So in fact it is not a stable tool, but an active tool, which will constantly has to be 
evaluated and adapted in the course of time. ICF Core Sets can already be helpful 
in the diagnostic phase: during anamnesis and examination the ICF Core Sets can 
be used as a checklist of items to be asked for or examined. By analysing the 
results of the anamnesis and the clinical examination, a physical therapist’s 
diagnosis and a prognosis can be formulated. Also in this phase of analysis the ICF 
Core Sets can act as a checklist. When it is decided that physical therapy is a useful 
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intervention, a treatment plan is developed together with the patient based on 
the physical therapist’s diagnosis, starting with the formulation of the treatment 
goals. In this stage, the ICF Core Sets are useful in discussing with the patient the 
possible short and long term goals for the treatment (4-8). To evaluate the 
treatment goals, outcomes have to be formulated in connection to the treatment 
goals; during the evaluation phase it must be possible to determine – based on 
the outcomes - whether the treatment goals are reached. Subsequently 
appropriate measurement instruments have to be chosen (9). Following the 
outcomes of the measurements before the treatment, the treatment goals, and 
the prognosis the intervention and the frequency of treatment can be determined 
(10). And finally, the results of re-examination can provide feedback about the 
effect of the treatment.  
All these steps are already implemented in electronic patient files and the 
diagnostic process (i.e. anamnesis, examination and measurements) can serve as 
a basis for the defining of the contents of the RPS form. In this way the ICF Core 
Sets for lymphedema provide a less time-consuming administration and a 
transparency of the clinical reasoning (11). This is achieved by the fact that the 
Core Sets already offer a format of categories to be examined and so more or less 
direct the anamnesis and clinical examination although sound clinical reasoning 
must always be the basis for therapeutic decisions. 
Unfortunately, knowledge on lymphedema epidemiology is scarce because  good 
registration is absent. However the number of patients worldwide is estimated to 
be approximately 140-250 million (12). In the Netherlands information about the 
incidence of lymphedema is hard to find, because of the great variance in studies, 
expressions, the way lymphedema is diagnosed, and the fact that there is no 
sufficient registration of lymphedema patients, since patients are predominantly 
classified in hospital registration systems according to the ‘first’ disease such as 
cancer. Besides, in most patients lymphedema is developing after hospital 
discharge. For this reasons the incidence of lymphedema can only be estimated.   
For a proper description of the problems in (daily) functioning of the patient the 
ICF is needed. ICF Core Sets for lymphedema offer a way to document these 
problems and facilitating uniformity of data (by using the codes that are specific 
for the ICF category), not only in the Netherlands but worldwide. Clinicians and 
researchers are probably more willing to document these items, because the Core 
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Sets are compact and easier to apply than the total ICF. Also the selection of 
measurement instruments is easier when Core Sets are available , creating an 
increase of the relevance of these measurement instruments and increasing the 
chance that researchers use the same measurement instruments in different 
studies. In this way a basic set of measurement instruments can be designed 
which creates an opportunity to compare the results of different studies using 
these instruments, increasing the knowledge of lymphedema. Implementation of 
the ICF Core Sets in the Dutch guideline for lymphedema in the Netherlands (13), 
the consensus document of the International Society for Lymphedema (ISL) (14), 
as well as the best practice document of the International Lymphedema 
Framework (ILF) (15) is a way to achieve uniformity in several ways such as  
administrating, describing, and classifying the problems of lymphedema patients. 
Currently patient education, including self-management, is becoming an 
increasingly important part of holistic patient treatment. In lymphedema 
treatment  this is also the case. The ICF offers the opportunity to facilitate patient 
education, but is too comprehensive to handle in daily practice. ICF Core Sets are 
better suitable to apply in daily practice, because of their compactness. Also they 
could serve as a stepping-stone to discuss functioning and treatment with the 
lymphedema patient. In the Dutch guideline for lymphedema, the possibility for 
the use of ICF Core Sets in patient education is already mentioned (13). ICF Core 
Sets can be incorporated in the guideline, so that the guideline also makes use of 
an internationally broadly accepted framework.  
Comments on the project  
Every project has its strengths and weaknesses. The outcome of the project with 
six solid Core Sets was overall successful, although  there are some flaws and we 
will discuss these here.  
Qualitative research  
In the qualitative research a great deal of patients with upper limb lymphedema 
were included and only a relatively small group of patients with genital and head 
and neck (midline) lymphedema. Not only is the latter group of patients relatively 
small, but often they are not willing to talk about their problems. This is especially 
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true for patients with genital lymphedema. These circumstances may have had 
some effects on the kind of items that the total group of interviewed patients 
indicated as important. However this distribution reflects  the composition of the 
lymphedema patient group in total.  
 
Cross-sectional study 
For the development of the Core Sets we followed a systematic method as 
indicated by the WHO and described by the group of Stucki et al. (16, 17). 
According to that method a cross-sectional survey among health professionals 
had to be performed using a multi-center approach. However, in The Netherlands 
there is only one hospital really specialized in the treatment of lymphedema 
patients. This centre attracts diverse patients with lymphedema  from all over the  
country, with a good mix of in- and outpatients, and thereby covering the total 
spectrum of the lymphedema patient, as well in clinical presentation, as genotype 
and geographical distribution. To compensate this, a study was done in Australia 
as well, but only the results of the first group of patients could be used during the 
consensus conference. The results of the Australian study will be published 
separately. In the cross-sectional study we asked the patients for only specific 
categories  as mentioned in the literature reviews, whereas the original method  
makes use of the ICF in total.  
 
International perspective 
The project was initiated and performed in The Netherlands with international 
contributions in the expert research and the cross sectional clinical study in 
Australia, of which a part of the data were used for the consensus conference. 
There were also international contributions in the consensus conference itself. 
Although the literature review concerns world-wide articles and there were 
contributions from India in the expert research, much of the other parts of the 
development process had contributions from Western countries only. Future 
validation research in other, non-Western countries, including developing 
countries will reveal if the Core Sets are fully applicable in these countries, or may 
need extensions or additions. Circumstances are so different between the 
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developed and underdeveloped world that special projects should be run for 
validation in the different regions.  
 
Patient involvement and perspective 
Patients were involved in the preparatory studies (19). In the study about the 
health professionals’ clinical perspective the health professionals had to rank the 
patients’ health on a scale from 0 to 10 and the patients had to do that also. It 
came forward that health professionals judge the health of the patients lower 
than the patients themselves. It could well be that most of the patients have 
adapted to the problems caused by the lymphedema and therefore judge 
themselves at a higher level. One of the results of the validation study on the 
ULL27 was that there was no correlation between swelling of the arm and health-
related quality of life (18). This is in line with the reflections on adaptation to the 
lymphedema problems. Another reason for this higher level judgement could be 
that patients categorize problems like lymphedema not as part of their health, 
since cancer, being the basic reason of lymphedema, has been cured what  makes 
that patients judge their  health  higher. 
Although not included in the WHO procedure for developing Core Sets, it would 
have been an attractive option to involve patients in the consensus conference as 
well. Although we have considered this possibility, but it appeared to create 
problems with respect to (universal conference) language, costs, and travelling 
possibilities. We recommend to involve the patient perspective in the validation 
studies for the Core Sets for lymphedema, as was done already in the validation 
studies for other Core Sets (4-6). Hieblinger et al. examined the patient point of 
view in fibromyalgia patients and concluded that most of the categories of the ICF 
Core Set were relevant, but a few new categories emerged and these should be 
considered to be incorporated in the Core Sets for fibromyalgia (19). Validation 
studies point at the fact that Core Sets themselves as well as the criteria for the 
development process need updates at a regular basis. 
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The development process of the Core Sets for 
lymphedema in comparison to other Core Sets 
This project followed a structured development process (1, 20, 21). In the 
preparatory phase five studies were conducted. Originally there is a set of four 
studies, including one literature review on disease-specific questionnaires. In this 
project a second literature review was performed, linking meaningful concepts 
from the Method and Results sections of articles about lymphedema to ICF 
categories. The purpose was to compare the items which were discussed in these 
sections with the content of the questionnaires. In other words, did the questions 
in the used questionnaires connect to the concepts in the text of the article. The 
results indicate that for upper limb lymphedema the ICF categories in the text 
were similar to those in the questionnaires, whereas for lower limb lymphedema 
this was not the case. The addition of this second literature review was not done 
previously.  
When overviewing the various processes in the development of Core Sets, one 
can say that in the course of time the initial format has been abandoned by the 
developers (22). For instance the development of Core Sets for Low Back Pain, 
Acute hospital, and Rheumatoid Arthritis consisted of three preliminary studies, 
lacking the qualitative research (17, 23, 24). In the process to come to Core Sets 
for Ankylosing Spondylitis the cross-sectional study is absent (25). In a systematic 
review about ICF Core Sets developing from 2001 to 2012 Yen et al. (26) came to 
what they call the ‘most commonly adopted approach’. This approach contains 
two preliminary studies - the cross-sectional study followed by a systematic 
literature review - followed by a consensus procedure, as the final phase. When 
comparing the preliminary phase of the development of ICF Core Sets for 
lymphedema with previous developments of other Core Sets, one can say that 
with five studies a comprehensive picture of important categories for the 
lymphedema patient has been achieved.  
Compared with the average final consensus conference this project used a one-
day conference instead of a two- or even three-days conference (26). Much of the 
preparation was done preceding the conference by sending information on the 
ICF and all the data that were gathered in the preparatory phase to the 
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participants of the conference. By planning the consensus conference on the day 
before the start of an international conference on lymphedema, we were able to 
gather an interesting group of 23 experts. These experts represented six different 
health professions, whereas four are obligatory (26). The division of these 
professionals was slightly different compared with the overall division in the 
review of Yen et al. (26). In most other ICF Core Sets development processes, 
physicians were most represented, whereas in this conference physical therapists 
were maybe over represented (30%). Representatives of stocking suppliers and 
skin therapists were not participating in other Core Set projects, but were 
contributing for 22% and 4% respectively in this conference. This is because 
lymphedema requires a very specialized approach of specific health professionals. 
Six Core Sets were produced at the end of the consensus conference (all other 
Core Sets contain only two sets, namely one Comprehensive and one Brief Core 
Set). The choice for six Core Sets was made because of the different ways of 
functioning in the three different lymphedema regions, i.e. upper limb, lower limb 
and midline region. From the study of Yen et al. (26) it was learned that 
Comprehensive Core Sets had an average of 92.5 categories and Brief Core Sets 26 
categories. The Comprehensive Core Sets for lymphedema (Upper limb, Lower 
limb and Midline) consist of 101, 111 and 89 categories respectively; the Brief 
Core Sets of 23, 18 and 20 categories. It can be concluded that the amount of 
categories of all six Core Sets for lymphedema are within the ‘normal’ range. 
In earlier Core Set development studies it was expected that the focus would lie 
on domains within Body Functions and Activities and Participation, but it turned 
out that Environmental Factors were of equal importance (27, 28). The Core Sets 
for stroke, for instance, contained 25% environmental factors (27). For the Core 
Sets for lymphedema the Comprehensive Core Sets for upper limb, lower limb, 
and midline contain 22%, 23%, 24% Environmental Factors, respectively. The Brief 
Core Sets contain 17%, 27%, 20% Environmental Factors respectively. These 
percentages stress the importance of environmental factors for the functioning of 
people with lymphedema. 
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ICF Core Sets in a broader way 
Currently a lot of disease-specific ICF Core Sets already exist (1, 17, 19, 23, 24, 29-
33), but Core Sets for lymphedema were not yet composed. As stated in the 
introduction, the ICF provides a comprehensive framework of human functioning 
as well as a classification system (21). The ICF offers a universal language 
understood by health professionals, researchers, policy makers, patients, and 
patient organizations. By adding environmental and personal factors and a mutual 
influence between the different components, to its predecessor the International 
Classification of Impairments, Disabilities and Handicaps (ICIDH), the ICF moved 
away from a framework describing the consequences of a disease to a bio-psycho-
social framework (34). The reason for constructing disease-specific Core Sets is 
that the ICF itself contains more than 1400 categories and is not quite workable in 
daily practice. Core Sets will make the ICF useful for health care providers (35), 
because they contain the most important items for patients with a specific health 
condition, collected from the perspective of all persons involved. The Core Sets 
facilitate the description of the functioning of patients and the formulation of 
treatment goals. Description uniformity is needed to compare data for the 
evaluation of treatment efficacy and to collect data for research. ICF Core Sets will 
be more inviting for health care providers, researchers and all other professionals 
or institutes to use them for these purposes. The ICF Core Sets may be used as a 
guide for clinical reasoning and to record the results of clinical reasoning in 
electronic patient files. By being more ‘user-friendly’, ICF Core Sets could help 
raise the profile and impact of specific diseases on functioning for a particular 
client group to a larger audience (36).  
Comprehensive ICF Core Sets have proved to be beneficial to clarify team roles 
and facilitate clinical reasoning (36, 37). We hope that the introduction of the ICF 
Core Sets for lymphedema can further guide multidisciplinary cooperation and 
individual practitioners in service delivery. The Core Sets can serve as an eye-
opener for the risk that health professionals tend to use only the components 
they are comfortable with, i.e. body functions and structures. The inclusion of 
environmental factors, for instance, will facilitate consideration of these concepts 
by professionals, who traditionally would not do so (36). 
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McIntyre and Tempest (36) proclaim a possible disadvantage of Core Sets, namely 
that health professionals are often working with people with co-morbid 
conditions and multiple pathologies. So, in fact more than one disease-specific 
Core Set should be necessary to ensure a correct description of the impact on 
functioning of the patient. For instance, patients with breast-cancer related 
lymphedema have functioning problems which are the result of both the 
lymphedema as the consequences of the cancer itself. These two conditions are 
closely interwoven and there is no getting away from that. During the 
construction of the project this problem is encountered by the fact that in many 
cases the consequences of cancer, being the most important cause of the 
lymphedema, were in fact incorporated in the different studies of the 
development process, and therefore the Core Sets are in fact ‘real life’ sets. When 
the Core Sets for upper limb lymphedema are compared with the already existing 
Core Sets for breast cancer (consisting of 78 items for the Comprehensive and 29 
items for the Brief Core Set) (38), there is an overlap of 16 items of the Brief Core 
Sets. Compared with the Comprehensive Core Set there is an overlap of 45 items. 
It is obvious that both Core Sets have similar items, but on the other hand are 
complementary. 
McIntyre and Tempest also discuss the fact that Core Sets could be a step 
backwards towards the medical model (36). Utilizing a core set would imply the 
focus on the disease and its consequences, rather than the bio-psycho-social 
impact on the individual or group. With the introduction of Environmental Factors 
and the focus on Activities and Participation, the ICF and the ICF Core Sets are well 
prepared to tackle this possible relapse to ICF’s predecessor the ICIDH, in which 
this medical model was more prominent. 
Opponents also claim that the ICF only addresses the negative aspects of having a 
specific health condition (i.e. what the patient cannot do), instead of the positive 
aspects (what the patient still can do despite of his health condition) (42). 
However the wording of the ICF is neutral (instead of the negative wording in the 
ICIDH) and addressing the limitations and impairments of the patient does not 
exclude having attention for the aspects which are without problems.   
A shortcoming of the ICF system and subsequently the ICF Core Sets, is that 
personal factors are not included. Some attempts to resolve this problem were 
done (39-41) in the past, but the inclusion of personal factors is still experimental. 
- 227 -
Therefore until further notice some space for personal factors has to be available 
when using the ICF Core Sets.  
Finally, developed as a means to facilitate clinical reasoning, Core Sets should not 
feel like ‘corsets’, stifling reasoning and act like recipes in a cookbook. Space to 
describe the functioning of an individual patient is always required, also when 
using Core Sets. Core Sets are aids for the treatment and coaching of the patient 
besides many other tools used by health care workers. For example, Core Sets can 
help choosing patient related outcome measures (PROMs), because the Core Sets 
also contain the patients’ perspective. By using the Core Sets in selecting PROMs 
you know that relevant aspects are measured, leading to a better understanding 
of the experienced health and more insight in the quality of care given.  
ICF Core Sets for lymphedema and the Dutch 
guideline for lymphedema 
The Dutch guideline for lymphedema mentions the ICF Core Sets for lymphedema 
(13) as being under development. With the results presented in this thesis  it is  
possible to integrate the Core Sets in the guideline from now on. For example, the 
conclusions of Chapter H3 ‘Consequences of lymphedema for the patient’ can be 
compared with the Core Sets. These conclusions were based on several reviews 
(42, 43). The consequences of lymphedema mentioned were: pain (part of all Core 
Sets), functional limitations (not included in the Core Sets because it is no ICF 
category, but when interpreted as limitations in activities part of all Core Sets), 
fatigue (present in all Comprehensive Core Sets, but only mentioned in the Brief 
Core Set for the upper limb), decreased physical activity (not included in the Core 
Sets because the description is too broad), decreased adaptation to illness (being 
a personal factor, which is not included in the present Core Sets), decreased social 
support (again this is a rather broad term, but all Core Sets have categories 
concerning this social support (chapter 3 of the list of environmental factors is 
about support)), loss of self-confidence (part of the Comprehensive Core Sets for 
upper and lower limb, but lacking in midline and in all Brief Core Sets), depression 
(only mentioned in the Comprehensive Core Set for upper limb lymphedema), and 
disturbed self-image (the term ‘self-image’ is only part of the Comprehensive Core 
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Set for midline lymphedema, but when interpreted as ‘body-image’ part of all 
Core Sets). 
Integration of the ICF Core Sets into the Dutch guideline also provides the 
possibility to analyze the measurement instruments, advised by the guideline. As 
an example, two health-related quality of life questionnaires for lymphedema in 
the upper limb are compared with the Brief Core Set for upper limb lymphedema, 
namely the Lymph-ICF for the upper limb (44) and the Upper Limb Lymphedema 
27 (ULL27) (18). The ULL27 is linked to the ICF following existing rules (45, 46), the 
Lymph-ICF is not linked according these rules, but translated by the authors, 
following their own interpretation and based on the results of the preparatory 
studies for the construction of this questionnaire (Table 1).  
 
 
 
 
 
 
 
 
 
 
 
Table 1. HRQOL questionnaires and the Brief Core Set for upper limb lymphedema. 
              (+) = Code d4250 is no ICF code but added by the composers of the measurement instrument. 
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ICF code 
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b1263 Psychic stability / Psychische stabiliteit  x x 
b1265 Optimism / Optimisme  x  
b1266 Confidence / Vertrouwen x x  
b1301 Motivation / Motivatie  x  
b134 Sleep functions / Slaap  x  
b1341 Onset of sleep / Inslapen  x  
b1342 Maintenance of sleep / Doorslapen  x  
b152 Emotional functions / Stemming x   
b1522 Range of emotion / Bereik van stemmingen  x  
b164 Higher level cognitive functions / Hogere cognitieve functies   x 
b1801 Experience of self / Lichaamsbeeld   x 
b265 Touch function / Tast  x  
b280 Sensation of pain / Pijngewaarwording  x x 
b18014 Pain in upper limb / Pijn in bovenste extremiteit x   
b4352 Functions of lymphatic vessels / Functies van lymfevaten  x  
b439 Functions of the haematological and immunological systems, 
other specified and unspecified / Functies van 
hematologisch systeem en afweersysteem, anders 
gespecificeerd en niet gespecificeerd 
x   
b4550 General physical endurance / Algemeen fysiek 
uithoudingsvermogen 
  x 
b4552 Fatiguability / Vermoeibaarheid x  x 
b710 Mobility of joint functions / Mobiliteit van gewrichten   x 
b7101 Mobility of several joints / Mobiliteit van meerdere 
gewrichten 
x   
b730 Muscle power functions / Spiersterkte   x 
b7301 Power of muscles of one limb / Sterkte van spieren in één 
ledemaat 
x   
b840 Sensation related to the skin / Gewaarwording verband 
houdend met huid 
x x  
d230 Carrying out daily routine / Uitvoeren van dagelijkse 
routinehandelingen 
  x 
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d415 Maintaining a body position / Handhaven van 
lichaamshouding 
 x  
d4150 Maintaining a lying position / Handhaven van liggende 
houding 
x   
d4250 Sunbathe / Zonnebaden (+) x   
d4301 Carrying in the hands / Dragen in handen x   
d4401 Grasping / Grijpen  x  
d445 Hand and arm use / Gebruiken van hand en arm  x x 
d4452 Reaching / Reiken x x   
d4453 Turning or twisting the hands or arms / Om- of ronddraaien 
met armen of handen 
 x  
d4458 Hand and arm use, other specified / Gebruiken van hand en 
arm, anders gespecificeerd 
x   
d450 Walking / Lopen  x  
d4501 Walking long distances / Lopen van lange afstanden x   
d4702 Using public motorized transportation / Gebruiken van 
gemotoriseerd openbaar vervoer 
 x  
d4750 Driving human-powered transportation / Besturen van door 
menskracht voortbewogen vervoermiddel 
x   
d4751 Driving motorized vehicles / Besturen van gemotoriseerde 
voertuigen 
x   
d5 SELF-CARE / ZELFVERZORGING   x 
d5200 Caring for skin / Verzorgen van huid  x  
d5202 Caring for hair / Verzorgen van het haar  x  
d540 Dressing / Zich kleden x x  
d5404 Choosing appropriate clothing / Kiezen van juiste kleding    
d570 Looking after one’s health / Zorgdragen voor eigen 
gezondheid 
  x 
d5701 Managing diet and fitness / Zorgdragen voor dieet en fitheid   x 
d5702 Maintaining one’s health / Behouden van eigen gezondheid  x  
d6200 Shopping / Boodschappen doen  x  
d6300 Preparing simple meals / Bereiden van eenvoudige 
maaltijden 
x   
d640 Doing housework / Huishouden doen   x 
d6400 Washing and drying clothes and garments / Wassen en 
drogen van kleding  
 x  
d6402 Cleaning living area / Schoonmaken van woonruimte x   
d6403 Using household appliances / Bedienen van huishoudelijke 
apparatuur 
x   
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d6505 Taking care of plants, indoors and outdoors / Verzorgen van 
planten, binnens- en buitenshuis 
x   
d770 Intimate relationships / Intieme relaties   x 
d7701 Spousal relationships / Samenlevingsrelaties  x  
d850 Remunerative employment / Betaald werk x x x 
d920 Recreation and leisure / Recreatie en vrije tijd  x x 
d9201 Sports / Sport x   
d9202 Arts and culture / Kunst en cultuur  x  
d9204 Hobbies / Hobby's x   
d9205 Socializing / Sociale activiteiten x x  
d9209 Recreation and leisure, unspecified / Recreatie en vrije tijd, 
niet gespecificeerd 
x   
e1151 Assistive products and technology for personal use in daily 
living / Ondersteunende producten en technologie voor 
persoonlijk gebruik in het dagelijks leven 
  x 
e310 Immediate family / Naaste familie  x x 
e320 Friends / Vrienden   x 
e355 Health professionals / Hulpverleners in de gezondheidszorg   x 
s420 Structure of immune system / Anatomische eigenschappen 
van afweersysteem 
  x 
s730 Structure of upper extremity / Anatomische eigenschappen 
van bovenste extremiteit 
  x 
 
As shown in table 1 it is possible to compare the similarities as well as the 
differences between the two questionnaires and the ICF Core Sets. It is also 
possible to compare the representation of the components of the ICF (Body 
Functions, Body Structures, Activities and Participation, and Environmental 
Factors) in the two questionnaires, in order to get an impression of which 
questionnaire has the broadest coverage of the ICF.  In this case, for instance, the 
Lymph-ICF has no coverage of Environmental Factors. 
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Conclusion and recommendations 
A consensus process integrating evidence and expert opinion contributed to the 
development of six solid ICF Core Sets for lymphedema. The Core Sets reflect the 
multidisciplinary and complex characteristics of treatment of patients with 
lymphedema. This development is a first step towards an internationally accepted 
and standardized framework when collecting and reporting variables or measures 
in the field and practice of lymphedema. 
Since the ICF Core Sets for lymphedema are now available, it is possible to look at 
possibilities for implementation and for further research / validation.  
 
1) The present versions are first versions, i.e. they need adaptation in daily 
practice to find out if the selected categories of the Core Sets are really 
that important and if other categories need to be added. The best way for 
health professionals to participate in the further development of the Core 
Sets is to seize this opportunity to debate and influence the direction of 
the next steps in this development. Since the project was initiated in The 
Netherlands, it would be advisable to start the implementation also in The 
Netherlands. The best way is to start top-down as well as bottom-up. If 
the Core Sets will be integrated in the education courses for lymphedema 
treatment and, on the other hand, the Core Sets are integrated in the 
Dutch guideline for lymphedema and the Dutch umbrella organizations 
concerning lymphedema (such as the Nederlandse Vereniging voor 
Dermatologie en Venereologie (NVDV), Nederlandse Vereniging voor 
Fysiotherapie binnen de Lymfologie (NVFL), and het Nederlands 
Lymfoedeem Netwerk (NLNet)) embrace them, this can be achieved 
easier. Moreover, also international organisations, like the International 
Lymphedema Framework (ILF) and the International Society for 
Lymphedema (ISL), can contribute to the implementation by including the 
Core Sets in their Best Practice Documents and education programs.  
 
2) After the implementation of the Core Sets, a re-evaluation has to take 
place while considering the results of the validation and testing of the first 
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versions of the ICF Core Sets, preferably after about five years (phase III) 
(Figure 1). 
 
Fig 1. Addition of phase III in the schedule of the development of the ICF Core Sets for lymphedema. 
 
3) It would also be advisable to implement the RPS form together with the 
ICF Core Sets in the electronic patient files, because of the compatibility 
between the two. 
Like all other ICF Core Sets, the Core Sets for lymphedema need 
adaptation for specific health professionals and countries. For instance 
physical therapists use other categories of the ICF than physicians or 
nurses. Cross-validation for different countries is needed, because of the 
differences in social and cultural aspects. For example, Zeldenryk et al 
found out that current generic disability measurement instruments used 
within the lymphatic filariasis field of Bangladesh, fail to adequately 
measure the known impact of lymphatic filariasis-related disability (47-
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49). They conclude that there remains a need for a lymphatic filariasis-
specific quality of life/disability measurement instrument, to adequately 
measure the impact of disability for individuals and communities.  
 
4) Finally, with the Core Sets as a basis, basic sets of measurement 
instruments in lymphedema can be developed or chosen from the existing 
instruments.  
 
All the above mentioned recommendations serve only one purpose, and that is to 
collect more information about the health condition and to facilitate and improve 
the lymphedema care for the individual patient. With this thesis being the start of 
it, the development of ICF Core Sets for lymphedema should be a continuing 
process.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“All ends with beginning”. 
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Summary 
 
This thesis describes a project on the development of ICF Core Sets for 
lymphedema. The motivation for this project is the fact that within lymphology 
little structure and unity can be found in the area of clinical reasoning, the use of 
measurement instruments and registration data sets, and patient education in 
mono- and multidisciplinary settings. ICF Core Sets are considered to offer an 
appropriate tool in this respect. 
Chapter 1 is a general introduction of this thesis. Lymphedema is defined as an 
abnormal accumulation of fluid and protein in the body tissues as a result of a dis 
balance between the flow and the discharge of fluid. Lymphedema is a chronic 
condition and its influence on physical functioning can result in distress and loss of 
quality of life. Altered body shape and the necessity for daily use of specialized 
garments or bandaging as a standard treatment for stabilized lymphedema make 
acceptance of the condition difficult for the patient as well as for his or her family 
and environment. In addition, lymphedema requires lifelong self-care: patients 
must follow prescribed regimens, such as daily bandaging or the use of special 
garments, utilize skin care regimens, and exercise caution with open wounds. 
Generally, the activity and participation levels of persons with lymphedema are 
lower than those of their healthy peers. The ICF is accepted by the World Health 
Assembly as a universal framework for classifying and describing functioning in 
people with specific health conditions. Although the ICF classification system with 
more than 1400 categories can serve as a reference, the ICF is not easily 
applicable in clinical practice. Therefore, tools such as ICF Core Sets (health-
specific selections of ICF categories) are helpful to make the ICF more appealing 
for implementation in medical/allied health care. The advantages of the use of ICF 
Core Sets are in the field of: determining relevant outcome measures, making a 
proper choice of measurement instruments, offering a framework for guidelines, 
giving structure in reporting and clinical reasoning, and giving the possibility to 
determine the severity of certain components of functioning, to generate more 
knowledge about lymphedema, to help in communicating with patients, and to 
provide structure in multidisciplinary settings. 
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In chapter 2 we give an overview of the development process to come to ICF Core 
Sets for lymphedema. The process contains two phases: a preparatory 
(developmental) phase and a validation (implementation) phase. In this thesis the 
developmental phase will be described. In this phase five preparatory studies 
were performed: a literature review from the researchers’ point of view (this 
study existed of two separate researches), a qualitative research from the 
patients’ perspective, a cross-sectional clinical study to reveal the health 
professionals’ point of view, and an expert research among experts in the field of 
lymphedema. The data of four of the five preparatory studies were presented at 
an international consensus conference resulting in the first versions of the Core 
Sets. The second phase (validation and implementation) is beyond this thesis. 
Chapter 3 discusses the first literature review. In this research we explored the 
measurement instruments for lymphedema and especially the lymphedema-
specific questionnaires. The meaningful concepts in these questionnaires were 
linked to the ICF in order to obtain frequency tables of the most occurring ICF 
categories. Of the - by means of a structured search procedure - 2381 abstracts 
retrieved, 136 studies were included, based on the in- and exclusion criteria. The 
selected studies were divided in 88 about lymphedema in the upper limb (65%), 
34 about the lower limb (25%), five about the midline (3%) and nine about 
combinations of these areas (7%). Considering the questionnaires, it is striking 
that there are 51 different questionnaires in the included studies, so it seems that 
every researcher used his/her own questionnaire. In total, 12 lymphedema-
specific questionnaires were found (nine for the upper limb, two for the lower 
limb and one for lymphedema in general). A total of 301 ‘meaningful concepts’ 
was extracted from the questionnaires, of which 271 (90%) could be linked to the 
ICF. There were 45 two-level ICF categories linked to concepts in more than two 
questionnaires; 13 in Body Functions, six in Body Structures, 16 in Activities and 
Participation, and 10 in Environmental Factors. The most frequently measured 
categories were ‘Structure of upper extremity’, ‘Immunological system functions’, 
‘Looking after one’s health’, ‘Sensation of pain’, ‘Touch functions’, ‘Dressing’, and 
‘Health services, systems and policies’. The ICF appeared a valuable means to 
point out items from questionnaires, which are important for patients with 
lymphedema. 
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Chapter 4 describes a second analysis of the literature. In this review the Methods 
and Results section of the 136 selected articles were explored for ‘meaningful 
concepts’, which were linked to the ICF, resulting in frequency tables of the most 
occurring ICF categories. The ICF categories of the studies were then compared 
with the ICF categories linked to the ‘meaningful concepts’ found in the 
questionnaires to determine whether or not researchers explored these items. By 
examining both the questionnaires and the studies themselves, a useful selection 
of ICF categories has been identified. We recommend the use of both 
questionnaires and studies because these approaches are complementary and 
because the use of both methods yields more data than can be obtained by using 
either method alone. 
 
In chapter 5 we describe the translation and cross-validation (i.e. the applicability 
of the questions in the Dutch culture and society) from French into Dutch of one 
of the analyzed health-related quality of life questionnaires for upper limb 
lymphedema; the Upper Limb Lymphedema 27 (ULL27). In chapter 3 this 
questionnaire is linked to the ICF. Considering the Dutch version the internal 
consistency of the domains of the questionnaire (physical, psychological and 
social dimensions) was good as were the convergent validity and discriminant 
validity. Upper limb volume and the domains of the ULL27 were not correlated. 
The Dutch translation of the ULL27 questionnaire has good internal consistency 
and validity but further research is needed to determine its responsiveness. 
 
The study to explore the patients’ perspective is described in chapter 6. We 
performed a qualitative research with focus groups of lymphedema patients to 
identify and quantify ‘meaningful concepts’ from the patients’ perspective about 
the most important factors, which influence functioning and health-related 
quality of life. This was done identifying and subsequently quantifying ‘meaningful 
concepts’ about lymphedema. Six focus group interviews in five different centers 
were organized, audiotaped, transcribed verbatim and analyzed. A total of 2681 
relevant ICF linkings were performed with the focus group data, resulting in 130 
different second-level categories. Of these 130 second-level categories, 41 
(31.5%) categories were categorized as Body Functions, 20 (15.5%) as Body 
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Structures, 41 (31.5%) as Activities and Participation, and 28 (21.5%) as 
Environmental Factors. Overall, the most important issues according to the 
patients were the use of hosiery and bandages, support and relationships, and the 
fact that their arms and legs were so malformed. Based on their experiences with 
lymphedema, patients reported activity limitations and participation restrictions 
combined with impaired body functions. Anatomical changes (Body Structures) 
were also often mentioned as a problem in daily life. Environmental factors such 
as health professionals, hosiery and family members are reported to act as a 
barrier or facilitator for patient functioning.  
 
Chapter 7 reports the results of a cross-sectional survey in which lymphedema 
patients (n = 200) were interviewed by their health professionals on the basis of a 
specific questionnaire. This questionnaire contained the items that resulted from 
the literature review of the questionnaires. By means of the Parantion database 
the severity of specific ICF categories could be determined for each patient, 
making it possible to describe the functioning of lymphedema patients and to 
identify their problems. The most frequent mentioned items were in the Body 
Functions component: muscle power and mobility of joints, in the Activities and 
Participation component: doing housework, and changing and maintaining a body 
position, and in the Environmental Factors component: Health professionals, who 
can act as both facilitators and barriers. Interestingly, patients assessed their 
health more positively than health professionals do. 
 
Chapter 8 describes the results of an email based worldwide survey among 
experts in the field of lymphedema with questions based on components of the 
ICF. The purpose was to identify and quantify meaningful concepts in 
lymphedema from health professionals’ perspectives. In total, 142 health 
professionals from seven different health professions and 20 different countries 
answered the questions. The answers of the health professionals included 7373 
aspects of functioning, of which 6296 could be linked to 359 different ICF 
categories. Of these categories, 109 belonged to body functions (30.4%), 55 to 
body structures (15.3%), 121 to activities and participation (33.7%), and 74 to 
environmental factors (20.6%). Overall, the most mentioned items were: ‘ Health 
services, systems and policies’ (686 times), ‘Immunological system functions’ (563 
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times), ‘Looking after one’s health’ (385 times), ‘Products and technology for 
personal use in daily life’ (299 times), and ‘Dressing’ (285 times). 
 
Chapter 9 presents the outcomes of the consensus conference to determine the 
first ICF Core Sets for lymphedema, based on the preparatory studies. In order to 
achieve this, frequency rankings were made of the ICF categories derived from 
these studies. By means of discussions in working groups and plenary sessions 
with invited international experts in the field of lymphedema from different 
professions and countries, final consensus on ICF categories was achieved. This 
resulted in Comprehensive and Brief Core Sets for lymphedema, each for three 
regions: upper limb, lower limb and midline lymphedema. ICF Core Sets for 
lymphedema appeared to contain different items in relation with the region of 
the edema. For instance in midline lymphedema urinating and sexual functions 
are important and in lymphedema of the upper or lower limb the mobility of 
joints. In the future these Core Sets need to be validated for different groups of 
health professions and for different countries. 
 
In Chapter 10 the main findings from the studies presented in this thesis are 
discussed and placed into a broader perspective. Thus, a comparison is made with 
the development of other Core Sets and certain criticisms discussed about the 
Core Sets. In addition, the Core Sets for lymphedema are compared with the 
Dutch Guideline for Lymphedema. It appears that the ICF Core Sets can be 
properly implemented in certain parts of the guideline. The distinction between 
measurement instruments recommended by the guideline with respect to the 
Core Sets can be made. As an example the ULL27 and Lymph-ICF for the upper 
extremity questionnaire are discussed. Furthermore, the limitations of the various 
studies and the project in total are discussed and suggestions about validation and 
implementation procedures are given. 
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Samenvatting 
 
Dit proefschrift beschrijft een project over de ontwikkeling van ICF Core Sets voor 
lymfoedeem. De motivatie voor dit project komt voort uit het feit dat er binnen 
de lymfologie weinig structuur en eenheid is op het gebied van: klinisch 
redeneren, het gebruik van meetinstrumenten, het vastleggen van datasets en 
voorlichting van de patiënt in mono- en multidisciplinaire omgevingen. In dit 
opzicht worden ICF Core Sets gezien als een geschikt instrument. 
 
Hoofdstuk 1 is een algemene introductie van dit proefschrift. Lymfoedeem wordt 
gedefinieerd als een abnormale ophoping van vocht en eiwit in de 
lichaamsweefsels als gevolg van een disbalans tussen aanvoer en afvoer van 
vocht. Lymfoedeem is een chronische aandoening en heeft invloed op het fysiek 
functioneren. Dit kan resulteren in pijn, angst en verlies van kwaliteit van leven. 
De veranderde lichaamsvorm maakt het noodzakelijk dagelijks gebruik te moeten 
maken van speciale kleding of zwachtels ( standaardbehandeling voor 
gestabiliseerd lymfoedeem). Dit maakt de acceptatie van de aandoening moeilijk 
voor de patiënt, familie en omgeving. Daarnaast vereist lymfoedeem levenslange 
zelfzorg: patiënten moeten voorgeschreven adviezen opvolgen, zoals het dagelijks 
zwachtelen of het gebruik van speciale kledingstukken, huidverzorging en het 
voorzichtig zijn met wondjes. In het algemeen zijn de activiteiten en participatie 
van mensen met lymfoedeem minder dan die van hun gezonde leeftijdsgenoten. 
De ICF is door de World Health Assembly erkend als een universeel raamwerk 
voor de classificatie en beschrijving van de functie van mensen met specifieke 
gezondheidsproblemen. Hoewel de ICF als classificatiesysteem met meer dan 
1400 categorieën kan dienen als naslagwerk, is de ICF niet eenvoudig toepasbaar 
in de klinische praktijk. Daarom zijn hulpmiddelen zoals ICF Core Sets 
(gezondheid-specifieke selecties van ICF categorieën) nuttig om de ICF makkelijker 
toepasbaar te maken voor het gebruik in de medische- en paramedische zorg. De 
voordelen van het gebruik van ICF Core Sets liggen op het gebied van: het bepalen 
van relevante uitkomstmaten, het maken van een geschikte keuze van 
meetinstrumenten, het bieden van een raamwerk voor richtlijnen, het bieden van 
structuur in rapportage en klinisch redeneren, de mogelijkheid om de ernst te 
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bepalen van bepaalde onderdelen van de functie, het genereren van meer kennis 
over lymfoedeem, de communicatie met de patiënt en het bieden van structuur in 
de multidisciplinaire samenwerking. 
 
In hoofdstuk 2 geven we een overzicht van het ontwikkelingsproces om te komen 
tot ICF Core Sets voor lymfoedeem. Het proces bestaat uit twee fasen: een 
voorbereidende (ontwikkelings) fase en een validatie (implementatie) fase. In dit 
proefschrift wordt de ontwikkelingsfase beschreven. In deze fase werden vijf 
voorbereidende studies uitgevoerd: een literatuurstudie vanuit het perspectief 
van de onderzoeker (deze studie bestond uit twee afzonderlijke onderzoeken), 
een kwalitatief onderzoek vanuit het standpunt van de patiënt, een cross-
sectionele klinische studie om het beeld van de hulpverlener te bepalen en een 
expert onderzoek onder deskundigen op het gebied van lymfoedeem. De 
gegevens van vier van de vijf voorbereidende studies werden gepresenteerd op 
een internationale consensus conferentie, hetgeen resulteerde in de eerste 
versies van de Core Sets. De tweede fase (validatie en implementatie) valt buiten 
dit proefschrift. 
 
Hoofdstuk 3 beschrijft het eerste literatuuronderzoek. In dit onderzoek 
onderzochten we de meetinstrumenten voor lymfoedeem en met name de 
lymfoedeem-specifieke vragenlijsten. De ‘meaningful concepts’ (items die van 
betekenis zijn) in deze vragenlijsten werden gecodeerd m.b.v. de ICF, teneinde 
frequentietabellen te krijgen van de meest voorkomende ICF categorieën. Van de, 
via een gestructureerde zoekprocedure, 2381 gevonden abstracts, werden 136 
studies opgenomen op basis van de in- en uitsluitingscriteria. De geselecteerde 
studies waren als volgt verdeeld: 88 over lymfoedeem in de bovenste extremiteit 
(65%), 34 betreffende de onderste extremiteit (25%), vijf over midline (3%) en 
negen over combinaties van deze gebieden (7%). Bij nadere beschouwing van de 
vragenlijsten valt op dat er in totaal 51 verschillende vragenlijsten in de studies 
voorkomen. Het lijkt erop dat elke onderzoeker zijn eigen vragenlijst gebruikt. In 
totaal werden 12 lymfoedeem-specifieke vragenlijsten aangetroffen (negen voor 
de bovenste extremiteit, twee voor de onderste extremiteit en een voor 
lymfoedeem in het algemeen). Een totaal van 301 'meaningful concepts’ werd 
gevonden in de vragenlijsten, waarvan 271 (90%) konden worden gekoppeld aan 
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de ICF. Er werden 45 tweede-level ICF categorieën gekoppeld in meer dan twee 
vragenlijsten; 13 behorend tot Functies, zes tot Anatomische eigenschappen, 16 
tot Activiteiten en Participatie en 10 tot Externe factoren. De meest frequente 
categorieën waren “Anatomische eigenschappen van de bovenste extremiteit", 
"Functies van het afweersysteem”, “Zorgdragen voor eigen gezondheid”, 
“Pijngewaarwording”, “Tast functies”, “Zich kleden” en “Voorzieningen, systemen 
en beleid met betrekking tot gezondheidszorg”. De ICF bleek een waardevol 
middel te zijn om uit vragenlijsten items te bepalen, die belangrijk zijn voor 
patiënten met lymfoedeem. 
 
Hoofdstuk 4 beschrijft een tweede analyse van de literatuur. In deze studie 
werden de Methode en Resultaten secties van de 136 geselecteerde artikelen 
onderzocht op ‘meaningful concepts’. Deze werden gecodeerd met de ICF, 
waardoor frequentietabellen van de meest voorkomende ICF categorieën 
ontstonden. De ICF categorieën van de studies werden vervolgens vergeleken met 
de ICF categorieën uit het onderzoek over de vragenlijsten om te bepalen of 
onderzoekers deze items ook daadwerkelijk onderzochten. Door zowel de 
vragenlijsten als de studies zelf te onderzoeken, kwam een bruikbare selectie van 
ICF categorieën naar voren. We raden het gebruik van zowel vragenlijsten als 
studies aan. Het gebruik van beide methoden samen levert meer data op dan 
afzonderlijk, daar zij complementair zijn.  
 
In hoofdstuk 5 beschrijven we de vertaling en cross-validatie ( de toepasbaarheid 
van de vragen in de Nederlandse cultuur en samenleving) van een van de 
geanalyseerde gezondheid gerelateerde kwaliteit van leven vragenlijsten voor 
lymfoedeem van de bovenste extremiteit; de Upper Limb lymphedema 27 (ULL27) 
vanuit het Frans naar het Nederlands. In hoofdstuk 3 is deze vragenlijst gecodeerd 
met de ICF. De interne consistentie van de domeinen van de Nederlandse versie 
van deze vragenlijst (fysieke, psychologische en sociale dimensies) was goed net 
als de convergente en discriminante validiteit. Het volume van de bovenste 
extremiteit en de domeinen van de ULL27 waren niet gecorreleerd. De 
Nederlandse vertaling van de ULL27 vragenlijst heeft een goede interne 
consistentie en validiteit, maar verder onderzoek is nodig om de responsiviteit te 
bepalen. 
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De studie om het perspectief van de patiënten te onderzoeken is beschreven in 
hoofdstuk 6. We hebben een kwalitatief onderzoek gedaan met focusgroepen van 
lymfoedeem patiënten om ‘meaningful concepts’ te identificeren en te 
kwantificeren vanuit het perspectief van de patiënt over de belangrijkste factoren 
die van invloed zijn op de functie en de gezondheid gerelateerde kwaliteit van 
leven. Dit werd gedaan door ‘meaningful concepts’ over lymfoedeem te 
identificeren en vervolgens te kwantificeren. Zes focusgroep interviews in vijf 
verschillende centra werden georganiseerd, op band opgenomen, uitgetypt en 
geanalyseerd. Met de focus groep gegevens werd een totaal van 2681 relevante 
ICF categorieën gevonden. Dit resulteerde in 130 verschillende categorieën op het 
tweede niveau. Van deze 130 tweede niveau categorieën, werden 41 (31,5%) 
categorieën gecategoriseerd als Functies, 20 (15,5%) als Anatomische 
eigenschappen, 41 (31,5%) als behorend bij Activiteiten en Participatie en 28 
(21,5%) als Externe factoren. In het algemeen waren, volgens de patiënten, de 
belangrijkste problemen: misvormde ledematen, gebruik moeten maken van 
kousen en bandages, het nodig hebben van ondersteuning en nadelige invloed op 
relaties. Op basis van hun ervaringen met lymfoedeem gaven patiënten aan dat ze 
beperkingen in activiteiten en restricties in participatie hadden, in combinatie met 
stoornissen in lichaamsfuncties. Anatomische veranderingen (Anatomische 
eigenschappen) werden vaak beschouwd als een probleem in het dagelijks leven. 
Verder kunnen omgevingsfactoren zoals hulpverleners, kousen en familieleden 
een herstel belemmerende of bevorderende factor voor de patiënt zijn. 
 
Hoofdstuk 7 vermeldt de resultaten van een cross-sectioneel onderzoek waarin 
lymfoedeem patiënten (n = 200) werden geïnterviewd door hun hulpverleners op 
basis van een specifieke vragenlijst. Deze vragenlijst bevatte de items die 
voortvloeiden uit het literatuuronderzoek over de vragenlijsten. Via de Parantion 
database kon de ernst van specifieke ICF categorieën worden bepaald voor elke 
patiënt, waardoor het mogelijk was om de functie van patiënten met lymfoedeem 
te beschrijven en hun problemen te identificeren. De meest voorkomende items 
waren in de Functies component: spierkracht en mobiliteit van de gewrichten, in 
de Activiteiten en Participatie component: het doen van huishoudelijk werk en het 
veranderen en onderhouden van bepaalde lichaamshoudingen en in de Externe 
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factoren component: zorgverleners, die zowel kunnen optreden als herstel 
belemmerende als herstel bevorderende factoren. Interessant is dat patiënten 
hun gezondheid positiever beoordelen dan hulpverleners dat doen. 
 
Hoofdstuk 8 beschrijft de resultaten n.a.v. een wereldwijd e-mail onderzoek 
onder lymfoedeem deskundigen met vragen op het gebied van lymfoedeem 
gebaseerd op onderdelen van de ICF. Het doel was om ‘meaningful concepts’ over 
lymfoedeem te identificeren en te kwantificeren vanuit het perspectief van de 
hulpverlener. In totaal 142 hulpverleners van zeven verschillende beroepen in de 
gezondheidszorg en uit 20 verschillende landen beantwoordden de vragen. De 
antwoorden van de hulpverleners bevatten 7373 aspecten over de functie, 
waarvan 6296 konden worden gekoppeld aan 359 verschillende ICF categorieën. 
Van deze categorieën, waren er 109 betreffende Functies (30,4%), 55 over 
Anatomische eigenschappen (15,3%), 121 over Activiteiten en Participatie (33,7%) 
en 74 betreffende Externe factoren (20,6%). De meest genoemde punten waren 
over het algemeen: “Voorzieningen, systemen en beleid met betrekking tot 
gezondheidszorg” (686 keer), "Functies van het afweersysteem” (563 keer), 
“Zorgdragen voor eigen gezondheid” (385 keer), “Producten en technologie voor 
persoonlijk gebruik in het dagelijks leven” (299 keer) en “Zich kleden” (285 keer). 
 
Hoofdstuk 9 beschrijft de uitkomsten van de consensusconferentie om de eerste 
ICF Core Sets voor lymfoedeem te bepalen, op basis van de voorbereidende 
studies. Om dit te bereiken werden van deze studies frequentie rangordes van de 
ICF categorieën gemaakt. Door middel van discussies in werkgroepen en plenaire 
sessies met uitgenodigde internationale experts op het gebied van lymfoedeem 
uit verschillende beroepen en landen, werd definitieve consensus over ICF 
categorieën bereikt. Dit resulteerde in uitgebreide en korte Core Sets voor 
lymfoedeem, elk voor drie regio's: de bovenste ledematen, onderste ledematen 
en midline lymfoedeem. ICF Core Sets voor lymfoedeem bleken verschillende 
items in relatie tot de regio van het oedeem te bevatten. Bijvoorbeeld bij midline 
lymfoedeem zijn urineren en seksuele functies belangrijk en bij lymfoedeem van 
de bovenste of onderste ledematen de mobiliteit van de gewrichten. In de 
toekomst is het noodzakelijk dat deze Core Sets worden gevalideerd voor de 
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verschillende beroepen in de gezondheidszorg en verschillende landen. 
 
In hoofdstuk 10 worden de belangrijkste bevindingen uit de studies in dit 
proefschrift besproken en geplaatst in een breder perspectief. Zo wordt een 
vergelijking gemaakt met de ontwikkeling van andere Core Sets en bestaande 
kritiek over de Core Sets besproken. Daarnaast worden de Core Sets voor 
lymfoedeem vergeleken met de Nederlandse Richtlijn voor lymfoedeem. Het blijkt 
dat de ICF Core Sets goed in bepaalde delen van de richtlijn kunnen worden 
geïmplementeerd. Het onderscheid tussen meetinstrumenten aanbevolen door 
de richtlijn ten opzichte van de Core Sets kan worden gemaakt. Als voorbeeld 
worden de ULL27 en de Lymph-ICF (vragenlijsten voor de bovenste extremiteit) 
besproken. Bovendien worden de beperkingen van de diverse studies en het 
project in totaal besproken en suggesties over de validatie en implementatie 
gedaan. 
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ID_ICF Title Clinical 
research 
Australia 
b BODY FUNCTIONS   
b1 CHAPTER 1  MENTAL FUNCTIONS   
b126 Temperament and personality functions 4 
b130 Energy and drive functions 12 
b152 Emotional functions 7 
b160 Thought functions 2 
b164 Higher-level cognitive functions  2 
b180 Experience of self and time functions 1 
b2 CHAPTER 2  SENSORY FUNCTIONS AND PAIN   
b210 Seeing functions 1 
b265 Touch function 13 
b270 Sensory functions related to temperature and other stimuli 11 
b280 Sensation of pain 21 
b4 CHAPTER 4 FUNCTIONS OF THE CARDIOVASCULAR, HAEMATOLOGICAL, 
IMMUNOLOGICAL AND RESPIRATORY SYSTEMS 
  
b415 Blood vessel functions 4 
b435 Immunological system functions 15 
b455 Exercise tolerance functions 15 
b5 CHAPTER 5 FUNCTIONS OF THE DIGESTIVE, METABOLIC AND ENDOCRINE 
SYSTEMS 
  
b530 Weight maintenance functions 9 
b540 General metabolic functions 2 
b550 Thermoregulatory functions 8 
b6 CHAPTER 6  GENITOURINARY AND REPRODUCTIVE FUNCTIONS   
b640 Sexual functions 1 
b7 CHAPTER 7 NEUROMUSCULOSKELETAL AND MOVEMENT-RELATED 
FUNCTIONS 
  
b710 Mobility of joint functions 11 
b730 Muscle power functions 12 
b8 CHAPTER 8 FUNCTIONS OF THE SKIN AND RELATED STRUCTURES   
b810 Protective functions of the skin 21 
b820 Repair functions of the skin 20 
b830 Other functions of the skin 13 
d ACTIVITIES AND PARTICIPATION   
d1 CHAPTER 1  LEARNING AND APPLYING KNOWLEDGE   
d155 Acquiring skills 2 
 
  
Table 1.  Total amount of ICF categories mentioned by patients with upper limb lymphedema (n = 42). 
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d170 Writing 4 
d2 CHAPTER 2  GENERAL TASKS AND DEMANDS   
d230 Carrying out daily routine 18 
d3 CHAPTER 3  COMMUNICATION     
d325 Communicating with - receiving - written messages 1 
d345 Writing messages  3 
d360 Using communication devices and techniques 3 
d4 CHAPTER 4  MOBILITY     
d410 Changing basic body position 15 
d415 Maintaining a body position 13 
d430 Lifting and carrying objects    27 
d445 Hand and arm use 23 
d450 Walking 8 
d460 Moving around in different locations 7 
d5 CHAPTER 5  SELF-CARE    
d510 Washing oneself 2 
d520 Caring for body parts 5 
d540 Dressing    9 
d550 Eating 2 
d570 Looking after one’s health 1 
d6 CHAPTER 6  DOMESTIC LIFE    
d640 Doing housework    17 
d660 Assisting others 4 
d7 CHAPTER 7  INTERPERSONAL INTERACTIONS AND RELATIONSHIPS   
d710 Basic interpersonal interactions 2 
d720 Complex interpersonal interactions 1 
d750 Informal social relationships 2 
d770 Intimate relationships 3 
d8 CHAPTER 8  MAJOR LIFE AREAS   
d845 Acquiring, keeping and terminating a job 4 
d850 Remunerative employment 5 
d870 Economic self-sufficiency 6 
d9 CHAPTER 9  COMMUNITY, SOCIAL AND CIVIC LIFE   
d910 Community life 5 
d920 Recreation and leisure 17 
e ENVIRONMENTAL FACTORS   
e1 CHAPTER 1  PRODUCTS AND TECHNOLOGY   
e110 Products or substances for personal consumption 5 
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e115 Products and technology for personal use in daily living  28 
e125 Products and technology for communication 11 
e130 Products and technology for education 22 
e135 Products and technology for employment 3 
e140 Products and technology for culture, recreation and sport 9 
e150 Design, construction and building products and technology of buildings for 
public use 
5 
e155 Design, construction and building products and technology of buildings for 
private use 
8 
e165 Assets 15 
e2 CHAPTER 2  NATURAL ENVIRONMENT AND HUMAN-MADE CHANGES TO 
ENVIRONMENT 
  
e210 Physical geography 4 
e215 Population 3 
e225 Climate 33 
e3 CHAPTER 3  SUPPORT AND RELATIONSHIPS   
e310 Immediate family 33 
e315 Extended family 17 
e320 Friends 30 
e325 Acquaintances, peers, colleagues, neighbours and community members 19 
e330 People in positions of authority 18 
e355 Health professionals 33 
e4 CHAPTER 4  ATTITUDES   
e410 Individual attitudes of immediate family members 14 
e415 Individual attitudes of extended family members 13 
e420 Individual attitudes of friends 18 
e425 Individual attitudes of acquaintances, peers, colleagues, neighbours and 
community members 
18 
e460 Societal attitudes 10 
e465 Social norms, practices and ideologies 2 
e5 CHAPTER 5  SERVICES, SYSTEMS AND POLICIES   
e535 Communication services, systems and policies 14 
e555 Associations and organizational services, systems and policies 16 
e570 Social security services, systems and policies 19 
e580 Health services, systems and policies 33 
e585 Education and training services, systems and policies 15 
s BODY STRUCTURES   
s4 CHAPTER 4 STRUCTURES OF THE CARDIOVASCULAR, IMMUNOLOGICAL 
AND RESPIRATORY SYSTEMS 
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s420 Structure of immune system 13 
s6 CHAPTER 6 STRUCTURES RELATED TO THE GENITOURINARY AND 
REPRODUCTIVE SYSTEMS 
  
s630 Structure of reproductive system 3 
s7 CHAPTER 7 STRUCTURES RELATED TO MOVEMENT   
s720 Structure of shoulder region 15 
s730 Structure of upper extremity 15 
s750 Structure of lower extremity 2 
s760 Structure of trunk 9 
s8 CHAPTER 8 SKIN AND RELATED STRUCTURES   
s810 Structure of areas of skin 14 
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ID_ICF Title Clinical 
research 
Australia 
b BODY FUNCTIONS   
b1 CHAPTER 1  MENTAL FUNCTIONS   
b126 Temperament and personality functions 1 
b130 Energy and drive functions 1 
b2 CHAPTER 2  SENSORY FUNCTIONS AND PAIN   
b280 Sensation of pain 1 
b7 CHAPTER 7 NEUROMUSCULOSKELETAL AND MOVEMENT-RELATED 
FUNCTIONS 
  
b730 Muscle power functions 1 
d4 CHAPTER 4  MOBILITY     
d410 Changing basic body position 1 
d415 Maintaining a body position 1 
d430 Lifting and carrying objects    1 
d5 CHAPTER 5  SELF-CARE    
d510 Washing oneself 1 
d520 Caring for body parts 1 
d540 Dressing    1 
d6 CHAPTER 6  DOMESTIC LIFE    
d640 Doing housework    1 
d8 CHAPTER 8  MAJOR LIFE AREAS   
d845 Acquiring, keeping and terminating a job 1 
d850 Remunerative employment 1 
d9 CHAPTER 9  COMMUNITY, SOCIAL AND CIVIC LIFE   
d920 Recreation and leisure 1 
e ENVIRONMENTAL FACTORS   
e1 CHAPTER 1  PRODUCTS AND TECHNOLOGY   
e110 Products or substances for personal consumption 1 
e115 Products and technology for personal use in daily living  1 
e155 Design, construction and building products and technology of buildings for 
private use 
1 
e2 CHAPTER 2  NATURAL ENVIRONMENT AND HUMAN-MADE CHANGES TO 
ENVIRONMENT 
  
e225 Climate 1 
e3 CHAPTER 3  SUPPORT AND RELATIONSHIPS   
e310 Immediate family 1 
e315 Extended family 1 
 
  
Table 2.  Total amount of ICF categories mentioned by patients with midline lymphedema (n = 1). 
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e320 Friends 1 
e325 Acquaintances, peers, colleagues, neighbours and community members 1 
e330 People in positions of authority 1 
e355 Health professionals 1 
e4 CHAPTER 4  ATTITUDES   
e410 Individual attitudes of immediate family members 1 
e415 Individual attitudes of extended family members 1 
e420 Individual attitudes of friends 1 
e425 Individual attitudes of acquaintances, peers, colleagues, neighbours and 
community members 
1 
e460 Societal attitudes 1 
e5 CHAPTER 5  SERVICES, SYSTEMS AND POLICIES   
e555 Associations and organizational services, systems and policies 1 
e570 Social security services, systems and policies 1 
e580 Health services, systems and policies 1 
s4 CHAPTER 4 STRUCTURES OF THE CARDIOVASCULAR, IMMUNOLOGICAL 
AND RESPIRATORY SYSTEMS 
  
s420 Structure of immune system 1 
s7 CHAPTER 7 STRUCTURES RELATED TO MOVEMENT   
s720 Structure of shoulder region 1 
s760 Structure of trunk 1 
s8 CHAPTER 8 SKIN AND RELATED STRUCTURES   
s810 Structure of areas of skin 1 
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ID_ICF Title Clinical 
research 
Australia 
b BODY FUNCTIONS   
b1 CHAPTER 1  MENTAL FUNCTIONS   
b114 Orientation functions 1 
b126 Temperament and personality functions 13 
b130 Energy and drive functions 20 
b152 Emotional functions 13 
b160 Thought functions 1 
b164 Higher-level cognitive functions  3 
b180 Experience of self and time functions 4 
b2 CHAPTER 2  SENSORY FUNCTIONS AND PAIN   
b210 Seeing functions 0 
b265 Touch function 11 
b270 Sensory functions related to temperature and other stimuli 18 
b280 Sensation of pain 24 
b4 CHAPTER 4 FUNCTIONS OF THE CARDIOVASCULAR, HAEMATOLOGICAL, 
IMMUNOLOGICAL AND RESPIRATORY SYSTEMS 
  
b415 Blood vessel functions 5 
b435 Immunological system functions 22 
b455 Exercise tolerance functions 27 
b5 CHAPTER 5 FUNCTIONS OF THE DIGESTIVE, METABOLIC AND ENDOCRINE 
SYSTEMS 
  
b530 Weight maintenance functions 16 
b540 General metabolic functions 8 
b550 Thermoregulatory functions 17 
b6 CHAPTER 6  GENITOURINARY AND REPRODUCTIVE FUNCTIONS   
b640 Sexual functions 4 
b7 CHAPTER 7 NEUROMUSCULOSKELETAL AND MOVEMENT-RELATED 
FUNCTIONS 
  
b710 Mobility of joint functions 20 
b730 Muscle power functions 22 
b8 CHAPTER 8 FUNCTIONS OF THE SKIN AND RELATED STRUCTURES   
b810 Protective functions of the skin 26 
b820 Repair functions of the skin 20 
b830 Other functions of the skin 19 
d ACTIVITIES AND PARTICIPATION   
d2 CHAPTER 2  GENERAL TASKS AND DEMANDS   
 
  
Table 3. Total amount of ICF categories mentioned by patients with lower limb lymphedema (n = 47).
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d230 Carrying out daily routine 10 
d3 CHAPTER 3  COMMUNICATION     
d330 Speaking 1 
d4 CHAPTER 4  MOBILITY     
d410 Changing basic body position 26 
d415 Maintaining a body position 21 
d430 Lifting and carrying objects    8 
d445 Hand and arm use 1 
d450 Walking 26 
d460 Moving around in different locations 20 
d5 CHAPTER 5  SELF-CARE    
d510 Washing oneself 8 
d520 Caring for body parts 9 
d540 Dressing    13 
d570 Looking after one’s health 2 
d6 CHAPTER 6  DOMESTIC LIFE    
d640 Doing housework    15 
d660 Assisting others 10 
d7 CHAPTER 7  INTERPERSONAL INTERACTIONS AND RELATIONSHIPS   
d710 Basic interpersonal interactions 3 
d720 Complex interpersonal interactions 3 
d750 Informal social relationships 8 
d770 Intimate relationships 5 
d8 CHAPTER 8  MAJOR LIFE AREAS   
d845 Acquiring, keeping and terminating a job 10 
d850 Remunerative employment 7 
d870 Economic self-sufficiency 5 
d9 CHAPTER 9  COMMUNITY, SOCIAL AND CIVIC LIFE   
d910 Community life 12 
d920 Recreation and leisure 21 
d930 Religion and spirituality 3 
e ENVIRONMENTAL FACTORS   
e1 CHAPTER 1  PRODUCTS AND TECHNOLOGY   
e110 Products or substances for personal consumption 14 
e115 Products and technology for personal use in daily living  31 
e125 Products and technology for communication 11 
e130 Products and technology for education 18 
e135 Products and technology for employment 2 
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e140 Products and technology for culture, recreation and sport 8 
e150 Design, construction and building products and technology of buildings for 
public use 
22 
e155 Design, construction and building products and technology of buildings for 
private use 
12 
e165 Assets 6 
e2 CHAPTER 2  NATURAL ENVIRONMENT AND HUMAN-MADE CHANGES TO 
ENVIRONMENT 
  
e210 Physical geography 9 
e215 Population 1 
e225 Climate 32 
e3 CHAPTER 3  SUPPORT AND RELATIONSHIPS   
e310 Immediate family 34 
e315 Extended family 24 
e320 Friends 27 
e325 Acquaintances, peers, colleagues, neighbours and community members 22 
e330 People in positions of authority 19 
e355 Health professionals 37 
e4 CHAPTER 4  ATTITUDES   
e410 Individual attitudes of immediate family members 21 
e415 Individual attitudes of extended family members 16 
e420 Individual attitudes of friends 16 
e425 Individual attitudes of acquaintances, peers, colleagues, neighbours and 
community members 
13 
e460 Societal attitudes 15 
e465 Social norms, practices and ideologies 3 
e5 CHAPTER 5  SERVICES, SYSTEMS AND POLICIES   
e535 Communication services, systems and policies 9 
e555 Associations and organizational services, systems and policies 13 
e570 Social security services, systems and policies 17 
e580 Health services, systems and policies 31 
e585 Education and training services, systems and policies 10 
s BODY STRUCTURES   
s4 CHAPTER 4 STRUCTURES OF THE CARDIOVASCULAR, IMMUNOLOGICAL AND 
RESPIRATORY SYSTEMS 
  
s410 Structure of cardiovascular system 3 
s420 Structure of immune system 26 
s6 CHAPTER 6 STRUCTURES RELATED TO THE GENITOURINARY AND 
REPRODUCTIVE SYSTEMS 
  
s630 Structure of reproductive system 4 
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s630 Structure of reproductive system 4 
s7 CHAPTER 7 STRUCTURES RELATED TO MOVEMENT   
s740 Structure of pelvic region 3 
s750 Structure of lower extremity 34 
s760 Structure of trunk 1 
s8 CHAPTER 8 SKIN AND RELATED STRUCTURES   
s810 Structure of areas of skin 29 
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b1 CHAPTER 1  MENTAL FUNCTIONS 
b1263 Psychic stability  
b1264 Openness to experience  
b1265 Optimism 
b1266 Confidence 
b1301 Motivation  
b134 Sleep functions 
b152 Emotional functions 
b164 Higher-level cognitive functions  
b1644 Insight  
b1801 Body image 
b260 Proprioceptive function 
b265 Touch function 
b2702 Sensitivity to pressure  
b280 Sensation of pain 
b435 Immunological system functions 
b4352 Functions of lymphatic vessels  
b4550 General physical endurance  
b4552 Fatiguability  
b530 Weight maintenance functions 
b5403 Fat metabolism  
b640 Sexual functions 
b7 CHAPTER 7 NEUROMUSCULOSKELETAL AND MOVEMENT-RELATED FUNCTIONS 
b710 Mobility of joint functions 
b730 Muscle power functions 
b780 Sensations related to muscles and movement functions 
b810 Protective functions of the skin 
b820 Repair functions of the skin 
b840 Sensation related to the skin 
d155 Acquiring skills 
d170 Writing 
d230 Carrying out daily routine 
  
Table 1. Comprehensive ICF Core Set for lymphedema in upper extremity. 
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d2400 Handling responsibilities 
d3 CHAPTER 3  COMMUNICATION   
d360 Using communication devices and techniques 
d4 CHAPTER 4  MOBILITY   
d410 Changing basic body position 
d415 Maintaining a body position 
d430 Lifting and carrying objects    
d4401 Grasping  
d445 Hand and arm use 
d4452 Reaching 
d450 Walking 
d4554 Swimming  
d4702 Using public motorized transportation  
d475 Driving 
d5 CHAPTER 5  SELF-CARE  
d510 Washing oneself 
d5200 Caring for skin  
d5202 Caring for hair 
d530 Toileting  
d540 Dressing    
d5404 Choosing appropriate clothing  
d570 Looking after one’s health 
d5700 Ensuring one’s physical comfort  
d5701 Managing diet and fitness  
d5702 Maintaining one's health  
d6200 Shopping  
d630 Preparing meals 
d640 Doing housework    
d6400 Washing and drying clothes and garments 
d6505 Taking care of plants, indoors and outdoors  
d660 Assisting others 
d7 CHAPTER 7  INTERPERSONAL INTERACTIONS AND RELATIONSHIPS 
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d770 Intimate relationships 
d850 Remunerative employment 
d870 Economic self-sufficiency 
d920 Recreation and leisure 
d9201 Sports 
d9205 Socializing 
e1101 Drugs  
e1150 General products and technology for personal use in daily living 
e1151 Assistive products and technology for personal use in daily living 
e1300 General products and technology for education  
e150 Design, construction and building products and technology of buildings for public use 
e155 Design, construction and building products and technology of buildings for private use 
e225 Climate 
e2250 Temperature  
e3 CHAPTER 3  SUPPORT AND RELATIONSHIPS 
e310 Immediate family 
e320 Friends 
e325 Acquaintances, peers, colleagues, neighbours and community members 
e330 People in positions of authority 
e340 Personal care providers and personal assistants 
e355 Health professionals 
e420 Individual attitudes of friends 
e425 Individual attitudes of acquaintances, peers, colleagues, neighbours and community members 
e450 Individual attitudes of health professionals 
e460 Societal attitudes 
e5550 Associations and organizational services 
e570 Social security services, systems and policies 
e5801 Health systems 
e5850 Education and training services 
s420 Structure of immune system 
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s4200 Lymphatic vessels  
s4201 Lymphatic nodes  
s7 CHAPTER 7 STRUCTURES RELATED TO MOVEMENT 
s710 Structure of head and neck region 
s720 Structure of shoulder region 
s730 Structure of upper extremity 
s7300 Structure of upper arm  
s7302 Structure of hand  
s760 Structure of trunk 
s810 Structure of areas of skin 
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b126 Temperament and personality functions 
b130 Energy and drive functions 
b134 Sleep functions 
b152 Emotional functions 
b164 Higher-level cognitive functions  
b1644 Insight  
b180 Experience of self and time functions 
b1801 Body image 
b265 Touch function 
b280 Sensation of pain 
b435 Immunological system functions 
b4350 Immune response  
b4352 Functions of lymphatic vessels  
b440 Respiration functions 
b455 Exercise tolerance functions 
b4552 Fatiguability  
b5104 Salivation  
b5105 Swallowing  
b530 Weight maintenance functions 
b540 General metabolic functions 
b620 Urination functions 
b640 Sexual functions 
b710 Mobility of joint functions 
b730 Muscle power functions 
b770 Gait pattern functions 
b780 Sensations related to muscles and movement functions 
 
  
Table 2. Comprehensive ICF Core Set for lymphedema in midline. 
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b810 Protective functions of the skin 
b820 Repair functions of the skin 
b840 Sensation related to the skin 
d155 Acquiring skills 
d230 Carrying out daily routine 
d240 Handling stress and other psychological demands 
d330 Speaking 
d350 Conversation 
d410 Changing basic body position 
d4100 Lying down  
d4153 Maintaining a sitting position  
d4154 Maintaining a standing position  
d430 Lifting and carrying objects    
d450 Walking 
d455 Moving around    
d470 Using transportation  
d475 Driving 
d510 Washing oneself 
d520 Caring for body parts 
d530 Toileting  
d540 Dressing    
d550 Eating 
d560 Drinking 
d570 Looking after one’s health 
d620 Acquisition of goods and services  
d640 Doing housework    
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d750 Informal social relationships 
d770 Intimate relationships 
d850 Remunerative employment 
d870 Economic self-sufficiency 
d920 Recreation and leisure 
d9201 Sports 
d9205 Socializing 
e1101 Drugs  
e1150 General products and technology for personal use in daily living 
e1151 Assistive products and technology for personal use in daily living 
e155 Design, construction and building products and technology of buildings for private use 
e225 Climate 
e2250 Temperature  
e310 Immediate family 
e320 Friends 
e325 Acquaintances, peers, colleagues, neighbours and community members 
e330 People in positions of authority 
e340 Personal care providers and personal assistants 
e355 Health professionals 
e410 Individual attitudes of immediate family members 
e420 Individual attitudes of friends 
e425 Individual attitudes of acquaintances, peers, colleagues, neighbours and community members 
e450 Individual attitudes of health professionals 
e460 Societal attitudes 
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e465 Social norms, practices and ideologies 
e555 Associations and organizational services, systems and policies 
e580 Health services, systems and policies 
e5850 Education and training services 
s330 Structure of pharynx 
s340 Structure of larynx 
s420 Structure of immune system 
s630 Structure of reproductive system 
s710 Structure of head and neck region 
s720 Structure of shoulder region 
s740 Structure of pelvic region 
s760 Structure of trunk 
s810 Structure of areas of skin 
 
 
- 276 -
b1261 Agreeableness  
b1263 Psychic stability  
b1266 Confidence 
b1301 Motivation  
b134 Sleep functions 
b152 Emotional functions 
b1644 Insight  
b1646 Problem-solving 
b1670 Reception of written language  
b1801 Body image 
b260 Proprioceptive function 
b2702 Sensitivity to pressure  
b280 Sensation of pain 
b415 Blood vessel functions 
b4150 Functions of arteries  
b435 Immunological system functions 
b4350 Immune response  
b4352 Functions of lymphatic vessels  
b4353 Functions of lymph nodes  
b455 Exercise tolerance functions 
b4552 Fatiguability  
b530 Weight maintenance functions 
b540 General metabolic functions 
b550 Thermoregulatory functions 
b640 Sexual functions 
b7101 Mobility of several joints  
b7303 Power of muscles in lower half of the body  
b770 Gait pattern functions 
b780 Sensations related to muscles and movement functions 
b810 Protective functions of the skin 
b820 Repair functions of the skin 
b840 Sensation related to the skin 
 
  
Table 3. Comprehensive ICF Core Set for lymphedema in lower extremity. 
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d155 Acquiring skills 
d230 Carrying out daily routine 
d410 Changing basic body position 
d4100 Lying down  
d4101 Squatting 
d4102 Kneeling 
d4103 Sitting  
d4104 Standing 
d4105 Bending 
d4153 Maintaining a sitting position  
d4154 Maintaining a standing position  
d430 Lifting and carrying objects    
d450 Walking 
d4500 Walking short distances  
d4501 Walking long distances  
d4551 Climbing 
d4552 Running  
d4600 Moving around within the home 
d4602 Moving around outside the home and other buildings 
d4702 Using public motorized transportation  
d4750 Driving human-powered transportation  
d4751 Driving motorized vehicles 
d510 Washing oneself 
d520 Caring for body parts 
d5200 Caring for skin  
d530 Toileting  
d540 Dressing    
d5402 Putting on footwear 
d570 Looking after one’s health 
d5701 Managing diet and fitness  
d5702 Maintaining one's health  
d6200 Shopping  
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d630 Preparing meals 
d640 Doing housework    
d660 Assisting others 
d770 Intimate relationships 
d845 Acquiring, keeping and terminating a job 
d850 Remunerative employment 
d920 Recreation and leisure 
d9205 Socializing 
e1101 Drugs  
e1150 General products and technology for personal use in daily living 
e1151 Assistive products and technology for personal use in daily living 
e1201 Assistive products and technology for personal indoor and  outdoor mobility and transportation  
e135 Products and technology for employment 
e150 Design, construction and building products and technology of  buildings for public use 
e155 Design, construction and building products and technology of  buildings for private use 
e1650 Financial assets 
e210 Physical geography 
e225 Climate 
e310 Immediate family 
e320 Friends 
e325 Acquaintances, peers, colleagues, neighbours and community  members 
e330 People in positions of authority 
e340 Personal care providers and personal assistants 
e355 Health professionals 
e410 Individual attitudes of immediate family members 
e420 Individual attitudes of friends 
e425 Individual attitudes of acquaintances, peers, colleagues,  neighbours and community members 
e460 Societal attitudes 
e5550 Associations and organizational services 
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e5600 Media services 
e580 Health services, systems and policies 
e5800 Health services 
e5850 Education and training services 
s420 Structure of immune system 
s4200 Lymphatic vessels  
s4201 Lymphatic nodes  
s630 Structure of reproductive system 
s6303 Structure of vagina and external genitalia  
s740 Structure of pelvic region 
s750 Structure of lower extremity 
s7500 Structure of thigh  
s7501 Structure of lower leg  
s75011 Knee joint  
s7502 Structure of ankle and foot 
s760 Structure of trunk 
s7701 Joints 
s810 Structure of areas of skin 
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b1263 Psychic stability  
b164 Higher-level cognitive functions  
b1801 Body image 
b280 Sensation of pain 
b4550 General physical endurance  
b4552 Fatiguability  
b710 Mobility of joint functions 
b730 Muscle power functions 
d230 Carrying out daily routine 
d445 Hand and arm use 
d5 CHAPTER 5  SELF-CARE  
d570 Looking after one’s health 
d5701 Managing diet and fitness  
d640 Doing housework    
d770 Intimate relationships 
d850 Remunerative employment 
d920 Recreation and leisure 
e1151 Assistive products and technology for personal use in daily living 
e310 Immediate family 
e320 Friends 
e355 Health professionals 
s420 Structure of immune system 
s730 Structure of upper extremity 
 
Table 4.  ICF Core Set for lymphedema in upper extremit  Brief y. 
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b1801 Body image 
b280 Sensation of pain 
b435 Immunological system functions 
b455 Exercise tolerance functions 
b640 Sexual functions 
d155 Acquiring skills 
d230 Carrying out daily routine 
d240 Handling stress and other psychological demands 
d455 Moving around    
d520 Caring for body parts 
d570 Looking after one’s health 
d850 Remunerative employment 
d920 Recreation and leisure 
e1151 Assistive products and technology for personal use in daily living 
e310 Immediate family 
e320 Friends 
e355 Health professionals 
s710 Structure of head and neck region 
s740 Structure of pelvic region 
s760 Structure of trunk 
 
Table . Brief ICF Core Set for lymphedema in midline  5 .
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b1301 Motivation  
b152 Emotional functions 
b1801 Body image 
b280 Sensation of pain 
b435 Immunological system functions 
b455 Exercise tolerance functions 
b7101 Mobility of several joints  
b7303 Power of muscles in lower half of the body  
d230 Carrying out daily routine 
d450 Walking 
d570 Looking after one’s health 
d845 Acquiring, keeping and terminating a job 
e1151 Assistive products and technology for personal use in daily living 
e310 Immediate family 
e355 Health professionals 
e580 Health services, systems and policies 
e5850 Education and training services 
s750 Structure of lower extremity 
 
Table . Brief ICF Core Set for lymphedema in lower extremity.
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Curriculum vitae 
 
In 1958 werd Peter Viehoff in Utrecht geboren op 29 november. Hij behaalde zijn 
Atheneum in 1977 en in datzelfde jaar begon hij met de opleiding Fysiotherapie 
aan de toenmalige Stichting Utrechtse Paramedische Academie (SUPA). Na het 
behalen van zijn diploma in 1981 moest hij in militaire dienst. Hij vervulde deze als 
sergeant-fysiotherapeut in het Militair Hospitaal te Utrecht. De verplichte 
dienstplicht werd omgezet in een Kort Verband Vrijwilliger (KVV) contract. 
Vervolgens bleef hij tot 1987 in het Militair Hospitaal en behaalde hij in die tijd de 
diploma’s Sportfysiotherapie en Oedeemtherapie. In 1985 trouwde hij met Irma 
Versteeg en ging hij in Nieuwegein wonen, waar hij nog steeds woont. Door de 
verslechterde arbeidsmarkt in Nederland week hij in 1988 uit naar Duitsland. Daar 
heeft hij 1 jaar gewerkt als “krankengymnast” in de Praxis Hanus in Düsseldorf. In 
1989 werd dochter Roxanne geboren en was het beter om dichter bij huis te gaan 
werken. Daarom ging hij vanaf 1990 werken in de Groepspraktijk voor fysio- en 
manuele therapie ’t Gilde in Gorinchem. Tot op heden werkt hij daar nog als 1 van 
de praktijkhouders. In de tussentijd werd in 1991 zoon Mitchell geboren en 
behaalde hij ook het diploma Manuele Therapie in 1998. Zijn interesse voor 
wetenschappelijk onderzoek werd gewekt door het volgen van de cursus Scholing 
in Wetenschap van het Nederlands Paramedisch Instituut. Toen dan ook de 
mogelijkheid bestond voor het volgen van de universitaire opleiding 
Fysiotherapiewetenschap in Utrecht was de stap om die opleiding te gaan volgen 
niet moeilijk. In 2006 behaalde hij de drs titel met onderzoek naar het vertalen en 
valideren van een Franse vragenlijst op het gebied van lymfoedeem. Dit smaakte 
naar meer en vanaf 2008 had hij de eer om in het Erasmus Medisch Centrum 
Rotterdam promotieonderzoek te gaan doen op het gebied van lymfoedeem. Dit 
deed hij naast zijn werk als fysiotherapeut en in de weekenden. Naast zijn werk 
heeft hij ook verschillende nevenfuncties bekleed. Zo was hij lid van de 
wetenschappelijke commissie van de Nederlandse Vereniging voor 
fysiotherapeuten in de Lymfologie (NVFL)(2004-2011) en bestuurslid van de 
studentenvereniging Scientia Fundus (2002-2009). Op dit moment is hij als docent 
verbonden aan de opleidingen “Fysiotherapie Master Lymfologie en Oncologie” 
van instituut De Berekuyl en “Master oncologiefysiotherapie” van Avans+. 
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Curriculum vitae 
 
Peter Viehoff was born in 1958 in Utrecht on the 29th of November. He received 
his secondary school diploma in 1977 and in that same year he began education in 
Physiotherapy at the Foundation Utrecht Paramedical College (SUPA). After 
graduating in 1981 he was in military service. He passed this as a sergeant 
physiotherapist at the Military Hospital in Utrecht. The mandatory conscription 
was converted into a Short Volunteer Relationship (KVV) contract. He remained in 
the Military Hospital until 1987 and during that time he earned the diplomas 
Sport Physiotherapy and Edema Therapy. In 1985 he married Irma Versteeg and 
he went to live in Nieuwegein, where he still lives. Due to the deteriorating labor 
market in the Netherlands he went to Germany in 1988. There he worked one 
year as "Krankengymnast" in Praxis Hanus in Düsseldorf. Daughter Roxanne was 
born in 1989 and it was better to work closer to home. Therefore, from 1990, he 
went to work in the Group Practice for Physiotherapy and Manual therapy 't Gilde 
in Gorinchem. To date, he's still working there as one of the practice holders. In 
the meantime, in 1991, son Mitchell was born and he also graduated Manual 
Therapy in 1998. His interest in research was woken by following the course 
Education in Science at the Dutch Institute of Allied Health Care. And then there 
was the possibility to follow university education in Physiotherapy Science in 
Utrecht. The step to follow that course was not difficult. In 2006 he achieved his 
Master of Science degree with research on the translation and validation of a 
French questionnaire in the field of lymphedema. This tasted for more and he had 
the honour to do PhD research in the field of lymphedema at the Erasmus Medical 
Center, Rotterdam from 2008. He did this in addition to his work as a 
physiotherapist and at weekends. Besides his work he also held several other 
positions. He was a member of the scientific committee of the Dutch Association 
for Physiotherapists in Lymphology (NVFL) (2004-2011) and member of the 
student association Scientia Fundus at Utrecht University (2002-2009). Currently 
he is a teacher related to the study " Master Lymphology and Oncology 
Physiotherapy " of the Berekuyl institute and "Master oncology physiotherapy" at 
Avans +. 
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List of publications 
 
Viehoff PB. PNF-patronen in de sport. Ned Tijdschrift v Fysiotherapie. 
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Dankwoord 
 
Een doctorandus is letterlijk “iemand die doctor aan het worden is”. Een 
metamorfose, die niet elke doctorandus daadwerkelijk ondergaat. Toen ik in 2006 
de drs titel behaalde was mijn idee hierover echter duidelijk: Ik wilde graag verder 
in het onderzoek doen, maar ik wist alleen niet hoe. Na 2 jaar kwamen in 2008 de 
ICF Core Sets op mijn pad na een bezoek aan een Internationaal Manueel 
Therapie congres. En opeens ontstond het idee om deze, via een PhD traject, te 
gaan ontwikkelen voor lymfoedeem.  
 
Een uitspraak luidt: “Een traject zonder obstakels leidt doorgaans nergens toe”, 
maar obstakels op je pad zijn er om te ontdekken of je ergens werkelijk voor wil 
gaan. Nou, gedurende de jaren die ik aan het project heb besteed, zijn de 
obstakels er veelvuldig geweest en weet ik ook waar de afkorting dr. voor staat. 
Wanneer deze afkorting voor iemands naam staat, kun je er zeker van zijn dat het 
een doorzetter is. Want dat is wel een van de competenties die je moet hebben, 
ofwel verkrijgen. Weliswaar is het de bedoeling dat je laat zien dat je zelfstandig 
onderzoek kunt doen, maar je staat er niet alleen voor. Ik prijs mij gelukkig dat ik 
van vele mensen ondersteuning heb gekregen. Een aantal wil ik hierbij graag in 
het bijzonder bedanken. 
 
Allereerst mijn promotor Prof. Dr. Neumann, beste Martino, bedankt voor je 
vertrouwen in mij. Ik ben blij dat je het in/met mij zag zitten na mijn 
“sollicitatiegesprek”. Ook bedankt voor de vrijheid die je me gaf tijdens het 
promotietraject, wellicht omdat ik een buitenpromovendus ben? Door je ervaring 
met promovendi en helikopterview gaven de stimulerende voortgangsgesprekken 
met jou mij altijd weer een aanzet om vol goede moed verder te gaan. 
 
Mijn beide co-promotoren, dr. Dorine van Ravensberg en dr. Yvonne Heerkens. Ik 
heb heel veel aan jullie te danken. Jullie specialistische kennis van de ICF was een 
enorme basis waar ik veel gebruik van heb kunnen maken. Ook bedankt voor het 
uit de put praten als ik het eens niet meer zag zitten en vooral ook de snelheid van 
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ons mailverkeer. Dank dat jullie tijd voor mij wilden vrij maken en voor de vele 
rode, gele en groene correcties. Gelukkig werden die gaandeweg wat minder…. 
 
Voor het ontwikkelen van ICF Core Sets is het gebruikelijk dat deze wordt 
ondersteund door een stuurgroep. Naast de boven genoemde personen bestond 
deze uit: 
Dr. Robert Damstra, beste Robert, bedankt dat je zo achter de ICF en het project 
staat. Je hebt me geholpen op diverse manieren. Uiteraard met je kijk op de 
lymfoedeempatiënt, de mogelijkheid om in Nij Smellinghe het cross-sectionele 
onderzoek te gaan doen en je medewerking aan andere onderzoeken. 
Janine Hidding MSc, jij was ook in veel gedaantes voor mij van belang. Allereerst 
steun en toeverlaat bij het literatuuronderzoek. Daar zat heel wat werk in. 
Daarnaast het feit dat je paranimf wilt zijn en gewoon als collega-promovendus 
om eens lekker tegen aan te mopperen hoe slecht het wel niet gaat met dat 
promoveren. 
Drs Huib ten Napel, bedankt dat je als vertegenwoordiger van de WHO-FIC plaats 
wilde nemen in de stuurgroep en tijd wilde vrij maken voor dit project. 
Alle stuurgroep leden bedankt dat jullie naar Glasgow wilden komen voor de 
consensus conferentie om daar een positieve bijdrage te leveren in welke functie 
dan ook. 
 
Prof. Dr. H.J. Stam, Prof. Dr. T.E.C. Nijsten en Dr. K.P. de Roos, dank voor uw 
bereidheid om plaats te nemen in de kleine commissie en voor het beoordelen 
van mijn proefschrift. Daarnaast wil ik de overige leden van de 
promotiecommissie Prof dr A.J.H.M.  Beurskens, Prof dr B.W. Koes, Prof dr N.L.U. 
van Meeteren, Dr M.G.R. de Maeseneer en Dr R.J. Damstra hartelijk danken voor 
de bereidheid om plaats te nemen in de grote commissie. 
 
Onderzoek is een proces van steegjes in gaan om te zien of ze doodlopen. Tijdens 
dit proces werd ik ook geholpen door een aantal reddende engelen. Zij 
voorkwamen dat  het aantal “doodlopers” beperkt bleef. Allereerst mijn co-
auteurs bij de diverse onderzoeken. Petra, bedankt dat je tijd hebt vrij kunnen 
maken voor het kwalitatieve onderzoek. Froukje, je kwam inderdaad als een 
geschenk uit de hemel, omdat mede door jouw inzet het cross-sectionele 
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onderzoek in Drachten daadwerkelijk plaats heeft kunnen vinden. Lianne, we 
hebben samen heel wat geskyped om uiteindelijk het expert onderzoek tot een 
goed resultaat te brengen. Malou, ook heel veel dank voor je inzet in Australië. 
Het onderzoek daar loopt nog steeds door en ik ben er van overtuigd dat we er 
volgend jaar een mooi eind aan kunnen maken. Lonneke, ook jij bedankt voor de 
statistische ondersteuning bij het cross-sectionele onderzoek. 
 
Ook een woord van dank voor de collega’s die op de een of andere manier 
gezorgd hebben dat het kwalitatieve onderzoek plaats heeft kunnen vinden: 
Gaike, Karin, Sylvia, Lilian, Wouter, Lilly-Ann en Wilma. Verder alle hulpverleners 
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onderzoek. Alle experts die mee hebben gedaan met het expert onderzoek en de 
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Ook de experts bij uitstek, alle patiënten, die mee hebben geholpen aan de 
patiënt-gerelateerde onderzoeken.  
 
Tevens wil ik Barbera van Tienhoven bedanken voor alle administratieve 
ondersteuning. 
 
Dirk-Jan bedankt dat je ook als paranimf aan mijn zijde hebt willen staan (of 
zitten). Nooit gedacht dat ik met jou nog eens in een zweetkamertje zou komen te 
zitten. 
 
Gemma (en Peter een beetje) bedankt voor de correcties voor het Nederlandse 
gedeelte van het proefschrift. 
 
Mijn directe collega’s Annet, Ynta, Ruud, Lotte, Martine en Nelle wil ik bedanken 
voor het feit dat jullie mij mijn gang maar hebben laten gaan. Excuses voor het feit 
dat ik regelmatig met mijn hoofd ergens anders was. 
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out voor dit proefschrift. Fijn dat jullie dit over hadden voor die “nerd”  van een 
vader. 
 
De Valpolicella Ripasso wil ook bedanken voor de ondersteuning. Jou kon je altijd 
gebruiken. Als dingen weer eens niet liepen zoals het moest, maar ook om de 
hoogtepunten van het project te vieren. 
 
Lieve pap en mam, mijn grootste fans als je dat zo kunt noemen. Hoewel het 
allemaal voor jullie een beetje moeilijk te volgen was zijn jullie altijd 
geïnteresseerd geweest in de voortgang van mijn project. Het is jammer dat pa de 
afsluiting niet meer heeft kunnen meemaken, maar ik ben er van overtuigd dat hij 
het ergens nog steeds met belangstelling volgt. En ma, al dat duimen heeft echt 
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die basis had ik het niet kunnen redden, bedankt voor al je liefde. Love you. Call it 
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PhD Portfolio 
 
Summary of PhD training and teaching activities 
Name PhD student     : Petrus Bernardus Viehoff 
PhD period      : 2010- 2015 
Erasmus MC Department    : Dermatology 
Promotor      : Prof.dr. H.A.M. Neumann 
Supervisor      : Dr. Y.F. Heerkens 
Supervisor      : Dr. C.D. van Ravensberg 
 
  
 Year Workload 
(Hours/ ECTS) 
PhD training   
General skills   
- NPI Course: Physical therapy for peripheral 
arterial suffering. 
2009 24 hours 
- NPI Masterclass: Bringing lymphology into 
holistic lymphedema management. 
2010 8 hours 
- Course medical library Erasmus Medical 
Centre: Endnote X3/X4. 
2011 4 hours 
Presentations   
- ISL conference, Sydney. ‘ULL27: Dutch 
Translation and Validation of an Illness-
Specific Health-related Quality of Life 
questionnaire for Patients with Upper 
Limb lymphedema’ and ‘The development 
of ICF Core Sets for lymphedema’. 
2009 1 ECTS 
- ILF conference, Toronto. Workshop: ‘The 
use of ICF Core Sets for lymphedema in 
daily practice’. 
2011 1 ECTS 
- ISL conference, Malmo. ‘Using ICF Core 
Sets for lymphedema in daily practice’ and 
‘The development of ICF Core Sets for 
lymphedema: Literature review’. 
2011 1 ECTS 
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- NVFL conference, Rotterdam. ‘De 
ontwikkeling van ICF Core Sets voor 
lymfoedeem’. 
2012 1 ECTS 
- ILF conference, Montpellier. ‘The 
development of ICF Core Sets for 
lymphedema: Qualitative research’. 
2012 1 ECTS 
- ISL conference, Rome. ‘The development of 
ICF Core Sets for lymphedema: Expert 
research’ and ‘The development of ICF 
Core Sets for lymphedema: Qualitative 
research’. 
2013 1 ECTS 
- ILF conference, Glasgow. ‘The 
development of ICF Core Sets for 
lymphedema’. 
2014 1 ECTS 
- BSL conference, Birmingham. ‘Developing 
ICF Core Sets for lymphedema and what 
can you do with it’ and ‘ICF Core Sets for 
lymphedema: The quest for  qualitative 
results’. 
2014 1 ECTS 
International conferences   
- International Society of Lymphology, 
Sydney, Australia. 
2009 1 ECTS 
- World Confederation for Physical Therapy, 
Amsterdam, The Netherlands. 
2011 1 ECTS 
- International Lymphedema Framework, 
Toronto, Canada. 
2011 1 ECTS 
- International Society of Lymphology, 
Malmo, Sweden. 
2011 1 ECTS 
- International Lymphedema Framework, 
Montpellier, France. 
2012 1 ECTS 
- International Society of Lymphology, 
Rome, Italy. 
2013 1 ECTS 
- International Lymphedema Framework, 
Glasgow, England. 
2014 1 ECTS 
- British Society of Lymphoedema, 
Birmingham, England. 
2014 1 ECTS 
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National conferences   
- Nascholing oedeemtherapeuten en 
fysiotherapeuten ‘Flebologie en 
lymfologie’, Utrecht, The Netherlands. 
2010 1 ECTS 
- Conference Lymphedema and 
Gynaecologic cancer, Utrecht, The 
Netherlands. 
2011 1 ECTS 
- Conference on lymphedema, Rotterdam, 
The Netherlands. 
2012 1 ECTS 
Other   
- Organization and presentation 
International Consensus Conference on the 
development of ICF Core Sets for 
lymphedema, Glasgow, England 
2014 0 
- Poster ‘The development of ICF Core Sets 
for lymphedema’. WHO-FIC congress, 
Barcelona, Spain. 
2014 1 ECTS 
Teaching activities   
- Oncological physical therapy ‘Thesis 
coach’, Avans+, Breda, The Netherlands. 
2006 80 hours 
- Oncological physical therapy ‘Masterclass 
Clinical Reasoning’, Avans+, Breda, The 
Netherlands. 
2012 32 hours 
- Physical therapy Master Lymphology and 
Oncology ‘ICF’, de Berekuyl, Hierden, The 
Netherlands. 
2013 40 hours 
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The cover photograph was taken in 2008 in National Park
Krka in Croatia. This photo was chosen, because the
waterfalls symbolize the opportunities the ICF Core Sets
offer, to eventually improve the discharge of lymphedema
in lymphedema patients.
